4-azaindole compounds
4-azaindole compounds are developed to inhibit TLR7, TLR8, and TLR9 signaling, addressing the inadequacies of current treatments by modulating cytokine production and B cell activity, thus providing therapeutic benefits for autoimmune, inflammatory, and allergic diseases.
Patent Information
- Application Number
- CA3085817
- Authority / Receiving Office
- CA · CA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-12-18
- Filing Date
- 2018-12-17
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2038-12-17
AI Technical Summary
Current treatments for autoimmune, inflammatory, and allergic diseases are inadequate in modulating Toll-like receptor (TLR) signaling, leading to uncontrolled inflammatory responses and disease exacerbation.
Development of 4-azaindole compounds that act as selective inhibitors of TLR7, TLR8, and TLR9, providing therapeutic benefits through pharmaceutical compositions with improved stability, bioavailability, and toxicity profiles.
The 4-azaindole compounds effectively inhibit TLR signaling, offering potential therapeutic benefits for autoimmune, inflammatory, and allergic diseases by modulating cytokine production and B cell activity, thereby reducing disease severity.
Abstract
Description
4-AZAINDOLE COMPOUNDS CROSS REFERENCE This application claims the benefit of U.S. Provisional Application Serial No. 62 / 599,875, filed December 18, 2017. DESCRIPTION The present invention generally relates to 4-azaindole compounds useful as inhibitors of signaling through Toll-like receptor 7, 8, or 9 (TLR7, TLR8, TLR9) or combinations thereof. Provided herein are 4-azaindole compounds, compositions comprising such compounds, and methods of their use. The invention further pertains to pharmaceutical compositions containing at least one compound according to the invention that are useful for the treatment of conditions related to TLR modulation, such as inflammatory and autoimmune diseases, and methods of inhibiting the activity of TLRs in a mammal. Toll / IL-1 receptor family members are important regulators of inflammation and host resistance. The Toll-like receptor family recognizes molecular patterns derived from infectious organisms including bacteria, fungi, parasites, and viruses (reviewed in Kawai, T. et al., Nature Immunol., 11:373-384 (2010)). Ligand binding to the receptor induces dimerization and recruitment of adaptor molecules to a conserved cytoplasmic motif in the receptor termed the Toll / IL-1 receptor (TIR) domain with the exception of TLR3, all TLRs recruit the adaptor molecule MyD88. The IL-1 receptor family also contains a cytoplasmic TIR motif and recruits MyD88 upon ligand binding (reviewed in Sims, J.E. et al., Nature Rev. Immunol., 10:89-102 (2010)). Toll-like receptors (TLRs) are a family of evolutionarily conserved, transmembrane innate immune receptors that participate in the first-line defense. As pattern recognition receptors, the TLRs protect against foreign molecules, activated by pathogen associated molecular patterns (PAMPs), or from damaged tissue, activated by danger associated molecular patterns (DAMPs). A total of 13 TLR family members have been identified, 10 in human, that span either the cell surface or the endosomal compartment. TLR7-9 are among the set that are endosomally located and respond to single-stranded RNA (TLR7 and TLR8) or unmethylated single-stranded DNA containing cytosine-phosphate-guanine (CpG) motifs (TLR9). Activation of TLR7 / 8 / 9 can initiate a variety of inflammatory responses (cytokine production, B cell activation and IgG production, Type I interferon response). In the case of autoimmune disorders, the aberrant sustained activation of TLR7 / 8 / 9 leads to worsening of disease states. Whereas overexpression of TLR7 in mice has been shown to exacerbate autoimmune disease, knockout of TLR7 in mice was found to be protective against disease in lupus-prone MRL / lpr mice. Dual knockout of TLR7 and 9 showed further enhanced protection. As numerous conditions may benefit by treatment involving modulation of cytokines, IFN production and B cell activity, it is immediately apparent that new compounds capable of modulating TLR7 and / or TLR8 and / or TLR9 and methods of using these compounds could provide substantial therapeutic benefits to a wide variety of patients. The present invention relates to a new class of 4-azaindole compounds found to be effective inhibitors of signaling through TLR7 / 8 / 9. These compounds are provided to be useful as pharmaceuticals with desirable stability, bioavailability, therapeutic index, and toxicity values that are important to their drugability. SUMMARY OF THE INVENTION The present invention provides compounds of Formula (I) that are useful as inhibitors of signaling through Toll-like receptor 7, 8, or 9 and are useful for the treatment of proliferative diseases, allergic diseases, autoimmune diseases and inflammatory diseases, or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof. The present invention also provides pharmaceutical compositions comprising a pharmaceutically acceptable carrier and at least one of the compounds of the present invention or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof. The present invention also provides a method for inhibition of Toll-like receptor 7, 8, or 9 comprising administering to a host in need of such treatment a therapeutically effective amount of at least one of the compounds of the present invention or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof. The present invention also provides a method for treating proliferative, metabolic, allergic, autoimmune and inflammatory diseases, comprising administering to a host in need of such treatment a therapeutically effective amount of at least one of the compounds of the present invention or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof. The present invention also provides a method of treating a disease or disorder associated with Toll-like receptor 7, 8, or 9 activity, the method comprising administering to a mammal in need thereof, at least one of the compounds of Formula (I) or salts, solvates, and prodrugs thereof. The present invention also provides processes and intermediates for making the compounds of Formula (I) including salts, solvates, and prodrugs thereof. The present invention also provides at least one of the compounds of Formula (I) or salts, solvates, and prodrugs thereof, for use in therapy. The present invention also provides the use of at least one of the compounds of Formula (I) or salts, solvates, and prodrugs thereof, for the manufacture of a medicament for the treatment of prophylaxis of Toll-like receptor 7, 8, or 9 related conditions, such as allergic disease, autoimmune diseases, inflammatory diseases, and proliferative diseases. The compound of Formula (I) and compositions comprising the compounds of Formula (I) may be used in treating, preventing, or curing various Toll-like receptor 7, 8, or 9 related conditions. Pharmaceutical compositions comprising these compounds are useful for treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as allergic disease, autoimmune diseases, inflammatory diseases, and proliferative diseases. These and other features of the invention will be set forth in expanded form as the disclosure continues. DETAILED DESCRIPTION The first aspect of the present invention provides at least one compound of Formula (I): <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> Α. N. G H <com:Math><semantics>(R5)n<annotation encoding="application / x-tex">(R_5)_n< / annotation>< / semantics>< / com:Math> (I) N-oxide, or a salt thereof, wherein: [Image disponible dans le document PDF, Image available in the PDF document] Cio. [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] ) 5 1 [Image disponible dans le document PDF, Image available in the PDF document] ~ 5 [Image disponible dans le document PDF, Image available in the PDF document] 5 A is. (i) <com:Math><semantics>−O−L1−R6<annotation encoding="application / x-tex">-O-L_1-R_6< / annotation>< / semantics>< / com:Math>; (ii) -NR7R8;<com:Br / >(iii) -L2-C(O)NR9R10; [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] (v) <com:Math><semantics>−CRxR12R13<annotation encoding="application / x-tex">-CR_xR_{12}R_{13}< / annotation>< / semantics>< / com:Math>, wherein <com:Math><semantics>R12<annotation encoding="application / x-tex">R_{12}< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>R13<annotation encoding="application / x-tex">R_{13}< / annotation>< / semantics>< / com:Math> together with the carbon atom to which they are attached form a cyclic group selected from azabicyclo[4.1.1]octanyl, azepanyl, azetidinyl, C<com:Sub>3-7< / com:Sub> cycloalkyl, diazepanyl, azaspiro[3.3]heptanyl, diazaspiro[4.5]decanonyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, piperazinyl, piperidinyl, pyrrolidinyl, and quinuclidinyl, each substituted with zero to 4 R<com:Sub>12a< / com:Sub>; (vi) <com:Math><semantics>−CRx=CRx<annotation encoding="application / x-tex">-CR_x=CR_x< / annotation>< / semantics>< / com:Math>(piperidinyl); or (vii) an aromatic group selected from [1,2,4]triazolo[1,5-a]pyridinyl, imidazo[1,2-a]pyridinyl, imidazolyl, indazolyl, isoquinolinyl, oxadiazolyl, oxazolyl, phenyl, pyrazinyl, pyrazolo[3,4-b]pyridinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, quinolinonyl, quinolinyl, quinoxalinyl, tetrahydro- [1,2,4]triazolo[1,5-a]pyrazinyl, tetrahydroimidazo[1,2-a]pyrazinyl, tetrahydroisoquinolinyl, tetrahydrothiazolo[5,4-c]pyridinyl, tetrahydrothieno[2,3-c]pyridinyl, thiadiazolyl, thiazolyl, thiooxadiazolyl, and triazolyl, each substituted with zero to 2 R<com:Sub>14a< / com:Sub> and zero to 3 R<com:Sub>14b< / com:Sub>; [Image disponible dans le document PDF, Image available in the PDF document] R<com:Sub>1< / com:Sub> is H, Cl, -CN, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-3< / com:Sub> fluoroalkyl, C<com:Sub>1-3< / com:Sub> hydroxyalkyl, C<com:Sub>1-3< / com:Sub> hydroxy- fluoroalkyl, -CR<com:Sub>v< / com:Sub>=CH<com:Sub>2< / com:Sub>, C<com:Sub>3-6< / com:Sub> cycloalkyl, -CH<com:Sub>2< / com:Sub>(C<com:Sub>3-6< / com:Sub> cycloalkyl), -C(O)O(C<com:Sub>1-3< / com:Sub> alkyl), or tetrahydropyranyl; each R<com:Sub>2< / com:Sub> is independently halo, -CN, -OH, -NO<com:Sub>2< / com:Sub>, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> fluoroalkyl, C<com:Sub>1-2< / com:Sub> cyanoalkyl, C<com:Sub>1-3< / com:Sub> hydroxyalkyl, C<com:Sub>1-3< / com:Sub> aminoalkyl, -O(CH<com:Sub>2< / com:Sub>)<com:Sub>1-2< / com:Sub>OH, -(CH<com:Sub>2< / com:Sub>)<com:Sub>0-4< / com:Sub>O(C<com:Sub>1-4< / com:Sub> alkyl), <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> fluoroalkoxy, <com:Math><semantics>−(CH2)1−4O(C1−3<annotation encoding="application / x-tex">-(CH_2)_{1-4}O(C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−O(CH2)1−2OC(O)(C1−3<annotation encoding="application / x-tex">-O(CH_2)_{1-2}OC(O)(C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−O(CH2)1−2NRxRx<annotation encoding="application / x-tex">-O(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)O(C1−3 alkyl)<annotation encoding="application / x-tex">-C(O)O(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)0−2C(O)NRyRy<annotation encoding="application / x-tex">-(CH_2)_{0-2}C(O)NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NRx(C1−5)<annotation encoding="application / x-tex">-C(O)NR_x(C_{1-5})< / annotation>< / semantics>< / com:Math> hydroxyalkyl), -C(O)NR<com:Sub>x< / com:Sub>(C<com:Sub>2-6< / com:Sub> alkoxyalkyl), -C(O)NR<com:Sub>x< / com:Sub>(C<com:Sub>3-6< / com:Sub> cycloalkyl), -NR<com:Sub>y< / com:Sub>R<com:Sub>y< / com:Sub>, <com:Math><semantics>−NRy(C1−3 fluoroalkyl),−NRy(C1−4 hydroxyalkyl),−NRxCH2(phenyl),<annotation encoding="application / x-tex">-NR_y(C_{1-3} \text{ fluoroalkyl}), -NR_y(C_{1-4} \text{ hydroxyalkyl}), -NR_xCH_2(\text{phenyl}),< / annotation>< / semantics>< / com:Math> -NR<com:Sub>x< / com:Sub>S(O)<com:Sub>2< / com:Sub>(C<com:Sub>3-6< / com:Sub> cycloalkyl), -NR<com:Sub>x< / com:Sub>C(O)(C<com:Sub>1-3< / com:Sub> alkyl), -NR<com:Sub>x< / com:Sub>CH<com:Sub>2< / com:Sub>(C<com:Sub>3-6< / com:Sub> cycloalkyl), <com:Math><semantics>−(CH2)0−2S(O)2(C1−3 alkyl),−(CH2)0−2(C3−6 cycloalkyl),−(CH2)0−2(phenyl),<annotation encoding="application / x-tex">-(CH_2)_{0-2}S(O)_2(C_{1-3} \text{ alkyl}), -(CH_2)_{0-2}(C_{3-6} \text{ cycloalkyl}), -(CH_2)_{0-2}(\text{phenyl}),< / annotation>< / semantics>< / com:Math> morpholinyl, dioxothiomorpholinyl, dimethyl pyrazolyl, methylpiperidinyl, methylpiperazinyl, amino-oxadiazolyl, imidazolyl, triazolyl, or -C(O)(thiazolyl); <com:Math><semantics>R2a<annotation encoding="application / x-tex">R_{2a}< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> aminoalkyl, <com:Math><semantics>−(CH2)0−4O(C1−3)<annotation encoding="application / x-tex">-(CH_2)_{0-4}O(C_{1-3})< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl, <com:Math><semantics>−(CH2)1−3C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-3}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2(C3−6<annotation encoding="application / x-tex">-CH_2(C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl), <com:Math><semantics>−CH2(phenyl)<annotation encoding="application / x-tex">-CH_2(phenyl)< / annotation>< / semantics>< / com:Math>, tetrahydrofuranyl, tetrahydropyranyl, or phenyl; each R<com:Sub>2b< / com:Sub> is independently H, halo, -CN, -NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, C<com:Sub>1-6< / com:Sub> alkyl, C<com:Sub>1-3< / com:Sub> fluoroalkyl, C<com:Sub>1-3< / com:Sub> hydroxyalkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> fluoroalkoxy, <com:Math><semantics>−(CH2)0−2O(C1−3<annotation encoding="application / x-tex">-(CH_2)_{0-2}O(C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−(CH2)0−3C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{0-3}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] R<com:Sub>2c< / com:Sub> is R<com:Sub>2a< / com:Sub> or R<com:Sub>2b< / com:Sub>; R<com:Sub>2d< / com:Sub> is R<com:Sub>2a< / com:Sub> or R<com:Sub>2b< / com:Sub>; provided that one of R<com:Sub>2c< / com:Sub> and R<com:Sub>2d< / com:Sub> is R<com:Sub>2a< / com:Sub>, and the other of R<com:Sub>2c< / com:Sub> and R<com:Sub>2< / com:Sub> is R26; each R<com:Sub>5< / com:Sub> is independently F, Cl, -CN, C<com:Sub>1-3< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> fluoroalkyl, or -OCH<com:Sub>3< / com:Sub>; R<com:Sub>6< / com:Sub> is: [Image disponible dans le document PDF, Image available in the PDF document] (ii) azabicyclo[3.2.1]octanyl, azaspiro[5.5]undecanyl, azetidinyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, diazabicyclo[2.2.1]heptanyl, diazaspiro[3.5]nonanyl, morpholinyl, tetrahydrofuranyl, tetrahydropyranyl, octahydrocyclopenta[c]pyrrolyl, piperazinyl, piperidinyl, pyrrolidinyl, or quinuclidinyl, each substituted with zero to 3 R<com:Sub>6a< / com:Sub>; each R<com:Sub>6a< / com:Sub> is independently F, Cl, -OH, -CN, C<com:Sub>1-6< / com:Sub> alkyl, C<com:Sub>1-4< / com:Sub> fluoroalkyl, C<com:Sub>1-6< / com:Sub> hydroxyalkyl, <com:Math><semantics>−(CH2)1−2O(C1−3 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRyRy<annotation encoding="application / x-tex">-NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CRxRx)1−2S(O)2(C1−3 alkyl),−(CRxRx)1−2C(O)NRxRx,−C(O)(CRxRx)1−2NRxRx,<annotation encoding="application / x-tex">-(CR_xR_x)_{1-2}S(O)_2(C_{1-3} \text{ alkyl}), -(CR_xR_x)_{1-2}C(O)NR_xR_x, -C(O)(CR_xR_x)_{1-2}NR_xR_x,< / annotation>< / semantics>< / com:Math> oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, azetidinyl, pyrrolidinyl, piperidinyl, isobutylpiperidinyl, piperazinyl, or -O(piperidinyl); R7 is: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] (ii) C<com:Sub>3-6< / com:Sub> cycloalkyl substituted with one substituent selected from -NR<com:Sub>x< / com:Sub>(CH<com:Sub>2< / com:Sub>)<com:Sub>2-3< / com:Sub>NR<com:Sub>y< / com:Sub>R<com:Sub>y< / com:Sub>, -NR<com:Sub>x< / com:Sub>(methylpiperidinyl), -NR<com:Sub>x< / com:Sub>(CH<com:Sub>2< / com:Sub>)<com:Sub>2-3< / com:Sub>(morpholinyl), dimethylamino piperidinyl, and piperazinyl substituted with a substituent selected from <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>−C(O)CH3<annotation encoding="application / x-tex">-C(O)CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2OCH3<annotation encoding="application / x-tex">-(CH_2)_{1-2}OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2<annotation encoding="application / x-tex">-CH_2< / annotation>< / semantics>< / com:Math>(methylphenyl), -(CH<com:Sub>2< / com:Sub>)<com:Sub>2-3< / com:Sub>(pyrrolidinyl), C<com:Sub>3-6< / com:Sub> cycloalkyl, pyridinyl, and methylpiperidinyl; R<com:Sub>7a< / com:Sub> is azaspiro[3.5]nonanyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, diazaspiro[3.5]nonanyl, diazaspiro[5.5]undecanyl, diazepanonyl, diazepanyl, morpholinyl, phenyl, piperazinyl, piperidinyl, pyrrolidinonyl, pyrrolidinyl, or pyrrolyl, each substituted with zero to 1 substituent selected from C<com:Sub>1-3< / com:Sub> alkyl, -NH<com:Sub>2< / com:Sub>, methylpiperidinyl, methylpyrrolidinyl, -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>(pyrrolidinyl), and -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NHCH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; and zero to 4 substituents selected from -CH<com:Sub>3< / com:Sub>; R76 is: (i) -OH, C<com:Sub>1-6< / com:Sub> alkyl, C<com:Sub>1-4< / com:Sub> fluoroalkyl, C<com:Sub>1-4< / com:Sub> hydroxyalkyl, C<com:Sub>1-3< / com:Sub> aminoalkyl, [Image disponible dans le document PDF, Image available in the PDF document] (ii) azepanyl, azetidinyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, diazepanyl, dioxotetrahydrothiopyranyl, dioxothiomorpholinyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxetanyl, piperazinonyl, piperazinyl, piperidinyl, pyridinyl, pyrimidinyl, pyrrolidinonyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydroisoquinolinyl, tetrahydropyranyl, or thiadiazolyl, each substituted with zero to 1 R<com:Sub>8a< / com:Sub> and zero to 3 R<com:Sub>8b< / com:Sub>; each R<com:Sub>7c< / com:Sub> is independently F, Cl, -CN, C<com:Sub>1-2< / com:Sub> alkyl, -CF<com:Sub>3< / com:Sub>, or -CH<com:Sub>2< / com:Sub>CN; R<com:Sub>7d< / com:Sub> is azaspiro[3.5]nonanyl, azetidinyl, bicyclo[1.1.1]pentanyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, dioxothiaazaspiro[3.3]heptanyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxaazaspiro[4.4]nonyl, oxetanyl, phenyl, piperidinyl, pyrazolyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydropyranyl, thiadiazolyl, or triazolyl, each substituted with zero to 2 substituents independently selected from F, -OH, C<com:Sub>1-3< / com:Sub> alkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkoxy, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH3<annotation encoding="application / x-tex">-C(O)CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)2CH3<annotation encoding="application / x-tex">-S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, methylpiperidinyl, methylpyrrolidinyl, tetramethylpiperidinyl, -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>(pyrrolidinyl), and -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NHCH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; and zero to 4 substituents selected from -CH<com:Sub>3< / com:Sub>; R<com:Sub>8< / com:Sub> is H or <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl; or R<com:Sub>7< / com:Sub> and R<com:Sub>8< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic ring selected from azetidinyl, diazabicyclo[2.2.1]heptanyl, diazabicyclo[2.2.2]octanyl, diazabicyclo[3.1.1]heptanyl, diazabicyclo[3.2.1]octanyl, azaspiro[3.3]heptanyl, diazaspiro[2.5]octanyl, diazaspiro[3.3]heptanyl, diazepanonyl, diazepanyl, diazaspiro[3.5]nonanyl, diazaspiro[5.5]undecanyl, imidazolyl, imidazolidinonyl, octahydro-1H-pyrrolo[3,4-b]pyridinyl, oxadiazabicyclo[3.3.1]nonanyl, piperazinyl, piperazinonyl, piperidinyl, pyrrolidinonyl, pyrrolidinyl, and pyrrolyl, wherein said heterocyclic ring is substituted with zero to 1 R<com:Sub>7b< / com:Sub> and zero to 2 R<com:Sub>7c< / com:Sub>; R<com:Sub>8a< / com:Sub> is -OH, <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>−(CH2)1−2O(C1−3<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkoxy, <com:Math><semantics>−C(O)(C1−3 alkyl)<annotation encoding="application / x-tex">-C(O)(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)O(C1−2 alkyl)<annotation encoding="application / x-tex">-C(O)O(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2(C3−6 cycloalkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}(C_{3-6} \text{ cycloalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−3<annotation encoding="application / x-tex">-(CH_2)_{1-3}< / annotation>< / semantics>< / com:Math> (methyl phenyl), <com:Math><semantics>−(CH2)1−3<annotation encoding="application / x-tex">-(CH_2)_{1-3}< / annotation>< / semantics>< / com:Math> (pyrrolidinyl), <com:Math><semantics>−(CH2)1−3<annotation encoding="application / x-tex">-(CH_2)_{1-3}< / annotation>< / semantics>< / com:Math> (methylpyrazolyl), <com:Math><semantics>−(CH2)1−3<annotation encoding="application / x-tex">-(CH_2)_{1-3}< / annotation>< / semantics>< / com:Math> (thiophenyl), <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl, methylpiperidinyl, pyridinyl, or pyrimidinyl; each R<com:Sub>8b< / com:Sub> is independently F, Cl, -CN, C<com:Sub>1-3< / com:Sub> alkyl, or -CF<com:Sub>3< / com:Sub>; R<com:Sub>9< / com:Sub> is C<com:Sub>1-6< / com:Sub> alkyl, C<com:Sub>1-4< / com:Sub> fluoroalkyl, C<com:Sub>1-6< / com:Sub> hydroxyalkyl, C<com:Sub>1-6< / com:Sub> hydroxy fluoroalkyl, C<com:Sub>1-3< / com:Sub> aminoalkyl, <com:Math><semantics>−(CH2)1−2O(C1−3 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−3NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-3}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−3S(O)2OH<annotation encoding="application / x-tex">-(CH_2)_{1-3}S(O)_2OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CRxRx)1−3NRxS(O)2(C1−2 alkyl)<annotation encoding="application / x-tex">-(CR_xR_x)_{1-3}NR_xS(O)_2(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, or <com:Math><semantics>−(CH2)0−3R9a<annotation encoding="application / x-tex">-(CH_2)_{0-3}R_{9a}< / annotation>< / semantics>< / com:Math>; R<com:Sub>9a< / com:Sub> is C<com:Sub>3-7< / com:Sub> cycloalkyl, furanyl, phenyl, piperazinyl, piperidinyl, pyrazolyl, pyridinyl, pyrrolidinyl, quinuclidinyl, thiazolyl, or octahydrocyclopenta[c]pyrrolyl, each substituted with zero to 3 substituents independently selected from F, Cl, -OH, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-3< / com:Sub> hydroxyalkyl, C<com:Sub>1-3< / com:Sub> hydroxy fluoroalkyl, C<com:Sub>1-3< / com:Sub> aminoalkyl, -NR<com:Sub>y< / com:Sub>R<com:Sub>y< / com:Sub>, oxetanyl, phenyl, piperazinyl, piperidinyl, and pyrrolidinyl; <com:Math><semantics>R10<annotation encoding="application / x-tex">R_{10}< / annotation>< / semantics>< / com:Math> is H, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>−(CH2)1−3O(C1−2<annotation encoding="application / x-tex">-(CH_2)_{1-3}O(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), or <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl; or R<com:Sub>9< / com:Sub> and R<com:Sub>10< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic ring selected from azabicyclo[3.1.1]heptanyl, azaspiro[5.5]undecanyl, diazabicyclo[2.2.1]heptanyl, diazabicyclo[3.1.1]heptanyl, diazabicyclo[3.2.0]heptanyl, diazaspiro[3.5]nonanyl, diazaspiro[4.4]nonanyl, diazaspiro[4.5]decanyl, diazepanyl, indolinyl, morpholinyl, octahydropyrrolo[3,4-c] pyrrolyl, piperazinonyl, piperazinyl, piperidinyl, and pyrrolidinyl, each substituted with zero to 3 R<com:Sub>10a< / com:Sub>; each <com:Math><semantics>R10a<annotation encoding="application / x-tex">R_{10a}< / annotation>< / semantics>< / com:Math> is independently <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>−(CH2)1−3O(C1−3<annotation encoding="application / x-tex">-(CH_2)_{1-3}O(C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−(CH2)1−3NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-3}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (methyltriazolyl), <com:Math><semantics>−CH2CH2(phenyl),−CH2CH2(morpholinyl),−C(O)(C1−2alkyl),−C(O)NRyRy,<annotation encoding="application / x-tex">-CH_2CH_2(phenyl), -CH_2CH_2(morpholinyl), -C(O)(C_{1-2} alkyl), -C(O)NR_yR_y,< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−C(O)CH2NRyRy<annotation encoding="application / x-tex">-C(O)CH_2NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRyRy<annotation encoding="application / x-tex">-NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NHC(O)(C1−3alkyl)<annotation encoding="application / x-tex">-NHC(O)(C_{1-3} alkyl)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(furanyl)<annotation encoding="application / x-tex">-C(O)(furanyl)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−O(piperidinyl)<annotation encoding="application / x-tex">-O(piperidinyl)< / annotation>< / semantics>< / com:Math>, -C(O)CH<com:Sub>2< / com:Sub>(diethylcarbamoylpiperidinyl), methylpiperazinyl, piperidinyl, methylpiperidinyl, diethylcarbamoylpiperidinyl, isopropylpiperidinyl, pyridinyl, trifluoromethylpyridinyl, pyrimidinyl, or dihydrobenzo[d]imidazolonyl; R<com:Sub>11< / com:Sub> is azetidinyl, azaspiro[3.5]nonanyl, dioxidothiomorpholinyl, hexahydropyrrolo[3,4-c]pyrrolyl, morpholinyl, piperazinyl, piperidinyl, pyridinyl, or pyrrolidinyl, each substituted with zero to 3 substituents independently selected from halo, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> aminoalkyl, <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (methyloxetanyl), <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math>(triazolyl), <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math>(phenyl), <com:Math><semantics>−C(O)CH2NRxRx<annotation encoding="application / x-tex">-C(O)CH_2NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−5<annotation encoding="application / x-tex">C_{1-5}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2S(O)2(C1−3 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}S(O)_2(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2S(O)(C1−3 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}S(O)(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, oxetanyl, tetrahydrofuranyl, and tetrahydropyranyl; each R<com:Sub>12a< / com:Sub> is independently F, Cl, -OH, C<com:Sub>1-6< / com:Sub> alkyl, C<com:Sub>1-4< / com:Sub> fluoroalkyl, C<com:Sub>1-4< / com:Sub> cyanoalkyl, C<com:Sub>1-6< / com:Sub> hydroxyalkyl, <com:Math><semantics>−(CH2)1−2O(C1−3 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2S(O)2(C1−2)<annotation encoding="application / x-tex">-(CH_2)_{1-2}S(O)_2(C_{1-2})< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−(CH2)1−2NRxHS(O)2(C1−2 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xHS(O)_2(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−3 alkoxy<annotation encoding="application / x-tex">C_{1-3} \text{ alkoxy}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRyRy<annotation encoding="application / x-tex">-NR_yR_y< / annotation>< / semantics>< / com:Math>, [Image disponible dans le document PDF, Image available in the PDF document] or <com:Math><semantics>−OR12b<annotation encoding="application / x-tex">-OR_{12b}< / annotation>< / semantics>< / com:Math>; or two <com:Math><semantics>R12a<annotation encoding="application / x-tex">R_{12a}< / annotation>< / semantics>< / com:Math> and the carbon atom to which they are attached form C=O; R<com:Sub>12b< / com:Sub> is azetidinyl, bicyclo[1.1.1]pentanyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, diazabicyclo[2.2.1]heptanyl, dioxolanyl, dioxothiaazaspiro[3.3]heptanyl, dioxidotetrahydrothiopyranyl, dioxidothiomorpholinyl, imidazolyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, octahydropyrrolo[3,4-c]pyrrolyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxaazaspiro[4.4]nonanyl, oxetanyl, phenyl, piperazinyl, piperazinonyl, piperidinyl, pyridinyl, pyrrolidinyl, quinuclidinyl, tetrahydrofuranyl, tetrahydropyranyl, or triazolyl, each substituted with zero to 4 substituents independently selected from F, Cl, -OH, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-3< / com:Sub> fluoroalkyl, C<com:Sub>1-3< / com:Sub> hydroxyalkyl, C<com:Sub>1-3< / com:Sub> aminoalkyl, C<com:Sub>1-4< / com:Sub> alkoxy, <com:Math><semantics>−(CH2)1−2O(C1−3 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NRxRx<annotation encoding="application / x-tex">-C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−(CRxRx)0−1S(O)2(C1−3)<annotation encoding="application / x-tex">-(CR_xR_x)_{0-1}S(O)_2(C_{1-3})< / annotation>< / semantics>< / com:Math> alkyl); each R<com:Sub>14a< / com:Sub> is independently is: (i) H, halo, <com:Math><semantics>−OH<annotation encoding="application / x-tex">-OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−23<annotation encoding="application / x-tex">C_{1-23}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>−(CH2)0−2O(C1−3)<annotation encoding="application / x-tex">-(CH_2)_{0-2}O(C_{1-3})< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−CRxRxNRyRy<annotation encoding="application / x-tex">-CR_xR_xNR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CRxRxNRx(C1−3 cyanoalkyl)<annotation encoding="application / x-tex">-CR_xR_xNR_x(C_{1-3} \text{ cyanoalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CRxRxNRx((CH2)1−2O(C1−2)<annotation encoding="application / x-tex">-CR_xR_xNR_x((CH_2)_{1-2}O(C_{1-2})< / annotation>< / semantics>< / com:Math> alkyl)), <com:Math><semantics>−CRxRxN((CH2)1−2OCH3)2<annotation encoding="application / x-tex">-CR_xR_xN((CH_2)_{1-2}OCH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CRxRxNRx(CH2C≡CRx)<annotation encoding="application / x-tex">-CR_xR_xNR_x(CH_2C\equiv CR_x)< / annotation>< / semantics>< / com:Math>, [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] (ii) 8-azabicyclo[3.2.1]octanyl, azaspiro[3.5]nonanyl, azetidinyl, benzo[c][1,2,5]oxadiazolyl, cyclopentyl, cyclohexyl, diazepanyl, morpholinyl, phenyl, piperazinyl, piperidinyl, pyrazolyl, pyridinyl, pyrrolidinonyl, quinolinyl, quinuclidinyl, tetrahydroisoquinolinyl, tetrahydropyridinyl, or thiazolidinyl, each substituted with zero to 2 substituents independently selected from C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> [Image disponible dans le document PDF, Image available in the PDF document] each R<com:Sub>14b< / com:Sub> is F, Cl, -OH, -CH<com:Sub>3< / com:Sub>, or -OCH<com:Sub>3< / com:Sub>; R<com:Sub>14c< / com:Sub> is adamantanyl, azepanyl, azetidinyl, C<com:Sub>3-7< / com:Sub> cycloalkyl, diazepanyl, imidazolyl, indolyl, morpholinyl, octahydropyrrolo[3,4-c]pyrrolyl, phenyl, piperazinonyl, piperazinyl, piperidinyl, pyridinyl, pyrrolidinonyl, pyrrolidinyl, pyrrolyl, triazolyl, or tetrazolyl, each substituted with zero to 1 substituent selected from F, -OH, C<com:Sub>1-4< / com:Sub> [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] <com:Math><semantics>Rv<annotation encoding="application / x-tex">R_v< / annotation>< / semantics>< / com:Math> is H, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl, or <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> fluoroalkyl; each R<com:Sub>x< / com:Sub> is independently H or -CH<com:Sub>3< / com:Sub>; each Ry is independently H or C<com:Sub>1-6< / com:Sub> alkyl; n is zero, 1, or 2; and p is zero, 1, 2, 3, or 4. The second aspect of the present invention provides at least one compound of Formula (I), N-oxide, or a salt thereof, wherein: G is defined in the first aspect; A is: (i) <com:Math><semantics>−O−L1−R6<annotation encoding="application / x-tex">-O-L_1-R_6< / annotation>< / semantics>< / com:Math>; (ii) <com:Math><semantics>−NR7R8<annotation encoding="application / x-tex">-NR_7R_8< / annotation>< / semantics>< / com:Math>; (iii) <com:Math><semantics>−L2<annotation encoding="application / x-tex">-L_2< / annotation>< / semantics>< / com:Math>-C(O)NR<com:Sub>9< / com:Sub>R<com:Sub>10< / com:Sub>; [Image disponible dans le document PDF, Image available in the PDF document] (v) -CR<com:Sub>x< / com:Sub>R<com:Sub>12< / com:Sub>R<com:Sub>13< / com:Sub>, wherein R<com:Sub>12< / com:Sub> and R<com:Sub>13< / com:Sub> together with the carbon atom to which they are attached form a cyclic group selected from azabicyclo[4.1.1]octanyl, azepanyl, azetidinyl, C<com:Sub>3-7< / com:Sub> cycloalkyl, diazepanyl, diazaspiro[4.5]decanonyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, piperazinyl, piperidinyl, pyrrolidinyl, and quinuclidinyl, each substituted with zero to 4 R<com:Sub>12a< / com:Sub>; (vi) <com:Math><semantics>−CRx=CRx<annotation encoding="application / x-tex">-CR_x=CR_x< / annotation>< / semantics>< / com:Math>(piperidinyl); or (vii) an aromatic group selected from [1,2,4]triazolo[1,5-a]pyridinyl, imidazo[1,2-a]pyridinyl, imidazolyl, indazolyl, isoquinolinyl, oxadiazolyl, oxazolyl, phenyl, pyrazinyl, pyrazolo[3,4-b]pyridinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, quinolinonyl, quinolinyl, quinoxalinyl, tetrahydro- [1,2,4]triazolo[1,5-a]pyrazinyl, tetrahydroimidazo[1,2-a]pyrazinyl, tetrahydroisoquinolinyl, tetrahydrothiazolo[5,4-c]pyridinyl, tetrahydrothieno[2,3-c]pyridinyl, thiadiazolyl, thiazolyl, thiooxadiazolyl, and triazolyl, each substituted with zero to 2 R<com:Sub>14a< / com:Sub> and zero to 3 R<com:Sub>14b< / com:Sub>; [Image disponible dans le document PDF, Image available in the PDF document] L<com:Sub>2< / com:Sub> is a bond or <com:Math><semantics>−(CRxRx)1−3<annotation encoding="application / x-tex">-(CR_xR_x)_{1-3}< / annotation>< / semantics>< / com:Math>; <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is H, Cl, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> hydroxy- fluoroalkyl, -CR<com:Sub>v< / com:Sub>=CH<com:Sub>2< / com:Sub>, C<com:Sub>3-6< / com:Sub> cycloalkyl, -CH<com:Sub>2< / com:Sub>(C<com:Sub>3-6< / com:Sub> cycloalkyl), -C(O)O(C<com:Sub>1-3< / com:Sub> alkyl), or tetrahydropyranyl; each R<com:Sub>2< / com:Sub> is independently halo, -CN, -OH, -NO<com:Sub>2< / com:Sub>, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> fluoroalkyl, C<com:Sub>1-2< / com:Sub> cyanoalkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> aminoalkyl, <com:Math><semantics>−O(CH2)1−2OH<annotation encoding="application / x-tex">-O(CH_2)_{1-2}OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)0−4O(C1−4)0−4O(C1−4)0−4O(C1−4)0−4O(C1−4)0−4O(C1−4)0−4O(C1−4)0−4O(C1−4)0−4O(C1−4)0−4O<annotation encoding="application / x-tex">-(CH_2)_{0-4}O(C_{1-4})_{0-4}O(C_{1-4})_{0-4}O(C_{1-4})_{0-4}O(C_{1-4})_{0-4}O(C_{1-4})_{0-4}O(C_{1-4})_{0-4}O(C_{1-4})_{0-4}O(C_{1-4})_{0-4}O< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> fluoroalkoxy, <com:Math><semantics>−(CH2)1−4O(C1−3<annotation encoding="application / x-tex">-(CH_2)_{1-4}O(C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−O(CH2)1−2OC(O)(C1−3<annotation encoding="application / x-tex">-O(CH_2)_{1-2}OC(O)(C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−O(CH2)1−2NRxRx<annotation encoding="application / x-tex">-O(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)O(C1−3 alkyl)<annotation encoding="application / x-tex">-C(O)O(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)0−2C(O)NRyRy<annotation encoding="application / x-tex">-(CH_2)_{0-2}C(O)NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NRx(C1−5)<annotation encoding="application / x-tex">-C(O)NR_x(C_{1-5})< / annotation>< / semantics>< / com:Math> hydroxyalkyl), <com:Math><semantics>−C(O)NRx(C2−6 alkoxyalkyl)<annotation encoding="application / x-tex">-C(O)NR_x(C_{2-6} \text{ alkoxyalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NRx(C3−6 cycloalkyl)<annotation encoding="application / x-tex">-C(O)NR_x(C_{3-6} \text{ cycloalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRyRy<annotation encoding="application / x-tex">-NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRy(C1−3 fluoroalkyl),−NRy(C1−4 hydroxyalkyl),−NRxCH2(phenyl),<annotation encoding="application / x-tex">-NR_y(C_{1-3} \text{ fluoroalkyl}), -NR_y(C_{1-4} \text{ hydroxyalkyl}), -NR_xCH_2(\text{phenyl}),< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRxS(O)2(C3−6 cycloalkyl),−NRxC(O)(C1−3 alkyl),−NRxCH2(C3−6 cycloalkyl),<annotation encoding="application / x-tex">-NR_xS(O)_2(C_{3-6} \text{ cycloalkyl}), -NR_xC(O)(C_{1-3} \text{ alkyl}), -NR_xCH_2(C_{3-6} \text{ cycloalkyl}),< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−(CH2)0−2S(O)2(C1−3 alkyl),−(CH2)0−2(C3−6 cycloalkyl),−(CH2)0−2(phenyl),<annotation encoding="application / x-tex">-(CH_2)_{0-2}S(O)_2(C_{1-3} \text{ alkyl}), -(CH_2)_{0-2}(C_{3-6} \text{ cycloalkyl}), -(CH_2)_{0-2}(\text{phenyl}),< / annotation>< / semantics>< / com:Math> morpholinyl, dioxothiomorpholinyl, dimethyl pyrazolyl, methylpiperidinyl, methylpiperazinyl, amino-oxadiazolyl, imidazolyl, triazolyl, or -C(O)(thiazolyl); <com:Math><semantics>R2a<annotation encoding="application / x-tex">R_{2a}< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> aminoalkyl, <com:Math><semantics>−(CH2)0−4O(C1−3)<annotation encoding="application / x-tex">-(CH_2)_{0-4}O(C_{1-3})< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl, <com:Math><semantics>−(CH2)1−3C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-3}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2(C3−6<annotation encoding="application / x-tex">-CH_2(C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl), <com:Math><semantics>−CH2(phenyl)<annotation encoding="application / x-tex">-CH_2(phenyl)< / annotation>< / semantics>< / com:Math>, tetrahydrofuranyl, tetrahydropyranyl, or phenyl; each R<com:Sub>2b< / com:Sub> is independently H, halo, -CN, -NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, C<com:Sub>1-6< / com:Sub> alkyl, C<com:Sub>1-3< / com:Sub> fluoroalkyl, C<com:Sub>1-3< / com:Sub> hydroxyalkyl, C<com:Sub>1-3< / com:Sub> fluoroalkoxy, -(CH<com:Sub>2< / com:Sub>)<com:Sub>0-2< / com:Sub>O(C<com:Sub>1-3< / com:Sub> alkyl), -(CH<com:Sub>2< / com:Sub>)<com:Sub>0-3< / com:Sub>C(O)NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, <com:Math><semantics>−(CH2)1−3(C3−6 cycloalkyl),−C(O)O(C1−3 alkyl),−C(O)NRx(C1−3 alkyl),<annotation encoding="application / x-tex">-(CH_2)_{1-3}(C_{3-6} \text{ cycloalkyl}), -C(O)O(C_{1-3} \text{ alkyl}), -C(O)NR_x(C_{1-3} \text{ alkyl}),< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−CRx=CRxRx<annotation encoding="application / x-tex">-CR_x=CR_xR_x< / annotation>< / semantics>< / com:Math>, or <com:Math><semantics>−CRx=CH(C3−6 cycloalkyl)<annotation encoding="application / x-tex">-CR_x=CH(C_{3-6} \text{ cycloalkyl})< / annotation>< / semantics>< / com:Math>; R<com:Sub>2c< / com:Sub> is R<com:Sub>2a< / com:Sub> or R<com:Sub>2b< / com:Sub>; R<com:Sub>2d< / com:Sub> is R<com:Sub>2a< / com:Sub> or R<com:Sub>2b< / com:Sub>; provided that one of R<com:Sub>2c< / com:Sub> and R<com:Sub>2d< / com:Sub> is R<com:Sub>2a< / com:Sub>, and the other of R<com:Sub>2c< / com:Sub> and R<com:Sub>2< / com:Sub> is <com:Math><semantics>R2b<annotation encoding="application / x-tex">R_{2b}< / annotation>< / semantics>< / com:Math>; each R<com:Sub>5< / com:Sub> is independently F, Cl, -CN, C<com:Sub>1-3< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> fluoroalkyl, or -OCH<com:Sub>3< / com:Sub>; R<com:Sub>6< / com:Sub> is: [Image disponible dans le document PDF, Image available in the PDF document] (ii) azabicyclo[3.2.1]octanyl, azaspiro[5.5]undecanyl, azetidinyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, diazabicyclo[2.2.1]heptanyl, diazaspiro[3.5]nonanyl, morpholinyl, tetrahydrofuranyl, tetrahydropyranyl, octahydrocyclopenta[c]pyrrolyl, piperazinyl, piperidinyl, pyrrolidinyl, or quinuclidinyl, each substituted with zero to 3 R<com:Sub>6a< / com:Sub>; each R<com:Sub>6a< / com:Sub> is independently F, Cl, -OH, -CN, C<com:Sub>1-6< / com:Sub> alkyl, C<com:Sub>1-4< / com:Sub> fluoroalkyl, C<com:Sub>1-6< / com:Sub> [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, azetidinyl, pyrrolidinyl, piperidinyl, isobutylpiperidinyl, piperazinyl, or -O(piperidinyl); R7 is: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] (ii) C<com:Sub>3-6< / com:Sub> cycloalkyl substituted with one substituent selected from [Image disponible dans le document PDF, Image available in the PDF document] dimethylamino piperidinyl, and piperazinyl substituted with a substituent selected [Image disponible dans le document PDF, Image available in the PDF document] -(CH<com:Sub>2< / com:Sub>)<com:Sub>2-3< / com:Sub>(pyrrolidinyl), C<com:Sub>3-6< / com:Sub> cycloalkyl, pyridinyl, and methylpiperidinyl; R<com:Sub>7a< / com:Sub> is azaspiro[3.5]nonanyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, diazaspiro[3.5]nonanyl, diazaspiro[5.5]undecanyl, diazepanonyl, diazepanyl, morpholinyl, phenyl, piperazinyl, piperidinyl, pyrrolidinonyl, pyrrolidinyl, or pyrrolyl, each substituted with zero to 1 substituent selected from C<com:Sub>1-3< / com:Sub> alkyl, -NH<com:Sub>2< / com:Sub>, methylpiperidinyl, methylpyrrolidinyl, -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>(pyrrolidinyl), and -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NHCH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; and zero to 4 substituents selected from –CH<com:Sub>3< / com:Sub>; R7b is: [Image disponible dans le document PDF, Image available in the PDF document] (ii) azepanyl, azetidinyl, diazepanyl, dioxothiomorpholinyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxetanyl, piperazinonyl, piperazinyl, piperidinyl, pyridinyl, pyrrolidinonyl, pyrrolidinyl, or tetrahydroisoquinolinyl, each substituted with zero to 1 Rsa and zero to 3 Rsb; each R<com:Sub>7c< / com:Sub> is independently F, Cl, -CN, C<com:Sub>1-2< / com:Sub> alkyl, -CF<com:Sub>3< / com:Sub>, or -CH<com:Sub>2< / com:Sub>CN; <com:Math><semantics>R7d<annotation encoding="application / x-tex">R_{7d}< / annotation>< / semantics>< / com:Math> is azaspiro[3.5]nonanyl, bicyclo[1.1.1]pentanyl, <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl, morpholinyl, oxetanyl, phenyl, piperidinyl, pyrazolyl, pyrrolidinyl, tetrahydrofuranyl, or tetrahydropyranyl, each substituted with zero to 1 substituent selected from C<com:Sub>1-3< / com:Sub> alkyl, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH3<annotation encoding="application / x-tex">-C(O)CH_3< / annotation>< / semantics>< / com:Math>, methylpiperidinyl, methylpyrrolidinyl, tetramethylpiperidinyl, -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>(pyrrolidinyl), and -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NHCH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; and zero to 4 substituents selected from -CH<com:Sub>3< / com:Sub>; R<com:Sub>8< / com:Sub> is H or <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl; or R<com:Sub>7< / com:Sub> and R<com:Sub>8< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic ring selected from azetidinyl, diazepanonyl, diazepanyl, diazaspiro[3.5]nonanyl, diazaspiro[5.5]undecanyl, imidazolyl, imidazolidinonyl, octahydro-1H-pyrrolo[3,4-b]pyridinyl, piperazinyl, piperidinyl, pyrrolidinonyl, pyrrolidinyl, and pyrrolyl, wherein said heterocyclic ring is substituted with zero to 1 <com:Math><semantics>R7b<annotation encoding="application / x-tex">R_{7b}< / annotation>< / semantics>< / com:Math> and zero to 2 <com:Math><semantics>R7c<annotation encoding="application / x-tex">R_{7c}< / annotation>< / semantics>< / com:Math>; R<com:Sub>8a< / com:Sub> is -OH, C<com:Sub>1-6< / com:Sub> alkyl, C<com:Sub>1-4< / com:Sub> fluoroalkyl, C<com:Sub>1-4< / com:Sub> hydroxyalkyl, <com:Math><semantics>−(CH2)1−2O(C1−3<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−C(O)(C1−3 alkyl),−(CH2)1−2(C3−6 cycloalkyl),−(CH2)1−3 (methyl phenyl),<annotation encoding="application / x-tex">-C(O)(C_{1-3} \text{ alkyl}), -(CH_2)_{1-2}(C_{3-6} \text{ cycloalkyl}), -(CH_2)_{1-3} \text{ (methyl phenyl)},< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−(CH2)1−3<annotation encoding="application / x-tex">-(CH_2)_{1-3}< / annotation>< / semantics>< / com:Math> (pyrrolidinyl), <com:Math><semantics>−(CH2)1−3<annotation encoding="application / x-tex">-(CH_2)_{1-3}< / annotation>< / semantics>< / com:Math> (methylpyrazolyl), <com:Math><semantics>−(CH2)1−3<annotation encoding="application / x-tex">-(CH_2)_{1-3}< / annotation>< / semantics>< / com:Math> (thiophenyl), <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, C<com:Sub>3< / com:Sub>-6 cycloalkyl, methylpiperidinyl, pyridinyl, or pyrimidinyl; each R<com:Sub>86< / com:Sub> is independently F, Cl, -CN, C<com:Sub>1-3< / com:Sub> alkyl, or -CF<com:Sub>3< / com:Sub>; R<com:Sub>9< / com:Sub> is <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> hydroxy fluoroalkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> aminoalkyl, <com:Math><semantics>−(CH2)1−2O(C1−3 alkyl),−(CH2)1−3NRxRx,−(CH2)1−2C(O)NRxRx,−(CH2)1−3S(O)2OH,<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-3} \text{ alkyl}), -(CH_2)_{1-3}NR_xR_x, -(CH_2)_{1-2}C(O)NR_xR_x, -(CH_2)_{1-3}S(O)_2OH,< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−−(CRxRx)1−3NRxS(O)2(C1−2 alkyl), or −(CH2)0−3R9a;<annotation encoding="application / x-tex">--(CR_xR_x)_{1-3}NR_xS(O)_2(C_{1-2} \text{ alkyl}), \text{ or } -(CH_2)_{0-3}R_{9a};< / annotation>< / semantics>< / com:Math> R<com:Sub>9a< / com:Sub> is C<com:Sub>3-7< / com:Sub> cycloalkyl, furanyl, phenyl, piperazinyl, piperidinyl, pyrazolyl, pyridinyl, pyrrolidinyl, quinuclidinyl, thiazolyl, or octahydrocyclopenta[c]pyrrolyl, each substituted with zero to 3 substituents independently selected from F, Cl, -OH, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-3< / com:Sub> hydroxyalkyl, C<com:Sub>1-3< / com:Sub> hydroxy fluoroalkyl, C<com:Sub>1-3< / com:Sub> aminoalkyl, -NR<com:Sub>y< / com:Sub>R<com:Sub>y< / com:Sub>, oxetanyl, phenyl, piperazinyl, piperidinyl, and pyrrolidinyl; <com:Math><semantics>R10<annotation encoding="application / x-tex">R_{10}< / annotation>< / semantics>< / com:Math> is H, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>−(CH2)1−3O(C1−2<annotation encoding="application / x-tex">-(CH_2)_{1-3}O(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), or <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl; or R<com:Sub>9< / com:Sub> and R<com:Sub>10< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic ring selected from azabicyclo[3.1.1]heptanyl, azaspiro[5.5]undecanyl, diazabicyclo[2.2.1]heptanyl, diazabicyclo[3.1.1]heptanyl, diazabicyclo[3.2.0]heptanyl, diazaspiro[3.5]nonanyl, diazaspiro[4.4]nonanyl, diazaspiro[4.5]decanyl, diazepanyl, indolinyl, morpholinyl, octahydropyrrolo[3,4-c] pyrrolyl, piperazinonyl, piperazinyl, piperidinyl, and pyrrolidinyl, each substituted with zero to 3 R<com:Sub>10a< / com:Sub>; each R<com:Sub>10a< / com:Sub> is independently C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-4< / com:Sub> hydroxyalkyl, -(CH<com:Sub>2< / com:Sub>)<com:Sub>1-3< / com:Sub>O(C<com:Sub>1-3< / com:Sub> alkyl), <com:Math><semantics>−(CH2)1−3NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-3}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (methyltriazolyl), -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>(phenyl), -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>(morpholinyl), -C(O)(C<com:Sub>1-2< / com:Sub> alkyl), -C(O)NR<com:Sub>y< / com:Sub>R<com:Sub>y< / com:Sub>, <com:Math><semantics>−C(O)CH2NRyRy<annotation encoding="application / x-tex">-C(O)CH_2NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRyRy<annotation encoding="application / x-tex">-NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NHC(O)(C1−3alkyl)<annotation encoding="application / x-tex">-NHC(O)(C_{1-3} alkyl)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(furanyl)<annotation encoding="application / x-tex">-C(O)(furanyl)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−O(piperidinyl)<annotation encoding="application / x-tex">-O(piperidinyl)< / annotation>< / semantics>< / com:Math>, -C(O)CH<com:Sub>2< / com:Sub>(diethylcarbamoylpiperidinyl), methylpiperazinyl, piperidinyl, methylpiperidinyl, diethylcarbamoylpiperidinyl, isopropylpiperidinyl, pyridinyl, trifluoromethylpyridinyl, pyrimidinyl, or dihydrobenzo[d]imidazolonyl; R<com:Sub>11< / com:Sub> is azetidinyl, azaspiro[3.5]nonanyl, dioxidothiomorpholinyl, hexahydropyrrolo[3,4-c]pyrrolyl, morpholinyl, piperazinyl, piperidinyl, pyridinyl, or pyrrolidinyl, each substituted with zero to 3 substituents independently selected from halo, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> aminoalkyl, <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (phenyl), <com:Math><semantics>−C(O)CH2NRxRx<annotation encoding="application / x-tex">-C(O)CH_2NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−5<annotation encoding="application / x-tex">C_{1-5}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2S(O)2(C1−3 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}S(O)_2(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2S(O)(C1−3 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}S(O)(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, oxetanyl, tetrahydrofuranyl, and tetrahydropyranyl; each R<com:Sub>12a< / com:Sub> is independently F, Cl, -OH, C<com:Sub>1-6< / com:Sub> alkyl, C<com:Sub>1-4< / com:Sub> fluoroalkyl, C<com:Sub>1-4< / com:Sub> cyanoalkyl, C<com:Sub>1-6< / com:Sub> hydroxyalkyl, <com:Math><semantics>−(CH2)1−2O(C1−3 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2S(O)2(C1−2)<annotation encoding="application / x-tex">-(CH_2)_{1-2}S(O)_2(C_{1-2})< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−(CH2)1−2NRxHS(O)2(C1−2 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xHS(O)_2(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−3 alkoxy<annotation encoding="application / x-tex">C_{1-3} \text{ alkoxy}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRyRy<annotation encoding="application / x-tex">-NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(C1−4 fluoroalkyl),−NRx(C1−2 cyanoalkyl),−NRxCH2NRxRx,−NRx(C1−4 cyanoalkyl),<annotation encoding="application / x-tex">-NR_x(C_{1-4} \text{ fluoroalkyl}), -NR_x(C_{1-2} \text{ cyanoalkyl}), -NR_xCH_2NR_xR_x, -NR_x(C_{1-4} \text{ cyanoalkyl}),< / annotation>< / semantics>< / com:Math> hydroxyalkyl), <com:Math><semantics>−NRx(CRxRxCRxRx)O(C1−3 alkyl)<annotation encoding="application / x-tex">-NR_x(CR_xR_xCR_xR_x)O(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(CH2C(O)NRxRx)<annotation encoding="application / x-tex">-NR_x(CH_2C(O)NR_xR_x)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(C1−3 alkoxy),−NRxCH2CH2S(O)2(C1−2 alkyl),−NRxC(O)CH3,−NRxC(O)(C1−2 alkyl),<annotation encoding="application / x-tex">-NR_x(C_{1-3} \text{ alkoxy}), -NR_xCH_2CH_2S(O)_2(C_{1-2} \text{ alkyl}), -NR_xC(O)CH_3, -NR_xC(O)(C_{1-2} \text{ alkyl}),< / annotation>< / semantics>< / com:Math> fluoroalkyl), <com:Math><semantics>−NRxC(O)CRxRxNRxRx<annotation encoding="application / x-tex">-NR_xC(O)CR_xR_xNR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxC(O)CH2NRyRy<annotation encoding="application / x-tex">-NR_xC(O)CH_2NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxC(O)CH2NRx(C1−4 hydroxyalkyl),−NRx(CH2)1−2C(O)NRxRx,−NRxS(O)2(C1−2)1−2C(O)RxRx<annotation encoding="application / x-tex">-NR_xC(O)CH_2NR_x(C_{1-4} \text{ hydroxyalkyl}), -NR_x(CH_2)_{1-2}C(O)NR_xR_x, -NR_xS(O)_2(C_{1-2})_{1-2}C(O)R_xR_x< / annotation>< / semantics>< / com:Math> [Image disponible dans le document PDF, Image available in the PDF document] or <com:Math><semantics>−OR12b<annotation encoding="application / x-tex">-OR_{12b}< / annotation>< / semantics>< / com:Math>; or two <com:Math><semantics>R12a<annotation encoding="application / x-tex">R_{12a}< / annotation>< / semantics>< / com:Math> and the carbon atom to which they are attached form C=O; R<com:Sub>12b< / com:Sub> is azetidinyl, bicyclo[1.1.1]pentanyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, diazabicyclo[2.2.1]heptanyl, dioxolanyl, dioxidotetrahydrothiopyranyl, dioxidothiomorpholinyl, imidazolyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, octahydropyrrolo[3,4-c]pyrrolyl, oxaazaspiro[3.3]heptanyl, oxetanyl, phenyl, piperazinyl, piperazinonyl, piperidinyl, pyridinyl, pyrrolidinyl, quinuclidinyl, tetrahydrofuranyl, tetrahydropyranyl, or triazolyl, each substituted with zero to 4 substituents independently selected from F, Cl, -OH, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-3< / com:Sub> fluoroalkyl, C<com:Sub>1-3< / com:Sub> hydroxyalkyl, C<com:Sub>1-3< / com:Sub> aminoalkyl, C<com:Sub>1-4< / com:Sub> alkoxy, <com:Math><semantics>−(CH2)1−2O(C1−3 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NRxRx<annotation encoding="application / x-tex">-C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−(CRxRx)0−1S(O)2(C1−3 alkyl)<annotation encoding="application / x-tex">-(CR_xR_x)_{0-1}S(O)_2(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math> alkyl); each R<com:Sub>14a< / com:Sub> is independently is: [Image disponible dans le document PDF, Image available in the PDF document] phenyl, piperazinyl, piperidinyl, pyrazolyl, pyridinyl, pyrrolidinonyl, quinolinyl, quinuclidinyl, tetrahydroisoquinolinyl, tetrahydropyridinyl, or thiazolidinyl, each substituted with zero to 2 substituents independently selected from C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> fluoroalkyl, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(C1−2<annotation encoding="application / x-tex">-C(O)(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−C(O)CH2NRxRx<annotation encoding="application / x-tex">-C(O)CH_2NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)O(C1−3 alkyl)<annotation encoding="application / x-tex">-C(O)O(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)NRxRx<annotation encoding="application / x-tex">-CH_2C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C3−6 cycloalkyl<annotation encoding="application / x-tex">C_{3-6} \text{ cycloalkyl}< / annotation>< / semantics>< / com:Math>, -CH<com:Sub>2< / com:Sub>(phenyl), -CH<com:Sub>2< / com:Sub>(pyrrolyl), -CH<com:Sub>2< / com:Sub>(morpholinyl), -CH<com:Sub>2< / com:Sub>(methylpiperazinyl), -CH<com:Sub>2< / com:Sub>(thiophenyl), methylpiperidinyl, isobutylpiperidinyl, and pyridinyl; or (iii) <com:Math><semantics>−L3−R14c<annotation encoding="application / x-tex">-L_3-R_{14c}< / annotation>< / semantics>< / com:Math>; each R<com:Sub>14b< / com:Sub> is F, Cl, -OH, -CH<com:Sub>3< / com:Sub>, or -OCH<com:Sub>3< / com:Sub>; R<com:Sub>14c< / com:Sub> is adamantanyl, azepanyl, azetidinyl, C<com:Sub>3-7< / com:Sub> cycloalkyl, diazepanyl, imidazolyl, indolyl, morpholinyl, octahydropyrrolo[3,4-c]pyrrolyl, phenyl, piperazinonyl, piperazinyl, piperidinyl, pyridinyl, pyrrolidinonyl, pyrrolidinyl, pyrrolyl, triazolyl, or tetrazolyl, each substituted with zero to 1 substituent selected from F, -OH, C<com:Sub>1-4< / com:Sub> alkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>−NRxRy<annotation encoding="application / x-tex">-NR_xR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxC(O)CH3<annotation encoding="application / x-tex">-NR_xC(O)CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(C1−2<annotation encoding="application / x-tex">-C(O)(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−C(O)NRxRx<annotation encoding="application / x-tex">-C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)N(CH2CH3)2<annotation encoding="application / x-tex">-C(O)N(CH_2CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(tetrahydrofuranyl)<annotation encoding="application / x-tex">-C(O)(tetrahydrofuranyl)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)O(C1−2alkyl)<annotation encoding="application / x-tex">-C(O)O(C_{1-2} alkyl)< / annotation>< / semantics>< / com:Math>, -CH<com:Sub>2< / com:Sub>C(O)NR<com:Sub>x< / com:Sub>R<com:Sub>y< / com:Sub>, morpholinyl, methylpiperidinyl, pyrazinyl, pyridinyl, and pyrrolidinyl; [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] <com:Math><semantics>Rv<annotation encoding="application / x-tex">R_v< / annotation>< / semantics>< / com:Math> is H, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl, or <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> fluoroalkyl; each <com:Math><semantics>Rx<annotation encoding="application / x-tex">R_x< / annotation>< / semantics>< / com:Math> is independently H or <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math>; each R<com:Sub>y< / com:Sub> is independently H or C<com:Sub>1-6< / com:Sub> alkyl; n is zero, 1, or 2; and p is zero, 1, 2, 3, or 4. The compounds of Formula (1) or salts thereof in which A is -CR<com:Sub>x< / com:Sub>R<com:Sub>12< / com:Sub>R<com:Sub>13< / com:Sub>; and R<com:Sub>12< / com:Sub> and R<com:Sub>13< / com:Sub> together with the carbon atom to which they are attached form a cyclic group and the cyclic group has one or more heteroatoms, the cyclic group is bonded to the indole ring by a carbon atom in the cyclic group. One embodiment provides a compound of Formula (I) or a salt thereof wherein G [Image disponible dans le document PDF, Image available in the PDF document] is: ; and A, R<com:Sub>1< / com:Sub>, R<com:Sub>5< / com:Sub>, and n are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I) or a salt thereof wherein G [Image disponible dans le document PDF, Image available in the PDF document] ; and A, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, n, and p are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I) or a salt thereof wherein G [Image disponible dans le document PDF, Image available in the PDF document] is ; and A, <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>R2a<annotation encoding="application / x-tex">R_{2a}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>R2b<annotation encoding="application / x-tex">R_{2b}< / annotation>< / semantics>< / com:Math>, R<com:Sub>2c< / com:Sub>, R<com:Sub>2d< / com:Sub>, R<com:Sub>5< / com:Sub>, n, and p are defined in the first aspect or the second aspect. Included in this embodiment are compounds in which R<com:Sub>2a< / com:Sub> is C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> fluoroalkyl, C<com:Sub>1-4< / com:Sub> hydroxyalkyl, –(CH<com:Sub>2< / com:Sub>)<com:Sub>1–3< / com:Sub>OCH<com:Sub>3< / com:Sub>, C<com:Sub>3–6< / com:Sub> cycloalkyl, –CH<com:Sub>2< / com:Sub>C(O)NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, –CH<com:Sub>2< / com:Sub>(C<com:Sub>3–6< / com:Sub> cycloalkyl), -CH<com:Sub>2< / com:Sub>(phenyl), tetrahydrofuranyl, or phenyl; and each R<com:Sub>2b< / com:Sub> is independently H, F, Cl, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>−(CH2)0−2O(C1−2)<annotation encoding="application / x-tex">-(CH_2)_{0-2}O(C_{1-2})< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−(CH2)0−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{0-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−3(cyclopropyl)<annotation encoding="application / x-tex">-(CH_2)_{1-3}(cyclopropyl)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)O(C1−2alkyl)<annotation encoding="application / x-tex">-C(O)O(C_{1-2} alkyl)< / annotation>< / semantics>< / com:Math>, -C(O)NR<com:Sub>x< / com:Sub>(C<com:Sub>1-3< / com:Sub> alkyl), -CR<com:Sub>x< / com:Sub>=CH<com:Sub>2< / com:Sub>, or -CH=CH(C<com:Sub>3-6< / com:Sub> cycloalkyl). Also included in this embodiment are compounds in which R<com:Sub>2a< / com:Sub> is -CH<com:Sub>3< / com:Sub>; and each R<com:Sub>2b< / com:Sub> is independently H, Cl, or <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math>. One embodiment provides a compound of Formula (I) or a salt thereof wherein G is a 9-membered heterocyclic ring selected from: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] ) 5 [Image disponible dans le document PDF, Image available in the PDF document] A 2 5 [Image disponible dans le document PDF, Image available in the PDF document] and A, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, n, and p are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I) or a salt thereof wherein G is a 10-membered heterocyclic ring selected from: [Image disponible dans le document PDF, Image available in the PDF document] 10 [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] and and A, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, n, and p are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein A is: (i) <com:Math><semantics>−O−L1−R6<annotation encoding="application / x-tex">-O-L_1-R_6< / annotation>< / semantics>< / com:Math>; (ii) -NR7R8; (iii) <com:Math><semantics>−L2<annotation encoding="application / x-tex">-L_2< / annotation>< / semantics>< / com:Math>-C(O)NR<com:Sub>9< / com:Sub>R<com:Sub>10< / com:Sub>; (iv) <com:Math><semantics>−(CRxRx)1−2R11<annotation encoding="application / x-tex">-(CR_xR_x)_{1-2}R_{11}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> aminoalkyl, <com:Math><semantics>−(CRxRx)1−2NRxC(O)R11<annotation encoding="application / x-tex">-(CR_xR_x)_{1-2}NR_xC(O)R_{11}< / annotation>< / semantics>< / com:Math>, -CH<com:Sub>2< / com:Sub>NR<com:Sub>x< / com:Sub>C(O)(CH<com:Sub>2< / com:Sub>)<com:Sub>1-2< / com:Sub>(piperidinyl), -CH<com:Sub>2< / com:Sub>NR<com:Sub>x< / com:Sub>C(O)OCH<com:Sub>2< / com:Sub>(piperidinyl), or <com:Math><semantics>−CH2NRxC(O)(CH2)1−2NRxRx;<annotation encoding="application / x-tex">-CH_2NR_xC(O)(CH_2)_{1-2}NR_xR_x;< / annotation>< / semantics>< / com:Math> (v) -CR<com:Sub>x< / com:Sub>R<com:Sub>12< / com:Sub>R<com:Sub>13< / com:Sub>, wherein R<com:Sub>12< / com:Sub> and R<com:Sub>13< / com:Sub> together with the carbon atom to which they are attached form a cyclic group selected from azabicyclo[4.1.1]octanyl, azepanyl, azetidinyl, C<com:Sub>3-7< / com:Sub> cycloalkyl, diazepanyl, azaspiro[3.3]heptanyl, diazaspiro[4.5]decanonyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, piperazinyl, piperidinyl, pyrrolidinyl, and quinuclidinyl, each substituted with zero to 3 R<com:Sub>12a< / com:Sub>; (vi) <com:Math><semantics>−CRx=CRx<annotation encoding="application / x-tex">-CR_x=CR_x< / annotation>< / semantics>< / com:Math>(piperidinyl); or (vii) an aromatic group selected from [1,2,4]triazolo[1,5-a]pyridinyl, imidazo[1,2-a]pyridinyl, imidazolyl, indazolyl, isoquinolinyl, oxadiazolyl, oxazolyl, phenyl, pyrazinyl, pyrazolo[3,4-b]pyridinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, quinolinonyl, quinolinyl, quinoxalinyl, tetrahydro- [1,2,4]triazolo[1,5-a]pyrazinyl, tetrahydroimidazo[1,2-a]pyrazinyl, tetrahydroisoquinolinyl, tetrahydrothiazolo[5,4-c]pyridinyl, tetrahydrothieno[2,3-c]pyridinyl, thiadiazolyl, thiazolyl, thiooxadiazolyl, and triazolyl, each substituted with zero to 2 R<com:Sub>14a< / com:Sub> and zero to 3 R<com:Sub>14b< / com:Sub>; L<com:Sub>1< / com:Sub> is bond, <com:Math><semantics>−(CRxRx)1−2−<annotation encoding="application / x-tex">-(CR_xR_x)_{1-2-}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)<annotation encoding="application / x-tex">-CH_2C(O)< / annotation>< / semantics>< / com:Math>-, <com:Math><semantics>−CH2C(O)NRx(CRxRx)0−2−<annotation encoding="application / x-tex">-CH_2C(O)NR_x(CR_xR_x)_{0-2-}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2NRxC(O)<annotation encoding="application / x-tex">-CH_2NR_xC(O)< / annotation>< / semantics>< / com:Math>-, or [Image disponible dans le document PDF, Image available in the PDF document] L<com:Sub>2< / com:Sub> is a bond or <com:Math><semantics>−(CRxRx)1−2<annotation encoding="application / x-tex">-(CR_xR_x)_{1-2}< / annotation>< / semantics>< / com:Math>; R<com:Sub>1< / com:Sub> is H, Cl, <com:Math><semantics>−<annotation encoding="application / x-tex">-< / annotation>< / semantics>< / com:Math>CN, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> fluoroalkyl, C<com:Sub>1-2< / com:Sub> hydroxyalkyl, or <com:Math><semantics>−<annotation encoding="application / x-tex">-< / annotation>< / semantics>< / com:Math>C(O)O(C<com:Sub>1-2< / com:Sub> alkyl); each R<com:Sub>2< / com:Sub> is independently F, Cl, -CN, -OH, C<com:Sub>1-3< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> fluoroalkyl, C<com:Sub>1-2< / com:Sub> cyanoalkyl, C<com:Sub>1-3< / com:Sub> hydroxyalkyl, C<com:Sub>1-2< / com:Sub> aminoalkyl, -(CH<com:Sub>2< / com:Sub>)<com:Sub>0-2< / com:Sub>O(C<com:Sub>1-3< / com:Sub> alkyl), C<com:Sub>3-6< / com:Sub> cycloalkyl, [Image disponible dans le document PDF, Image available in the PDF document] R<com:Sub>2a< / com:Sub> is C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> fluoroalkyl, C<com:Sub>1-4< / com:Sub> hydroxyalkyl, -(CH<com:Sub>2< / com:Sub>)<com:Sub>1-3< / com:Sub>OCH<com:Sub>3< / com:Sub>, C<com:Sub>3-6< / com:Sub> cycloalkyl, -CH<com:Sub>2< / com:Sub>C(O)NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, -CH<com:Sub>2< / com:Sub>(C<com:Sub>3-6< / com:Sub> cycloalkyl), -CH<com:Sub>2< / com:Sub>(phenyl), tetrahydrofuranyl, or phenyl; [Image disponible dans le document PDF, Image available in the PDF document] each R<com:Sub>5< / com:Sub> is independently F, Cl, -CN, C<com:Sub>1-2< / com:Sub> alkyl, or -OCH<com:Sub>3< / com:Sub>; R<com:Sub>6< / com:Sub> is: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] (ii) azabicyclo[3.2.1]octanyl, azaspiro[5.5]undecanyl, azetidinyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, diazabicyclo[2.2.1]heptanyl, diazaspiro[3.5]nonanyl, morpholinyl, tetrahydropyranyl, octahydrocyclopenta[c]pyrrolyl, piperazinyl, piperidinyl, pyrrolidinyl, or quinuclidinyl, each substituted with zero to 3 R<com:Sub>6a< / com:Sub>; each R<com:Sub>6a< / com:Sub> is independently F, -OH, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-4< / com:Sub> fluoroalkyl, C<com:Sub>1-4< / com:Sub> hydroxyalkyl, [Image disponible dans le document PDF, Image available in the PDF document] alkyl), <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH2NRxRx<annotation encoding="application / x-tex">-C(O)CH_2NR_xR_x< / annotation>< / semantics>< / com:Math>, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, piperidinyl, isobutylpiperidinyl, piperazinyl, or -O(piperidinyl); R7 is: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] (ii) C<com:Sub>3-6< / com:Sub> cycloalkyl substituted with one substituent selected from [Image disponible dans le document PDF, Image available in the PDF document] R76 is: [Image disponible dans le document PDF, Image available in the PDF document] (ii) azepanyl, azetidinyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, diazepanyl, dioxotetrahydrothiopyranyl, dioxothiomorpholinyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxetanyl, piperazinonyl, piperazinyl, piperidinyl, pyridinyl, pyrimidinyl, pyrrolidinonyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydroisoquinolinyl, tetrahydropyranyl, or thiadiazolyl, each substituted with zero to 1 Rsa and zero to 3 Rsb; each R<com:Sub>7c< / com:Sub> is independently F, -CH<com:Sub>3< / com:Sub> or -CH<com:Sub>2< / com:Sub>CN; R<com:Sub>7d< / com:Sub> is azaspiro[3.5]nonanyl, azetidinyl, bicyclo[1.1.1]pentanyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, dioxothiaazaspiro[3.3]heptanyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxaazaspiro[4.4]nonyl, oxetanyl, phenyl, piperidinyl, pyrazolyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydropyranyl, thiadiazolyl, or triazolyl, each substituted with zero to 2 substituents independently selected from F, -OH, C<com:Sub>1-3< / com:Sub> alkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkoxy, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH3<annotation encoding="application / x-tex">-C(O)CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)2CH3<annotation encoding="application / x-tex">-S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, methylpiperidinyl, methylpyrrolidinyl, tetramethylpiperidinyl, -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>(pyrrolidinyl), and -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NHCH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; and zero to 4 substituents selected from –CH<com:Sub>3< / com:Sub>; <com:Math><semantics>R8<annotation encoding="application / x-tex">R_8< / annotation>< / semantics>< / com:Math> is H or <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl; or R<com:Sub>7< / com:Sub> and R<com:Sub>8< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic ring selected from azetidinyl, diazabicyclo[2.2.1]heptanyl, diazabicyclo[2.2.2]octanyl, diazabicyclo[3.1.1]heptanyl, diazabicyclo[3.2.1]octanyl, azaspiro[3.3]heptanyl, diazaspiro[2.5]octanyl, diazaspiro[3.3]heptanyl, diazepanonyl, diazepanyl, diazaspiro[3.5]nonanyl, diazaspiro[5.5]undecanyl, imidazolyl, imidazolidinonyl, octahydro-1H-pyrrolo[3,4-b]pyridinyl, oxadiazabicyclo[3.3.1]nonanyl, piperazinyl, piperazinonyl, piperidinyl, pyrrolidinonyl, pyrrolidinyl, and pyrrolyl, wherein said heterocyclic ring is substituted with zero to 1 R<com:Sub>7b< / com:Sub> and zero to 2 R<com:Sub>7c< / com:Sub>; Rsa is <com:Math><semantics>−OH<annotation encoding="application / x-tex">-OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>−(CH2)1−2O(C1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkoxy, <Formule mathématique disponible dans le document PDF, Math available in the PDF document>-C(O)(C_{1-2})_{1-2}O(C_{1-2})_{1-2}O(C_{1-2})_{1-2}O(C_{1-2})_{1-2}O(C_{1-2})_{1-2}O(C_{1-2})_{1-2}O(C_{1-2})_{1-2 alkyl), <com:Math><semantics>−C(O)O(C1−2 alkyl)<annotation encoding="application / x-tex">-C(O)O(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2(C3−6 cycloalkyl)<annotation encoding="application / x-tex">-CH_2(C_{3-6} \text{ cycloalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2 (methyl phenyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2} \text{ (methyl phenyl)}< / annotation>< / semantics>< / com:Math>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>1-3< / com:Sub>(pyrrolidinyl), -(CH<com:Sub>2< / com:Sub>)<com:Sub>1-2< / com:Sub>(methylpyrazolyl), -(CH<com:Sub>2< / com:Sub>)<com:Sub>1-2< / com:Sub>(thiophenyl), -NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, C<com:Sub>3-6< / com:Sub> cycloalkyl, methylpiperidinyl, or pyridinyl; each R<com:Sub>8b< / com:Sub> is independently F or -CH<com:Sub>3< / com:Sub>; R9 is C1-3 alkyl, C1-3 fluoroalkyl, C1-5 hydroxyalkyl, C2-5 hydroxy fluoroalkyl, C1-2 aminoalkyl, <com:Math><semantics>−(CH2)1−2O(C1−2 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−3N(CH3)2<annotation encoding="application / x-tex">-(CH_2)_{1-3}N(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2C(O)NH2<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NH_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2S(O)2OH<annotation encoding="application / x-tex">-(CH_2)_{1-2}S(O)_2OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2CRxRxNHS(O)2CH3<annotation encoding="application / x-tex">-(CH_2)_{1-2}CR_xR_xNHS(O)_2CH_3< / annotation>< / semantics>< / com:Math>, or <com:Math><semantics>−(CH2)0−3R9a<annotation encoding="application / x-tex">-(CH_2)_{0-3}R_{9a}< / annotation>< / semantics>< / com:Math>; R<com:Sub>9a< / com:Sub> is C<com:Sub>5-7< / com:Sub> cycloalkyl, furanyl, phenyl, piperazinyl, piperidinyl, pyrazolyl, pyridinyl, pyrrolidinyl, quinuclidinyl, thiazolyl, or octahydrocyclopenta[c]pyrrolyl, each substituted with zero to 2 substituents independently selected from -OH, C<com:Sub>1-3< / com:Sub> alkyl, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, oxetanyl, phenyl, piperazinyl, piperidinyl, and pyrrolidinyl; <com:Math><semantics>R10<annotation encoding="application / x-tex">R_{10}< / annotation>< / semantics>< / com:Math> is H, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>−(CH2)1−2O(C1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), or <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl; or R<com:Sub>9< / com:Sub> and R<com:Sub>10< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic ring selected from azabicyclo[3.1.1]heptanyl, azaspiro[5.5]undecanyl, diazabicyclo[2.2.1]heptanyl, diazabicyclo[3.1.1]heptanyl, diazabicyclo[3.2.0]heptanyl, diazaspiro[3.5]nonanyl, diazaspiro[4.4]nonanyl, diazaspiro[4.5]decanyl, diazepanyl, indolinyl, morpholinyl, octahydropyrrolo[3,4- c]pyrrolyl, piperazinonyl, piperazinyl, piperidinyl, and pyrrolidinyl, each substituted with zero to 3 R<com:Sub>10a< / com:Sub>; each <com:Math><semantics>R10a<annotation encoding="application / x-tex">R_{10a}< / annotation>< / semantics>< / com:Math> is independently <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>−(CH2)1−2O(C1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), [Image disponible dans le document PDF, Image available in the PDF document] <com:Math><semantics>R11<annotation encoding="application / x-tex">R_{11}< / annotation>< / semantics>< / com:Math> is azetidinyl, azaspiro[3.5]nonanyl, dioxidothiomorpholinyl, hexahydropyrrolo[3,4-c]pyrrolyl, morpholinyl, piperazinyl, piperidinyl, pyridinyl, or pyrrolidinyl, each substituted with zero to 3 substituents independently selected from F, Cl, -CN, C<com:Sub>1-3< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> aminoalkyl, -CH<com:Sub>2< / com:Sub>(methyloxetanyl), -CH<com:Sub>2< / com:Sub>(triazolyl), <com:Math><semantics>−CH2(phenyl),−C(O)CH2NRxRx,−CH2CRxRxOH,−CH2C(O)NRxRx,<annotation encoding="application / x-tex">-CH_2(phenyl), -C(O)CH_2NR_xR_x, -CH_2CR_xR_xOH, -CH_2C(O)NR_xR_x,< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−CH2CH2S(O)2(C1−3 alkyl),−CH2CH2S(O)(C1−3 alkyl), oxetanyl, tetrahydrofuranyl,<annotation encoding="application / x-tex">-CH_2CH_2S(O)_2(C_{1-3} \text{ alkyl}), -CH_2CH_2S(O)(C_{1-3} \text{ alkyl}), \text{ oxetanyl, tetrahydrofuranyl,}< / annotation>< / semantics>< / com:Math> and tetrahydropyranyl; [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] and the carbon atom to which they are attached form C=O; R<com:Sub>12b< / com:Sub> is azetidinyl, bicyclo[1.1.1]pentanyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, diazabicyclo[2.2.1]heptanyl, dioxolanyl, dioxothiaazaspiro[3.3]heptanyl, dioxidotetrahydrothiopyranyl, dioxidothiomorpholinyl, imidazolyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, octahydropyrrolo[3,4-c]pyrrolyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxaazaspiro[4.4]nonanyl, oxetanyl, phenyl, piperazinyl, piperazinonyl, piperidinyl, pyridinyl, pyrrolidinyl, quinuclidinyl, tetrahydrofuranyl, tetrahydropyranyl, or triazolyl, each substituted with zero to 4 substituents independently selected from F, Cl, <com:Math><semantics>−OH<annotation encoding="application / x-tex">-OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkoxy, <com:Math><semantics>−(CH2)1−2O(C1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NRxRx<annotation encoding="application / x-tex">-C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)2(C1−2 alkyl)<annotation encoding="application / x-tex">-S(O)_2(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−CH2S(O)2(C1−2 alkyl)<annotation encoding="application / x-tex">-CH_2S(O)_2(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>; each R<com:Sub>14a< / com:Sub> is independently: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] (ii) 8-azabicyclo[3.2.1]octanyl, azaspiro[3.5]nonanyl, azetidinyl, benzo[c][1,2,5]oxadiazolyl, cyclopentyl, cyclohexyl, diazepanyl, morpholinyl, phenyl, piperazinyl, piperidinyl, pyrazolyl, pyridinyl, pyrrolidinonyl, quinolinyl, quinuclidinyl, tetrahydroisoquinolinyl, tetrahydropyridinyl, or thiazolidinyl, each substituted with zero to 2 substituents independently selected from C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] -CH<com:Sub>2< / com:Sub>(phenyl), -CH<com:Sub>2< / com:Sub>(pyrrolyl), -CH<com:Sub>2< / com:Sub>(morpholinyl), -CH<com:Sub>2< / com:Sub>(methylpiperazinyl), -CH<com:Sub>2< / com:Sub>(thiophenyl), methylpiperidinyl, isobutylpiperidinyl, and pyridinyl; or (iii) <com:Math><semantics>−L3−R14c<annotation encoding="application / x-tex">-L_3-R_{14c}< / annotation>< / semantics>< / com:Math>; each R<com:Sub>14b< / com:Sub> is F, -CH<com:Sub>3< / com:Sub>, or -OCH<com:Sub>3< / com:Sub>; [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] R<com:Sub>14c< / com:Sub> is adamantanyl, azetidinyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, diazepanyl, imidazolyl, indolyl, morpholinyl, octahydropyrrolo[3,4-c]pyrrolyl, phenyl, piperazinonyl, piperazinyl, piperidinyl, pyridinyl, pyrrolidinonyl, pyrrolidinyl, or tetrazolyl, each substituted with zero to 1 substituent selected from F, -OH, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-3< / com:Sub> hydroxyalkyl, -NR<com:Sub>x< / com:Sub>R<com:Sub>y< / com:Sub>, [Image disponible dans le document PDF, Image available in the PDF document] <com:Math><semantics>−C(O)<annotation encoding="application / x-tex">-C(O)< / annotation>< / semantics>< / com:Math>(tetrahydrofuranyl), <com:Math><semantics>−C(O)O(C1−2 alkyl)<annotation encoding="application / x-tex">-C(O)O(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)NRxRy<annotation encoding="application / x-tex">-CH_2C(O)NR_xR_y< / annotation>< / semantics>< / com:Math>, morpholinyl, methylpiperidinyl, pyrazinyl, pyridinyl, and pyrrolidinyl; and G, n, and p is defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein: A is: (i) <com:Math><semantics>−O−L1−R6<annotation encoding="application / x-tex">-O-L_1-R_6< / annotation>< / semantics>< / com:Math>; (ii) -NR7R8; (iii) <com:Math><semantics>−L2−C(O)NR9R10<annotation encoding="application / x-tex">-L_2-C(O)NR_9R_{10}< / annotation>< / semantics>< / com:Math>; [Image disponible dans le document PDF, Image available in the PDF document] (v) -CHR<com:Sub>12< / com:Sub>R<com:Sub>13< / com:Sub>, wherein R<com:Sub>12< / com:Sub> and R<com:Sub>13< / com:Sub> together with the carbon atom to which they are attached form a cyclic group selected from azabicyclo[4.1.1]octanyl, azepanyl, azetidinyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, azaspiro[3.3]heptanyl, diazaspiro[4.5]decanonyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, piperidinyl, pyrrolidinyl, and quinuclidinyl, each substituted with zero to 3 R<com:Sub>12a< / com:Sub>; (vi) -CH=CH(piperidinyl); or (vii) an aromatic group selected from [1,2,4]triazolo[1,5-a]pyridinyl, imidazo[1,2-a]pyridinyl, imidazolyl, indazolyl, isoquinolinyl, oxadiazolyl, oxazolyl, phenyl, pyrazinyl, pyrazolo[3,4-b]pyridinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, quinolinonyl, quinolinyl, quinoxalinyl, tetrahydro- [1,2,4]triazolo[1,5-a]pyrazinyl, tetrahydroimidazo[1,2-a]pyrazinyl, tetrahydroisoquinolinyl, tetrahydrothiazolo[5,4-c]pyridinyl, tetrahydrothieno[2,3-c]pyridinyl, thiadiazolyl, thiazolyl, thiooxadiazolyl, and triazolyl, each substituted with zero to 2 R<com:Sub>14a< / com:Sub> and zero to 3 R<com:Sub>14b< / com:Sub>; L<com:Sub>1< / com:Sub> is bond, <com:Math><semantics>−CH2−<annotation encoding="application / x-tex">-CH_2-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH2−<annotation encoding="application / x-tex">-CH_2CH_2-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)−<annotation encoding="application / x-tex">-CH_2C(O)-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)NH−<annotation encoding="application / x-tex">-CH_2C(O)NH-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)N(CH3)−<annotation encoding="application / x-tex">-CH_2C(O)N(CH_3)-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)NHCH2−<annotation encoding="application / x-tex">-CH_2C(O)NHCH_2-< / annotation>< / semantics>< / com:Math>, or <com:Math><semantics>−CH2C(O)NHCH2CH2−<annotation encoding="application / x-tex">-CH_2C(O)NHCH_2CH_2-< / annotation>< / semantics>< / com:Math>; <com:Math><semantics>L2<annotation encoding="application / x-tex">L_2< / annotation>< / semantics>< / com:Math> is a bond, <com:Math><semantics>−CH(CH3)<annotation encoding="application / x-tex">-CH(CH_3)< / annotation>< / semantics>< / com:Math>-, <com:Math><semantics>−C(CH3)2<annotation encoding="application / x-tex">-C(CH_3)_2< / annotation>< / semantics>< / com:Math>-, or <com:Math><semantics>−CH2CH2<annotation encoding="application / x-tex">-CH_2CH_2< / annotation>< / semantics>< / com:Math>-; each R<com:Sub>5< / com:Sub> is independently F, Cl, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl, or <com:Math><semantics>−OCH3<annotation encoding="application / x-tex">-OCH_3< / annotation>< / semantics>< / com:Math>; R<com:Sub>6< / com:Sub> is: [Image disponible dans le document PDF, Image available in the PDF document] -CH<com:Sub>2< / com:Sub>C(O)NHCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NH<com:Sub>2< / com:Sub>, or -CH<com:Sub>2< / com:Sub>C(O)NHCH<com:Sub>2< / com:Sub>CHFC(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>OH; or (ii) azabicyclo[3.2.1]octanyl, azaspiro[5.5]undecanyl, azetidinyl, cyclohexyl, diazabicyclo[2.2.1]heptanyl, diazaspiro[3.5]nonanyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, piperazinyl, piperidinyl, pyrrolidinyl, or quinuclidinyl, each substituted with zero to 2 R<com:Sub>6a< / com:Sub>; each R<com:Sub>6a< / com:Sub> is independently F, -OH, -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -C(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CF<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)OH, -CH<com:Sub>2< / com:Sub>C(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>OH<com:Sub>3< / com:Sub> -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OCH<com:Sub>3< / com:Sub>, -NH<com:Sub>2< / com:Sub>, -N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -N(CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>NH<com:Sub>2< / com:Sub>, <com:Math><semantics>−CH2CH2NH2<annotation encoding="application / x-tex">-CH_2CH_2NH_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH2S(O)2CH3<annotation encoding="application / x-tex">-CH_2CH_2S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)N(CH3)2<annotation encoding="application / x-tex">-CH_2C(O)N(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH2N(CH3)2<annotation encoding="application / x-tex">-C(O)CH_2N(CH_3)_2< / annotation>< / semantics>< / com:Math>, oxetanyl, tetrahydropyranyl, piperidinyl, isobutylpiperidinyl, or -O(piperidinyl); R7 is: [Image disponible dans le document PDF, Image available in the PDF document] azaspiro[3.5]nonanyl), -CH<com:Sub>2< / com:Sub>(methylpyrrolidinyl), -C(O)(CH<com:Sub>2< / com:Sub>)<com:Sub>1-3< / com:Sub>NH<com:Sub>2< / com:Sub>, [Image disponible dans le document PDF, Image available in the PDF document] (ii) cyclohexyl substituted with <com:Math><semantics>−NRx(CH2)2−3N(CH3)2<annotation encoding="application / x-tex">-NR_x(CH_2)_{2-3}N(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NHCH2CH2NHCH3<annotation encoding="application / x-tex">-NHCH_2CH_2NHCH_3< / annotation>< / semantics>< / com:Math>, [Image disponible dans le document PDF, Image available in the PDF document] R7b is: [Image disponible dans le document PDF, Image available in the PDF document] (ii) azepanyl, azetidinyl, cyclobutyl, cyclobexyl, diazepanyl, dioxotetrahydrothiopyranyl, dioxothiomorpholinyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxetanyl, piperazinonyl, piperazinyl, piperidinyl, pyridinyl, pyrimidinyl, pyrrolidinonyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydroisoquinolinyl, tetrahydropyranyl, or thiadiazolyl, each substituted with zero to 1 R<com:Sub>8a< / com:Sub> and zero to 3 R<com:Sub>8b< / com:Sub>; each R<com:Sub>7c< / com:Sub> is independently -CH<com:Sub>3< / com:Sub> or -CH<com:Sub>2< / com:Sub>CN; R<com:Sub>7d< / com:Sub> is azaspiro[3.5]nonanyl, azetidinyl, bicyclo[1.1.1]pentanyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, dioxothiaazaspiro[3.3]heptanyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxaazaspiro[4.4]nonyl, oxetanyl, phenyl, piperidinyl, pyrazolyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydropyranyl, thiadiazolyl, or triazolyl, each substituted with zero to 2 substituents selected from F, <com:Math><semantics>−OH<annotation encoding="application / x-tex">-OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl, -CH<com:Sub>2< / com:Sub>OH, -OCH<com:Sub>3< / com:Sub>, -NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, -C(O)CH<com:Sub>3< / com:Sub>, -S(O)<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, methylpiperidinyl, methylpyrrolidinyl, tetramethylpiperidinyl, -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>(pyrrolidinyl), and -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NHCH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; and zero to 4 substituents selected from -CH<com:Sub>3< / com:Sub>; R<com:Sub>8< / com:Sub> is <com:Math><semantics>H1<annotation encoding="application / x-tex">H_1< / annotation>< / semantics>< / com:Math> –CH<com:Sub>3< / com:Sub> or –CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; or R7 and R8 together with the nitrogen atom to which they are attached form a heterocyclic ring selected from azetidinyl, diazabicyclo[2.2.1]heptanyl, diazabicyclo[2.2.2]octanyl, diazabicyclo[3.1.1]heptanyl, diazabicyclo[3.2.1]octanyl, azaspiro[3.3]heptanyl, diazaspiro[2.5]octanyl, diazaspiro[3.3]heptanyl, diazepanonyl, diazepanyl, diazaspiro[3.5]nonanyl, diazaspiro[5.5]undecanyl, imidazolidinonyl, octahydro-1H-pyrrolo[3,4-b]pyridinyl, oxadiazabicyclo[3.3.1]nonanyl, piperazinyl, piperazinonyl, piperidinyl, pyrrolidinonyl, and pyrrolidinyl, wherein said heterocyclic ring is substituted with zero to 1 R<com:Sub>7b< / com:Sub> and zero to 2 R<com:Sub>7c< / com:Sub>; R8a is <com:Math><semantics>−OH<annotation encoding="application / x-tex">-OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH3<annotation encoding="application / x-tex">-CH_2CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(CH3)3<annotation encoding="application / x-tex">-C(CH_3)_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH(CH3)2<annotation encoding="application / x-tex">-CH_2CH(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH2OCH3<annotation encoding="application / x-tex">-CH_2CH_2OCH_3< / annotation>< / semantics>< / com:Math>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CF<com:Sub>3< / com:Sub>, , -OCH<com:Sub>3< / com:Sub>, -C(O)CH<com:Sub>3< / com:Sub>, -C(O)OCH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>(cyclopropyl), -CH<com:Sub>2< / com:Sub>(methyl phenyl), -(CH<com:Sub>2< / com:Sub>)<com:Sub>2-3< / com:Sub>(pyrrolidinyl), -CH<com:Sub>2< / com:Sub>(methylpyrazolyl), -CH<com:Sub>2< / com:Sub>(thiophenyl), -NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, cyclopentyl, methylpiperidinyl, or pyridinyl; <com:Math><semantics>R8a<annotation encoding="application / x-tex">R_{8a}< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−OH<annotation encoding="application / x-tex">-OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH3<annotation encoding="application / x-tex">-CH_2CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(CH3)3<annotation encoding="application / x-tex">-C(CH_3)_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH(CH3)2<annotation encoding="application / x-tex">-CH_2CH(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH2OCH3<annotation encoding="application / x-tex">-CH_2CH_2OCH_3< / annotation>< / semantics>< / com:Math>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CF<com:Sub>3< / com:Sub>, -OCH<com:Sub>3< / com:Sub>, -C(O)CH<com:Sub>3< / com:Sub>, -C(O)OCH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>(cyclopropyl), -CH<com:Sub>2< / com:Sub>(methyl phenyl), <com:Math><semantics>−(CH2)2−3<annotation encoding="application / x-tex">-(CH_2)_{2-3}< / annotation>< / semantics>< / com:Math> (pyrrolidinyl), <com:Math><semantics>−CH2<annotation encoding="application / x-tex">-CH_2< / annotation>< / semantics>< / com:Math> (methylpyrazolyl), <com:Math><semantics>−CH2<annotation encoding="application / x-tex">-CH_2< / annotation>< / semantics>< / com:Math> (thiophenyl), -NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, cyclopentyl, methylpiperidinyl, or pyridinyl; each R<com:Sub>8b< / com:Sub> is -CH<com:Sub>3< / com:Sub>; [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] R<com:Sub>9a< / com:Sub> is cyclohexyl, cycloheptyl, furanyl, phenyl, piperazinyl, piperidinyl, pyrazolyl, pyridinyl, pyrrolidinyl, quinuclidinyl, thiazolyl, or octahydrocyclopenta[c]pyrrolyl, each substituted with zero to 2 substituents independently selected from -OH, C<com:Sub>1-3< / com:Sub> alkyl, -NH<com:Sub>2< / com:Sub>, -N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, oxetanyl, phenyl, piperazinyl, piperidinyl, and pyrrolidinyl; R<com:Sub>10< / com:Sub> is H<com:Sub>1< / com:Sub>, -CH<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OCH<com:Sub>3< / com:Sub>, or cyclopropyl; or R<com:Sub>9< / com:Sub> and R<com:Sub>10< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic ring selected from azabicyclo[3.1.1]heptanyl, azaspiro[5.5]undecanyl, diazabicyclo[2.2.1]heptanyl, diazabicyclo[3.1.1]heptanyl, diazabicyclo[3.2.0]heptanyl, diazaspiro[3.5]nonanyl, diazaspiro[4.4]nonanyl, diazaspiro[4.5]decanyl, diazepanyl, indolinyl, morpholinyl, octahydropyrrolo[3,4- clpyrrolyl, piperazinonyl, piperazinyl, piperidinyl, and pyrrolidinyl, each substituted with zero to 2 R<com:Sub>10a< / com:Sub>; each R<com:Sub>10a< / com:Sub> is independently -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, [Image disponible dans le document PDF, Image available in the PDF document] R<com:Sub>11< / com:Sub> is azetidinyl, azaspiro[3.5]nonanyl, dioxidothiomorpholinyl, hexabydropyrrolo[3,4-c]pyrrolyl, morpholinyl, piperazinyl, piperidinyl, or pyrrolidinyl, each substituted with zero to 2 substituents independently selected from F, -CH<com:Sub>3< / com:Sub>, -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CN, -CH<com:Sub>2< / com:Sub>(methyloxetanyl), -CH<com:Sub>2< / com:Sub>(triazolyl), <com:Math><semantics>−CH2(phenyl)<annotation encoding="application / x-tex">-CH_2(phenyl)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH2N(CH3)2<annotation encoding="application / x-tex">-C(O)CH_2N(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(CH3)2OH<annotation encoding="application / x-tex">-CH_2C(CH_3)_2OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)N(CH3)2<annotation encoding="application / x-tex">-CH_2C(O)N(CH_3)_2< / annotation>< / semantics>< / com:Math>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>S(O)<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>S(O)CH<com:Sub>3< / com:Sub>, oxetanyl, and tetrahydropyranyl; each R<com:Sub>12a< / com:Sub> is independently -OH, -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CF<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CF<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CF<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CN<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>C(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>OH<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OCH<com:Sub>3< / com:Sub>, [Image disponible dans le document PDF, Image available in the PDF document] R<com:Sub>12b< / com:Sub> is azetidinyl, bicyclo[1.1.1]pentanyl, cyclopropyl, diazabicyclo[2.2.1]heptanyl, dioxolanyl, dioxothiaazaspiro[3.3]heptanyl, dioxidotetrahydrothiopyranyl, dioxidothiomorpholinyl, imidazolyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, octahydropyrrolo[3,4-c]pyrrolyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxaazaspiro[4.4]nonanyl, oxetanyl, phenyl, piperazinyl, piperazinonyl, piperidinyl, pyridinyl, pyrrolidinyl, quinuclidinyl, tetrahydrofuranyl, tetrahydropyranyl, or triazolyl, each substituted with zero to 4 substituents independently selected from F, -OH, -CH<com:Sub>3< / com:Sub>, -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, -OCH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OCH<com:Sub>3< / com:Sub>, -NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, -C(O)NH<com:Sub>2< / com:Sub>, <com:Math><semantics>−C(O)N(CH3)2<annotation encoding="application / x-tex">-C(O)N(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)2CH3<annotation encoding="application / x-tex">-S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−CH2S(O)2CH3<annotation encoding="application / x-tex">-CH_2S(O)_2CH_3< / annotation>< / semantics>< / com:Math>; each R<com:Sub>14a< / com:Sub> is independently: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] 1 (iii) -L<com:Sub>3< / com:Sub>-R<com:Sub>14c< / com:Sub>;<com:Br / >each R<com:Sub>14b< / com:Sub> is -CH<com:Sub>3< / com:Sub>; [Image disponible dans le document PDF, Image available in the PDF document] R<com:Sub>14c< / com:Sub> is adamantanyl, azetidinyl, cyclopropyl, cyclohexyl, diazepanyl, imidazolyl, indolyl, morpholinyl, octahydropyrrolo[3,4-c]pyrrolyl, phenyl, piperazinonyl, piperazinyl, piperidinyl, pyridinyl, pyrrolidinonyl, pyrrolidinyl, or tetrazolyl, each substituted with zero to 1 substituent selected from -OH, -CH<com:Sub>3< / com:Sub>, -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, <com:Math><semantics>−C(CH3)2OH<annotation encoding="application / x-tex">-C(CH_3)_2OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NH2<annotation encoding="application / x-tex">-NH_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH3)2<annotation encoding="application / x-tex">-N(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NH(C(CH3)2<annotation encoding="application / x-tex">-NH(C(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NHC(O)CH3<annotation encoding="application / x-tex">-NHC(O)CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH3<annotation encoding="application / x-tex">-C(O)CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NH2<annotation encoding="application / x-tex">-C(O)NH_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)N(CH2CH3)2<annotation encoding="application / x-tex">-C(O)N(CH_2CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)<annotation encoding="application / x-tex">-C(O)< / annotation>< / semantics>< / com:Math>(tetrahydrofuranyl), <com:Math><semantics>−C(O)OCH2CH3<annotation encoding="application / x-tex">-C(O)OCH_2CH_3< / annotation>< / semantics>< / com:Math>, -CH<com:Sub>2< / com:Sub>C(O)NH(CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, morpholinyl, methylpiperidinyl, pyrazinyl, pyridinyl, and pyrrolidinyl; n is zero or 1; and p is zero, 1, 2, or 3. One embodiment provides a compound of Formula (I), or a salt thereof, wherein: G is: [Image disponible dans le document PDF, Image available in the PDF document] (i) [Image disponible dans le document PDF, Image available in the PDF document] (ii) [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] (iii) or [Image disponible dans le document PDF, Image available in the PDF document] (ir A is: (i) <com:Math><semantics>−OR6<annotation encoding="application / x-tex">-OR_6< / annotation>< / semantics>< / com:Math> or <com:Math><semantics>−O(CRxRx)1−2−R6<annotation encoding="application / x-tex">-O(CR_xR_x)_{1-2}-R_6< / annotation>< / semantics>< / com:Math>; (ii) -NR7R8; (iii) -C(O)NR<com:Sub>9< / com:Sub>R<com:Sub>10< / com:Sub>; (vi) <com:Math><semantics>−CH2CH2R11<annotation encoding="application / x-tex">-CH_2CH_2R_{11}< / annotation>< / semantics>< / com:Math>; (v) -CHR<com:Sub>12< / com:Sub>R<com:Sub>13< / com:Sub>, wherein R<com:Sub>12< / com:Sub> and R<com:Sub>13< / com:Sub> together with the carbon atom to which they are attached form a cyclic group selected from azetidinyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, morpholinyl, or piperidinyl, each substituted with zero to 3 R<com:Sub>12a< / com:Sub>; or (vi) an aromatic group selected from pyrazolyl substituted with zero to 1 R<com:Sub>14a< / com:Sub>; <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math> or <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; each R<com:Sub>2< / com:Sub> is independently Cl, -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CN, <com:Math><semantics>−OCH3<annotation encoding="application / x-tex">-OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2OCH3<annotation encoding="application / x-tex">-CH_2OCH_3< / annotation>< / semantics>< / com:Math>, or <com:Math><semantics>−CH2CH2S(O)2CH3<annotation encoding="application / x-tex">-CH_2CH_2S(O)_2CH_3< / annotation>< / semantics>< / com:Math>; R<com:Sub>6< / com:Sub> is: (a) <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math>; or (b) azetidinyl, cyclohexyl, or piperidinyl, each substituted with zero to 2 R<com:Sub>6a< / com:Sub>; each R<com:Sub>6a< / com:Sub> is independently -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -C(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>C(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>OH, -N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -N(CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>S(O)<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>C(O)N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, or tetrahydropyranyl; R<com:Sub>7< / com:Sub> and R<com:Sub>8< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic ring selected from azetidinyl, diazepanyl, diazaspiro[3.5]nonanyl, piperazinonyl, piperazinyl, piperidinyl, and pyrrolidinyl, wherein said heterocyclic ring is substituted with zero to 1 R<com:Sub>7b< / com:Sub> and zero to 2 R<com:Sub>7c< / com:Sub>; R7b is: (a) <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C2−3<annotation encoding="application / x-tex">C_{2-3}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> cyanoalkyl, <com:Math><semantics>−CHRxCH2OCH3<annotation encoding="application / x-tex">-CHR_xCH_2OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)NRxRx<annotation encoding="application / x-tex">-CH_2C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH2C(O)NRxRx<annotation encoding="application / x-tex">-CH_2CH_2C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)2−3S(O)2CH3<annotation encoding="application / x-tex">-(CH_2)_{2-3}S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH2NHS(O)2CH3,<math>−NRxRx<annotation encoding="application / x-tex">-CH2CH2NHS(O)2CH3, -NRxRx< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH3)(CH2CH3),<math>−N(CH2CH3)2<annotation encoding="application / x-tex">-N(CH3)(CH2CH3), -N(CH2CH3)2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NH(CH2CN)<annotation encoding="application / x-tex">-NH(CH_2CN)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2CN)2<annotation encoding="application / x-tex">-N(CH_2CN)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxCH2C(O)N(CH3)2<annotation encoding="application / x-tex">-NR_xCH_2C(O)N(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxC(O)CH2N(CH3)2<annotation encoding="application / x-tex">-NR_xC(O)CH_2N(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NH(CH2CH2S(O)2CH3),−N(CH2C(O)N(CH3)2)2,−S(O)2CH2CH2N(CH3)2,<annotation encoding="application / x-tex">-NH(CH_2CH_2S(O)_2CH_3), -N(CH_2C(O)N(CH_3)_2)_2, -S(O)_2CH_2CH_2N(CH_3)_2,< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−C(O)CH2CH2N(CH3)2<annotation encoding="application / x-tex">-C(O)CH_2CH_2N(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH2N(CH3)2<annotation encoding="application / x-tex">-C(O)CH_2N(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH2NH(CH(CH3)2)<annotation encoding="application / x-tex">-C(O)CH_2NH(CH(CH_3)_2)< / annotation>< / semantics>< / com:Math>, -C(O)CH<com:Sub>2< / com:Sub>NH(CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OCH<com:Sub>3< / com:Sub>), -C(O)CH<com:Sub>2< / com:Sub>NH(CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH), -CH<com:Sub>2< / com:Sub>(cyclopropyl), -CH<com:Sub>2< / com:Sub>(methyloxetanyl), -CH<com:Sub>2< / com:Sub>(tetrahydrofuranyl), -CH<com:Sub>2< / com:Sub>(methyltriazolyl), -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>(morpholinyl), -NR<com:Sub>x< / com:Sub>(cyclobutyl), -NR<com:Sub>x< / com:Sub>(oxetanyl), -NR<com:Sub>x< / com:Sub>(pyrimidinyl), -NR<com:Sub>x< / com:Sub>(tetrahydropyranyl), -NHCH<com:Sub>2< / com:Sub>(methylsulfonylcyclopropyl), -NHCH<com:Sub>2< / com:Sub>(methyloxetanyl), -NHCH<com:Sub>2< / com:Sub>(methoxypyrimidinyl), -C(O)CH<com:Sub>2< / com:Sub>NH(cyclobutyl), -N(CH<com:Sub>2< / com:Sub>(dimethoxypyrimidinyl))<com:Sub>2< / com:Sub>, <com:Math><semantics>−N(CH2(methoxypyrimidinyl))2<annotation encoding="application / x-tex">-N(CH_2(methoxypyrimidinyl))_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2(triazolyl))2<annotation encoding="application / x-tex">-N(CH_2(triazolyl))_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2(methyltriazolyl))2<annotation encoding="application / x-tex">-N(CH_2(methyltriazolyl))_2< / annotation>< / semantics>< / com:Math>, -N(CH<com:Sub>3< / com:Sub>)CH<com:Sub>2< / com:Sub>(cyclopropyl), -N(CH<com:Sub>3< / com:Sub>)CH<com:Sub>2< / com:Sub>(methylpyrazolyl), [Image disponible dans le document PDF, Image available in the PDF document] (b) cyclobutyl, cyclohexyl, dioxothiomorpholinyl, oxetanyl, piperazinyl, piperidinyl, tetrahydrofuranyl, or tetrahydropyranyl, each substituted with zero to 1 Rsa and zero to 3 Rsb; each R<com:Sub>7c< / com:Sub> is independently -CH<com:Sub>3< / com:Sub> or -CH<com:Sub>2< / com:Sub>CN; [Image disponible dans le document PDF, Image available in the PDF document] each R<com:Sub>8b< / com:Sub> is -CH<com:Sub>3< / com:Sub>; R<com:Sub>9< / com:Sub> is <com:Math><semantics>−CH2CH2CF3<annotation encoding="application / x-tex">-CH_2CH_2CF_3< / annotation>< / semantics>< / com:Math> or <com:Math><semantics>−CH2CH2N(CH3)2<annotation encoding="application / x-tex">-CH_2CH_2N(CH_3)_2< / annotation>< / semantics>< / com:Math>; <com:Math><semantics>R10<annotation encoding="application / x-tex">R_{10}< / annotation>< / semantics>< / com:Math> is H or <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl; or R<com:Sub>9< / com:Sub> and R<com:Sub>10< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic ring selected piperidinyl substituted with -C(O)CH<com:Sub>3< / com:Sub> or -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>; R<com:Sub>11< / com:Sub> is azetidinyl or piperidinyl, each substituted with zero to 1 substituent selected from -CH<com:Sub>2< / com:Sub>(triazolyl), -CH<com:Sub>2< / com:Sub>(methyloxetanyl), -C(O)CH<com:Sub>2< / com:Sub>N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>C(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>C(O)N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>S(O)<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, and oxetanyl; [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] 2 R<com:Sub>12b< / com:Sub> is azaspiro[3.5]nonanyl, azetidinyl, cyclopropyl, cyclopentyl, dioxotetrahydrothiofuranyl, dioxidotetrahydrothiopyranyl, dioxothiaazaspiro[3.3]heptanyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxazolyl, oxetanyl, phenyl, piperazinonyl, piperidinyl, pyrazinyl, pyridinyl, pyrimidinyl, pyrrolidinyl, pyrrolidinonyl, tetrahydrofuranyl, tetrahydropyranyl, or triazolyl, each substituted with zero to 4 substituents independently selected from F, -CN, -CH<com:Sub>3< / com:Sub>, -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, C<com:Sub>1-2< / com:Sub> cyanoalkyl, -OCH<com:Sub>3< / com:Sub>, <com:Math><semantics>−CH2C(O)NH(CH3)<annotation encoding="application / x-tex">-CH_2C(O)NH(CH_3)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NRxRx<annotation encoding="application / x-tex">-C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)2CH3<annotation encoding="application / x-tex">-S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)2CH3<annotation encoding="application / x-tex">-S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−CH2S(O)2CH3<annotation encoding="application / x-tex">-CH_2S(O)_2CH_3< / annotation>< / semantics>< / com:Math>; and <com:Math><semantics>R14a<annotation encoding="application / x-tex">R_{14a}< / annotation>< / semantics>< / com:Math> is piperidinyl or <com:Math><semantics>−CH2CH2<annotation encoding="application / x-tex">-CH_2CH_2< / annotation>< / semantics>< / com:Math> (morpholinyl); and R<com:Sub>5< / com:Sub> and n are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein: G is: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] <com:Math><semantics>R2b<annotation encoding="application / x-tex">R_{2b}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>R2b<annotation encoding="application / x-tex">R_{2b}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>R2b<annotation encoding="application / x-tex">R_{2b}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>R2b<annotation encoding="application / x-tex">R_{2b}< / annotation>< / semantics>< / com:Math> SAN ----() <com:Math><semantics>N−N<annotation encoding="application / x-tex">N-N< / annotation>< / semantics>< / com:Math> (iii) <com:Math><semantics>R2b<annotation encoding="application / x-tex">R_{2b}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>R2a<annotation encoding="application / x-tex">R_{2a}< / annotation>< / semantics>< / com:Math> or <com:Math><semantics>R2a<annotation encoding="application / x-tex">R_{2a}< / annotation>< / semantics>< / com:Math> ; or [Image disponible dans le document PDF, Image available in the PDF document] (iv) A is: (i) <com:Math><semantics>−OR6<annotation encoding="application / x-tex">-OR_6< / annotation>< / semantics>< / com:Math> or <com:Math><semantics>−O(CRxRx)1−2−R6<annotation encoding="application / x-tex">-O(CR_xR_x)_{1-2}-R_6< / annotation>< / semantics>< / com:Math>; (ii) -NR7R8; (iii) -C(O)NR<com:Sub>9< / com:Sub>R<com:Sub>10< / com:Sub>; (vi) <com:Math><semantics>−CH2CH2R11<annotation encoding="application / x-tex">-CH_2CH_2R_{11}< / annotation>< / semantics>< / com:Math>; (v) -CHR<com:Sub>12< / com:Sub>R<com:Sub>13< / com:Sub>, wherein R<com:Sub>12< / com:Sub> and R<com:Sub>13< / com:Sub> together with the carbon atom to which they are attached form a cyclic group selected from azetidinyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, morpholinyl, or piperidinyl, each substituted with zero to 3 R<com:Sub>12a< / com:Sub>; or (vi) an aromatic group selected from pyrazolyl substituted with zero to 1 R<com:Sub>14a< / com:Sub>; <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; each R<com:Sub>2< / com:Sub> is independently Cl, -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, -OCH<com:Sub>3< / com:Sub>, <com:Math><semantics>−CH2OCH3<annotation encoding="application / x-tex">-CH2OCH3< / annotation>< / semantics>< / com:Math>, or <com:Math><semantics>−CH2CH2S(O)2CH3;<annotation encoding="application / x-tex">-CH2CH2S(O)2CH3;< / annotation>< / semantics>< / com:Math> R<com:Sub>6< / com:Sub> is: (a) <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math>; or (b) azetidinyl, cyclohexyl, or piperidinyl, each substituted with zero to 2 R<com:Sub>6a< / com:Sub>; each R<com:Sub>6a< / com:Sub> is independently -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -C(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>C(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>OH, -N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -N(CH<com:Sub>2< / com:Sub>CHCH)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>S(O)<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>C(O)N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, or tetrahydropyranyl; R7 and R8 together with the nitrogen atom to which they are attached form a heterocyclic ring selected from azetidinyl, diazepanyl, diazaspiro[3.5]nonanyl, piperazinonyl, piperazinyl, piperidinyl, and pyrrolidinyl, wherein said heterocyclic ring is substituted with zero to 1 R<com:Sub>7b< / com:Sub> and zero to 2 R<com:Sub>7c< / com:Sub>; R7b is: (a) -NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, C<com:Sub>1-6< / com:Sub> alkyl, C<com:Sub>2-3< / com:Sub> fluoroalkyl, C<com:Sub>1-4< / com:Sub> hydroxyalkyl, C<com:Sub>1-2< / com:Sub> cyanoalkyl, [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] (b) cyclobutyl, cyclohexyl, dioxothiomorpholinyl, oxetanyl, piperazinyl, piperidinyl, tetrahydrofuranyl, or tetrahydropyranyl, each substituted with zero to 1 R<com:Sub>8a< / com:Sub> and zero to 3 R<com:Sub>8b< / com:Sub>; each R<com:Sub>7c< / com:Sub> is independently -CH<com:Sub>3< / com:Sub> or -CH<com:Sub>2< / com:Sub>CN; [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] R<com:Sub>10< / com:Sub> is H or C<com:Sub>1-2< / com:Sub> alkyl; or R<com:Sub>9< / com:Sub> and R<com:Sub>10< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic ring selected piperidinyl substituted with <com:Math><semantics>−C(O)CH3<annotation encoding="application / x-tex">-C(O)CH_3< / annotation>< / semantics>< / com:Math> or <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; R<com:Sub>11< / com:Sub> is azetidinyl or piperidinyl, each substituted with zero to 1 substituent selected from [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] each R<com:Sub>12a< / com:Sub> is independently -OH, -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] cyanoalkyl), <com:Math><semantics>−NRx(CH2CH2OH)<annotation encoding="application / x-tex">-NR_x(CH_2CH_2OH)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2CH2OH)(CH2C(O)N(CH3)2)<annotation encoding="application / x-tex">-N(CH_2CH_2OH)(CH_2C(O)N(CH_3)_2)< / annotation>< / semantics>< / com:Math>, -N(CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH)(CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>S(O)<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>), -N(CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>S(O)<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] <com:Math><semantics>−NRx(CRxRxC(O)CH2NRxRx)<annotation encoding="application / x-tex">-NR_x(CR_xR_xC(O)CH_2NR_xR_x)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NH(CH2C(O)N(CH3)CH2CH2OCH3)<annotation encoding="application / x-tex">-NH(CH_2C(O)N(CH_3)CH_2CH_2OCH_3)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2CH3)2<annotation encoding="application / x-tex">-N(CH_2CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2CH3)(CH2C(O)N(CH3)2)<annotation encoding="application / x-tex">-N(CH_2CH_3)(CH_2C(O)N(CH_3)_2)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2CH3)(CH2CH2S(O)2CH3)<annotation encoding="application / x-tex">-N(CH_2CH_3)(CH_2CH_2S(O)_2CH_3)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2CN)2<annotation encoding="application / x-tex">-N(CH_2CN)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2CN)(CH2C(O)N(CH3)2)<annotation encoding="application / x-tex">-N(CH_2CN)(CH_2C(O)N(CH_3)_2)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2CN)(CH2CH2S(O)2CH3)<annotation encoding="application / x-tex">-N(CH_2CN)(CH_2CH_2S(O)_2CH_3)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2C(O)NRxRx)2<annotation encoding="application / x-tex">-N(CH_2C(O)NR_xR_x)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2(methyloxetanyl))2<annotation encoding="application / x-tex">-N(CH_2(methyloxetanyl))_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH2N(CH3)2<annotation encoding="application / x-tex">-C(O)CH_2N(CH_3)_2< / annotation>< / semantics>< / com:Math>, [Image disponible dans le document PDF, Image available in the PDF document] <com:Math><semantics>−NRxCHRxR12b<annotation encoding="application / x-tex">-NR_xCHR_xR_{12b}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NHC(O)R12b<annotation encoding="application / x-tex">-NHC(O)R_{12b}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NHCRxRxC(O)R12b<annotation encoding="application / x-tex">-NHCR_xR_xC(O)R_{12b}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2CH3)(CH2R12b)<annotation encoding="application / x-tex">-N(CH_2CH_3)(CH_2R_{12b})< / annotation>< / semantics>< / com:Math>, -N(CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH)R<com:Sub>12b< / com:Sub>, -N(CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH)(CH<com:Sub>2< / com:Sub>R<com:Sub>12b< / com:Sub>), -N(CH<com:Sub>2< / com:Sub>CN)R<com:Sub>12b< / com:Sub>, <com:Math><semantics>−N(CH2CN)(CH2R12b)<annotation encoding="application / x-tex">-N(CH_2CN)(CH_2R_{12b})< / annotation>< / semantics>< / com:Math>, or <com:Math><semantics>−N(CH2(methyloxetanyl))2<annotation encoding="application / x-tex">-N(CH_2(methyloxetanyl))_2< / annotation>< / semantics>< / com:Math>; or two <com:Math><semantics>R12a<annotation encoding="application / x-tex">R_{12a}< / annotation>< / semantics>< / com:Math> and the carbon atom to which they are attached form C=O; <com:Math><semantics>R12b<annotation encoding="application / x-tex">R_{12b}< / annotation>< / semantics>< / com:Math> is azaspiro[3.5]nonanyl, azetidinyl, cyclopropyl, cyclopentyl, dioxotetrahydrothiofuranyl, dioxidotetrahydrothiopyranyl, dioxothiaazaspiro[3.3]heptanyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxazolyl, oxetanyl, phenyl, piperazinonyl, piperidinyl, pyrazinyl, pyridinyl, pyrimidinyl, pyrrolidinyl, pyrrolidinonyl, tetrahydrofuranyl, tetrahydropyranyl, or triazolyl, each substituted with zero to 4 substituents independently selected from F, -CN, -CH<com:Sub>3< / com:Sub>, -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, C<com:Sub>1-2< / com:Sub> cyanoalkyl, -OCH<com:Sub>3< / com:Sub>, [Image disponible dans le document PDF, Image available in the PDF document] <com:Math><semantics>R14a<annotation encoding="application / x-tex">R_{14a}< / annotation>< / semantics>< / com:Math> is piperidinyl or <com:Math><semantics>−CH2CH2<annotation encoding="application / x-tex">-CH_2CH_2< / annotation>< / semantics>< / com:Math> (morpholinyl); and G, n, R<com:Sub>5< / com:Sub>, and p are defined in the first aspect or the second aspect One embodiment provides a compound of Formula (I) or a salt thereof wherein G [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] is: <com:Math><semantics>(R2)p<annotation encoding="application / x-tex">(R_2)_p< / annotation>< / semantics>< / com:Math> or ; A is <com:Math><semantics>−NR7R8<annotation encoding="application / x-tex">-NR_7R_8< / annotation>< / semantics>< / com:Math>; and <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, n, and p are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I) or a salt thereof wherein G [Image disponible dans le document PDF, Image available in the PDF document] is: ; <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; A is piperazinyl; and <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>R2<annotation encoding="application / x-tex">R_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>R5<annotation encoding="application / x-tex">R_5< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>n<annotation encoding="application / x-tex">n< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>p<annotation encoding="application / x-tex">p< / annotation>< / semantics>< / com:Math> are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I) or a salt thereof wherein G [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] is Or ; A is <com:Math><semantics>−CRxR12R13<annotation encoding="application / x-tex">-CR_xR_{12}R_{13}< / annotation>< / semantics>< / com:Math>, wherein <com:Math><semantics>R12<annotation encoding="application / x-tex">R_{12}< / annotation>< / semantics>< / com:Math> and R<com:Sub>13< / com:Sub> together with the carbon atom to which they are attached form a cyclic group selected from azetidinyl, C<com:Sub>4-6< / com:Sub> cycloalkyl, or piperidinyl, each substituted with zero to 4 R<com:Sub>12a< / com:Sub>; and R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>2a< / com:Sub>, R<com:Sub>2b< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>12a< / com:Sub>, n, and p are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I) or a salt thereof wherein G [Image disponible dans le document PDF, Image available in the PDF document] is ; A is <com:Math><semantics>−CRxR12R13<annotation encoding="application / x-tex">-CR_xR_{12}R_{13}< / annotation>< / semantics>< / com:Math>, wherein <com:Math><semantics>R12<annotation encoding="application / x-tex">R_{12}< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>R13<annotation encoding="application / x-tex">R_{13}< / annotation>< / semantics>< / com:Math> together with the carbon atom to which they are attached form a cyclic group selected from cyclopentyl and cyclohexyl, each substituted with zero to 1 R<com:Sub>12a< / com:Sub>; R<com:Sub>1< / com:Sub> is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>; R<com:Sub>12a< / com:Sub> is -NR<com:Sub>y< / com:Sub>R<com:Sub>y< / com:Sub>, -NR<com:Sub>x< / com:Sub>(C<com:Sub>1-3< / com:Sub> fluoroalkyl), -NR<com:Sub>x< / com:Sub>(CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>O(C<com:Sub>1-3< / com:Sub> alkyl)), -NR<com:Sub>x< / com:Sub>(C<com:Sub>1-2< / com:Sub> cyanoalkyl), -NR<com:Sub>x< / com:Sub>CH<com:Sub>2< / com:Sub>NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, [Image disponible dans le document PDF, Image available in the PDF document] -NR<com:Sub>x< / com:Sub>CR<com:Sub>x< / com:Sub>R<com:Sub>12b< / com:Sub>; R<com:Sub>12b< / com:Sub> is cyclopropyl, cyclopentyl, dioxotetrahydrothiofuranyl, dioxidotetrahydrothiopyranyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxazolyl, oxetanyl, phenyl, piperidinyl, pyrazinyl, pyridinyl, pyrimidinyl, pyrrolidinyl, pyrrolidinonyl, tetrahydrofuranyl, tetrahydropyranyl, or triazolyl, each substituted with zero to 4 substituents independently selected from F, -CN, -CH<com:Sub>3< / com:Sub>, -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, C<com:Sub>1-2< / com:Sub> cyanoalkyl, -OCH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>C(O)NH(CH<com:Sub>3< / com:Sub>), -C(O)NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, -S(O)<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, and -CH<com:Sub>2< / com:Sub>S(O)<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; and R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, n, and p are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I) or a salt thereof, wherein R<com:Sub>1< / com:Sub> is H, Cl, <com:Math><semantics>−<annotation encoding="application / x-tex">-< / annotation>< / semantics>< / com:Math>CN, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> fluoroalkyl, C<com:Sub>1-2< / com:Sub> hydroxyalkyl, or <com:Math><semantics>−<annotation encoding="application / x-tex">-< / annotation>< / semantics>< / com:Math>C(O)O(C<com:Sub>1-2< / com:Sub> alkyl); and G, A, R<com:Sub>5< / com:Sub>, and n are defined in the first aspect or the second aspect. Included in this embodiment are compounds in which R<com:Sub>1< / com:Sub> is -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CHF<com:Sub>2< / com:Sub>, or -CH<com:Sub>2< / com:Sub>CF<com:Sub>3< / com:Sub>. Also included in this embodiment are compounds in which R<com:Sub>1< / com:Sub> is -CH<com:Sub>3< / com:Sub> or <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>. Additionally, included in this embodiment are compounds in which <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>. One embodiment provides a compound of Formula (I) or a salt thereof, wherein each R<com:Sub>2< / com:Sub> is independently F, Cl, -CN, -OH, C<com:Sub>1-3< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> fluoroalkyl, C<com:Sub>1-2< / com:Sub> cyanoalkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> aminoalkyl, <com:Math><semantics>−(CH2)0−2O(C1−3<annotation encoding="application / x-tex">-(CH_2)_{0-2}O(C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)0−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{0-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)0−2S(O)2(C1−3 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{0-2}S(O)_2(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2(C3−6 cycloalkyl)<annotation encoding="application / x-tex">-CH_2(C_{3-6} \text{ cycloalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2(phenyl)<annotation encoding="application / x-tex">-CH_2(phenyl)< / annotation>< / semantics>< / com:Math>, or phenyl; and G, A, R<com:Sub>1< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>x< / com:Sub>, and n are defined in the first aspect or the second aspect. Included in this embodiment are compounds in which each R<com:Sub>2< / com:Sub> is independently Cl, -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CN, -OCH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>OCH<com:Sub>3< / com:Sub>, or -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>S(O)<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>. Also, included in this embodiment are compounds in which each R<com:Sub>2< / com:Sub> is independently Cl, -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, -OCH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>OCH<com:Sub>3< / com:Sub>, or <com:Math><semantics>−CH2CH2S(O)2CH3<annotation encoding="application / x-tex">-CH_2CH_2S(O)_2CH_3< / annotation>< / semantics>< / com:Math>. One embodiment provides a compound of Formula (I) or a salt thereof wherein A is -O-L<com:Sub>1< / com:Sub>-R<com:Sub>6< / com:Sub>; and G, R<com:Sub>1< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>6< / com:Sub>, R<com:Sub>x< / com:Sub>, L<com:Sub>1< / com:Sub>, and n are defined in the first aspect or the second aspect. Included in this embodiment are compounds in which L<com:Sub>1< / com:Sub> is bond, <com:Math><semantics>−(CRxRx)1−2<annotation encoding="application / x-tex">-(CR_xR_x)_{1-2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)<annotation encoding="application / x-tex">-CH_2C(O)< / annotation>< / semantics>< / com:Math>-, <com:Math><semantics>−CH2C(O)NRx(CRxRx)0−2<annotation encoding="application / x-tex">-CH_2C(O)NR_x(CR_xR_x)_{0-2}< / annotation>< / semantics>< / com:Math>-, <com:Math><semantics>−CH2NRxC(O)<annotation encoding="application / x-tex">-CH_2NR_xC(O)< / annotation>< / semantics>< / com:Math>-, or <com:Math><semantics>−CH2NRxC(O)CH2<annotation encoding="application / x-tex">-CH_2NR_xC(O)CH_2< / annotation>< / semantics>< / com:Math>-; and each R<com:Sub>6a< / com:Sub> is independently F, -OH, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-4< / com:Sub> fluoroalkyl, C<com:Sub>1-4< / com:Sub> hydroxyalkyl, <com:Math><semantics>−(CH2)1−2OCH3<annotation encoding="application / x-tex">-(CH_2)_{1-2}OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(C2−3 alkyl)2<annotation encoding="application / x-tex">-N(C_{2-3} \text{ alkyl})_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2S(O)2(C1−2 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}S(O)_2(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH2NRxRx<annotation encoding="application / x-tex">-C(O)CH_2NR_xR_x< / annotation>< / semantics>< / com:Math>, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, piperidinyl, isobutylpiperidinyl, piperazinyl, or -O(piperidinyl). Also included in this embodiment are compounds in which each R<com:Sub>6a< / com:Sub> is independently F, -OH, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-4< / com:Sub> fluoroalkyl, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>−(CH2)1−2OCH3<annotation encoding="application / x-tex">-(CH_2)_{1-2}OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2S(O)2(C1−2 alkyl),−(CH2)1−2C(O)NRxRx,−C(O)CH2NRxRx, oxetanyl,<annotation encoding="application / x-tex">-(CH_2)_{1-2}S(O)_2(C_{1-2} \text{ alkyl}), -(CH_2)_{1-2}C(O)NR_xR_x, -C(O)CH_2NR_xR_x, \text{ oxetanyl},< / annotation>< / semantics>< / com:Math> tetrahydrofuranyl, tetrahydropyranyl, piperidinyl, isobutylpiperidinyl, piperazinyl, or -O(piperidinyl). One embodiment provides a compound of Formula (I) or a salt thereof wherein A is <com:Math><semantics>−O−L1−R6<annotation encoding="application / x-tex">-O-L_1-R_6< / annotation>< / semantics>< / com:Math>; L<com:Sub>1< / com:Sub> is bond, <com:Math><semantics>−(CRxRx)1−2−<annotation encoding="application / x-tex">-(CR_xR_x)_{1-2-}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)−<annotation encoding="application / x-tex">-CH_2C(O)-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)NRx(CRxRx)0−2−<annotation encoding="application / x-tex">-CH_2C(O)NR_x(CR_xR_x)_{0-2-}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2NRxC(O)<annotation encoding="application / x-tex">-CH_2NR_xC(O)< / annotation>< / semantics>< / com:Math>-, or <com:Math><semantics>−CH2NRxC(O)CH2<annotation encoding="application / x-tex">-CH_2NR_xC(O)CH_2< / annotation>< / semantics>< / com:Math>-; R6 is: (i) C1-2 alkyl, -CH<com:Sub>2< / com:Sub>C(O)NHCH<com:Sub>2< / com:Sub>CR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>C(O)NHCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>C(O)NHCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, or -CH<com:Sub>2< / com:Sub>C(O)NHCH<com:Sub>2< / com:Sub>CHFCR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>OH; or (ii) azabicyclo[3.2.1]octanyl, azaspiro[5.5]undecanyl, azetidinyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, diazabicyclo[2.2.1]heptanyl, diazaspiro[3.5]nonanyl, morpholinyl, tetrahydropyranyl, octahydrocyclopenta[c]pyrrolyl, piperazinyl, piperidinyl, pyrrolidinyl, or quinuclidinyl, each substituted with zero to 3 R<com:Sub>6a< / com:Sub>; and each R<com:Sub>6a< / com:Sub> is independently F, -OH, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-4< / com:Sub> fluoroalkyl, C<com:Sub>1-4< / com:Sub> hydroxyalkyl, -(CH<com:Sub>2< / com:Sub>)<com:Sub>1-2< / com:Sub>OCH<com:Sub>3< / com:Sub>, -NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, -N(C<com:Sub>2-3< / com:Sub> alkyl)<com:Sub>2< / com:Sub>, <com:Math><semantics>−(CH2)1−2NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2S(O)2(C1−2 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}S(O)_2(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH2NRxRx<annotation encoding="application / x-tex">-C(O)CH_2NR_xR_x< / annotation>< / semantics>< / com:Math>, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, piperidinyl, isobutylpiperidinyl, piperazinyl, or -O(piperidinyl). Also included in this embodiment are compounds in which each R<com:Sub>6a< / com:Sub> is independently F, -OH, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-4< / com:Sub> fluoroalkyl, C<com:Sub>1-4< / com:Sub> hydroxyalkyl, <com:Math><semantics>−(CH2)1−2OCH3<annotation encoding="application / x-tex">-(CH_2)_{1-2}OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2S(O)2(C1−2 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}S(O)_2(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH2NRxRx<annotation encoding="application / x-tex">-C(O)CH_2NR_xR_x< / annotation>< / semantics>< / com:Math>, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, piperidinyl, isobutylpiperidinyl, piperazinyl, or -O(piperidinyl); and G, R<com:Sub>1< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>x< / com:Sub>, and n are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I) or a salt thereof wherein A is -NR<com:Sub>7< / com:Sub>R<com:Sub>8< / com:Sub>; and G, R<com:Sub>1< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>7< / com:Sub>, R<com:Sub>8< / com:Sub>, R<com:Sub>x< / com:Sub>, R<com:Sub>y< / com:Sub>, n, and p are defined in the first aspect or the second aspect. Included in this embodiment are compounds in which R7 is: (i) -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NH<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NHC(O)CH<com:Sub>2< / com:Sub>N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>(isopropyl azaspiro[3.5]nonanyl), <com:Math><semantics>−CH2<annotation encoding="application / x-tex">-CH_2< / annotation>< / semantics>< / com:Math>(methylpyrrolidinyl), <com:Math><semantics>−C(O)(CH2)1−3NH2<annotation encoding="application / x-tex">-C(O)(CH_2)_{1-3}NH_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH(NH2)CH2CH2CH3<annotation encoding="application / x-tex">-C(O)CH(NH_2)CH_2CH_2CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH(NH2)CH2CH(CH3)2,<math>−C(O)CH(NH2)CH(CH3)CH2CH3,<annotation encoding="application / x-tex">-C(O)CH(NH2)CH2CH(CH3)2, -C(O)CH(NH2)CH(CH3)CH2CH3,< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−C(O)CH(NH2)CH2CH2C(O)OH,<math>−C(O)CH(NH2)(CH2)3−4NH2<annotation encoding="application / x-tex">-C(O)CH(NH2)CH2CH2C(O)OH, -C(O)CH(NH2)(CH2)3-4NH2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH(NH2)(CH2)1−2C(O)NH2,<math>−C(O)CH(NH2)(cyclohexyl)<annotation encoding="application / x-tex">-C(O)CH(NH2)(CH2)1-2C(O)NH2, -C(O)CH(NH2)(cyclohexyl)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH(NH2)<annotation encoding="application / x-tex">-C(O)CH(NH2)< / annotation>< / semantics>< / com:Math>(phenyl), <com:Math><semantics>−C(O)<annotation encoding="application / x-tex">-C(O)< / annotation>< / semantics>< / com:Math>(aminocyclohexyl), <com:Math><semantics>−C(O)<annotation encoding="application / x-tex">-C(O)< / annotation>< / semantics>< / com:Math>(morpholinyl), -C(O)(pyrrolidinyl), pentamethylpiperidinyl, methylpiperidinyl-piperidinyl, methylpyrrolidinyl-pyrrolidinyl, or phenyl substituted with -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>(pyrrolidinyl) or -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NHCH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; or (ii) cyclohexyl substituted with -NR<com:Sub>x< / com:Sub>(CH<com:Sub>2< / com:Sub>)<com:Sub>2-3< / com:Sub>N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -NHCH2CH2NHCH3, -NH(methylpiperidinyl), -NH(CH2)2-3(morpholinyl), dimethylamino piperidinyl, or piperazinyl substituted with -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -C(CH<com:Sub>3< / com:Sub>)<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -C(O)CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OCH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>(methylphenyl), -(CH<com:Sub>2< / com:Sub>)<com:Sub>2-3< / com:Sub>(pyrrolidinyl), cyclopentyl, pyridinyl, or methylpiperidinyl; R<com:Sub>7b< / com:Sub> is: (i) -OH, C<com:Sub>1-6< / com:Sub> alkyl, C<com:Sub>3-4< / com:Sub> fluoroalkyl, C<com:Sub>3-4< / com:Sub> hydroxyalkyl, -CH<com:Sub>2< / com:Sub>CN, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CN, <com:Math><semantics>−CH2CH2CH2C=CH<annotation encoding="application / x-tex">-CH_2CH_2CH_2C=CH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CRxRx)1−2OCH3<annotation encoding="application / x-tex">-(CR_xR_x)_{1-2}OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)2−3S(O)2CH3<annotation encoding="application / x-tex">-(CH_2)_{2-3}S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRyRy<annotation encoding="application / x-tex">-NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(C1−4 hydroxyalkyl)<annotation encoding="application / x-tex">-NR_x(C_{1-4} \text{ hydroxyalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NH(CH2CH2OCH3)<annotation encoding="application / x-tex">-NH(CH_2CH_2OCH_3)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRy(C1−2 cyanoalkyl),−N(CH2CH2CN)2,−NRx(C1−2 fluoroalkyl),−NRx(C2−4)<annotation encoding="application / x-tex">-NR_y(C_{1-2} \text{ cyanoalkyl}), -N(CH_2CH_2CN)_2, -NR_x(C_{1-2} \text{ fluoroalkyl}), -NR_x(C_{2-4})< / annotation>< / semantics>< / com:Math> hydroxyfluoroalkyl), <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-NR_x(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N((CH2)1−2C(O)NRxRx)2<annotation encoding="application / x-tex">-N((CH_2)_{1-2}C(O)NR_xR_x)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(CH2)1−2S(O)2(C1−2alkyl)<annotation encoding="application / x-tex">-NR_x(CH_2)_{1-2}S(O)_2(C_{1-2} alkyl)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(CH2)1−3NRxRx<annotation encoding="application / x-tex">-NR_x(CH_2)_{1-3}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxCH2CH2N(CH3)2<annotation encoding="application / x-tex">-NR_xCH_2CH_2N(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxC(O)(CH2)1−2NRxRx<annotation encoding="application / x-tex">-NR_xC(O)(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(CH2CH2S(O)2CH3)<annotation encoding="application / x-tex">-NR_x(CH_2CH_2S(O)_2CH_3)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OCH2CH2N(CH3)2<annotation encoding="application / x-tex">-OCH_2CH_2N(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(CRxRx)1−2NRyRy<annotation encoding="application / x-tex">-C(O)(CR_xR_x)_{1-2}NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(CRxRx)1−2NRy(C1−4 hydroxyalkyl)<annotation encoding="application / x-tex">-C(O)(CR_xR_x)_{1-2}NR_y(C_{1-4} \text{ hydroxyalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(CRxRx)1−2NRx(CH2CH2OCH3),−S(O)2CH2CH2N(CH3)2,−(CH2)1−2R7d,−NRxR7d,<annotation encoding="application / x-tex">-C(O)(CR_xR_x)_{1-2}NR_x(CH_2CH_2OCH_3), -S(O)_2CH_2CH_2N(CH_3)_2, -(CH_2)_{1-2}R_{7d}, -NR_xR_{7d},< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRx(CH2)1−2R7d<annotation encoding="application / x-tex">-NR_x(CH_2)_{1-2}R_{7d}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR7dR7d<annotation encoding="application / x-tex">-NR_{7d}R_{7d}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N((CH2)1−2R7d)2<annotation encoding="application / x-tex">-N((CH_2)_{1-2}R_{7d})_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OR7d<annotation encoding="application / x-tex">-OR_{7d}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)R7d<annotation encoding="application / x-tex">-C(O)R_{7d}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(CRxRx)1−2R7d<annotation encoding="application / x-tex">-C(O)(CR_xR_x)_{1-2}R_{7d}< / annotation>< / semantics>< / com:Math>, or -C(O)(CR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>)<com:Sub>1-2< / com:Sub>NR<com:Sub>x< / com:Sub>R<com:Sub>7d< / com:Sub>; or (ii) azepanyl, azetidinyl, cyclobutyl, cyclohexyl, diazepanyl, dioxotetrahydrothiopyranyl, dioxothiomorpholinyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxetanyl, piperazinonyl, piperazinyl, piperidinyl, pyridinyl, pyrimidinyl, pyrrolidinonyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydroisoquinolinyl, tetrahydropyranyl, or thiadiazolyl, each substituted with zero to 1 R<com:Sub>8a< / com:Sub> and zero to 3 R<com:Sub>8b< / com:Sub>; R<com:Sub>7d< / com:Sub> is azaspiro[3.5]nonanyl, azetidinyl, bicyclo[1.1.1]pentanyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, dioxothiaazaspiro[3.3]heptanyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxaazaspiro[4.4]nonyl, oxetanyl, phenyl, piperidinyl, pyrazolyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydropyranyl, thiadiazolyl, or triazolyl, each substituted with zero to 2 substituents selected from F, -OH, C<com:Sub>1-3< / com:Sub> alkyl, -CH<com:Sub>2< / com:Sub>OH, <com:Math><semantics>−OCH3<annotation encoding="application / x-tex">-OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH3<annotation encoding="application / x-tex">-C(O)CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)2CH3<annotation encoding="application / x-tex">-S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, methylpiperidinyl, methylpyrrolidinyl, tetramethylpiperidinyl, -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>(pyrrolidinyl), and -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NHCH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; and zero to 4 substituents selected from -CH<com:Sub>3< / com:Sub>; R<com:Sub>8< / com:Sub> is H, -CH<com:Sub>3< / com:Sub> or -CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; R<com:Sub>8a< / com:Sub> is -OH, C<com:Sub>1-4< / com:Sub> alkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>−(CH2)1−2O(C1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkoxy, <com:Math><semantics>−C(O)(C1−2<annotation encoding="application / x-tex">-C(O)(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−C(O)O(C1−2<annotation encoding="application / x-tex">-C(O)O(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−CH2(C3−6 cycloalkyl)<annotation encoding="application / x-tex">-CH_2(C_{3-6} \text{ cycloalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (methyl phenyl), <com:Math><semantics>−(CH2)1−3<annotation encoding="application / x-tex">-(CH_2)_{1-3}< / annotation>< / semantics>< / com:Math> (pyrrolidinyl), <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (methylpyrazolyl), <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (thiophenyl), <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl, methylpiperidinyl, or pyridinyl; and each R<com:Sub>8b< / com:Sub> is independently F or -CH<com:Sub>3< / com:Sub>. One embodiment provides a compound of Formula (I) or a salt thereof wherein A is -NR<com:Sub>7< / com:Sub>R<com:Sub>8< / com:Sub>; and G, R<com:Sub>1< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>7< / com:Sub>, R<com:Sub>8< / com:Sub>, R<com:Sub>x< / com:Sub>, and n are defined in the first aspect or the second aspect. Included in this embodiment are compounds in which R<com:Sub>7< / com:Sub> is: (i) R<com:Sub>7a< / com:Sub>, -CH<com:Sub>2< / com:Sub>R<com:Sub>7a< / com:Sub>, <com:Math><semantics>−C(O)R7a<annotation encoding="application / x-tex">-C(O)R_{7a}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH(NH2)R7a<annotation encoding="application / x-tex">-C(O)CH(NH_2)R_{7a}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(CH2)1−3NH2<annotation encoding="application / x-tex">-C(O)(CH_2)_{1-3}NH_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH(NH2)(C1−4 alkyl)<annotation encoding="application / x-tex">-C(O)CH(NH_2)(C_{1-4} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH(NH2)(CH2)1−2C(O)OH,−C(O)CH(NH2)(CH2)2−4NH2,or<annotation encoding="application / x-tex">-C(O)CH(NH_2)(CH_2)_{1-2}C(O)OH, -C(O)CH(NH_2)(CH_2)_{2-4}NH_2, or< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−C(O)CH(NH2)(CH2)1−3C(O)NH2<annotation encoding="application / x-tex">-C(O)CH(NH_2)(CH_2)_{1-3}C(O)NH_2< / annotation>< / semantics>< / com:Math>; or (ii) <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl substituted with one substituent selected from -NR<com:Sub>x< / com:Sub>(CH<com:Sub>2< / com:Sub>)<com:Sub>2-3< / com:Sub>NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, -NH(CH<com:Sub>2< / com:Sub>)<com:Sub>2-3< / com:Sub>NHCH<com:Sub>3< / com:Sub>, -NH(methylpiperidinyl), -NH(CH<com:Sub>2< / com:Sub>)<com:Sub>2-3< / com:Sub>(morpholinyl), dimethylamino piperidinyl, and piperazinyl substituted with a substituent selected from <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>−C(O)CH3<annotation encoding="application / x-tex">-C(O)CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2OCH3<annotation encoding="application / x-tex">-(CH_2)_{1-2}OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2<annotation encoding="application / x-tex">-CH_2< / annotation>< / semantics>< / com:Math>(methylphenyl), -(CH<com:Sub>2< / com:Sub>)<com:Sub>2-3< / com:Sub>(pyrrolidinyl), C<com:Sub>3-6< / com:Sub> cycloalkyl, pyridinyl, and methylpiperidinyl; R<com:Sub>7b< / com:Sub> is: (i) C<com:Sub>1-4< / com:Sub> alkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>−(CH2)2−3C≡CH<annotation encoding="application / x-tex">-(CH_2)_{2-3}C \equiv CH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)0−3NRxRx<annotation encoding="application / x-tex">-(CH_2)_{0-3}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(CH2)1−3NRxRx<annotation encoding="application / x-tex">-NR_x(CH_2)_{1-3}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH3)CH2CH2NH2<annotation encoding="application / x-tex">-N(CH_3)CH_2CH_2NH_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−O(CH2)1−3NRxRx<annotation encoding="application / x-tex">-O(CH_2)_{1-3}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2R7d<annotation encoding="application / x-tex">-(CH_2)_{1-2}R_{7d}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NHR7d<annotation encoding="application / x-tex">-NHR_{7d}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NH(CH2)1−2R7d<annotation encoding="application / x-tex">-NH(CH_2)_{1-2}R_{7d}< / annotation>< / semantics>< / com:Math>, or -OR<com:Sub>7d< / com:Sub>; or (ii) azepanyl, diazepanyl, morpholinyl, piperazinyl, piperidinyl, pyridinyl, pyrrolidinonyl, pyrrolidinyl, or tetrahydroisoquinolinyl, each substituted with zero to 1 R<com:Sub>8a< / com:Sub> and zero to 3 R<com:Sub>8b< / com:Sub>; R<com:Sub>7d< / com:Sub> is azaspiro[3.5]nonanyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, morpholinyl, phenyl, piperidinyl, or pyrrolidinyl, each substituted with zero to 1 substituent selected from <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl, -NH<com:Sub>2< / com:Sub>, methylpiperidinyl, methylpyrrolidinyl, -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>(pyrrolidinyl), -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NHCH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; and zero to 4 substituents selected from -CH<com:Sub>3< / com:Sub>; and R<com:Sub>8< / com:Sub> is H or <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl; <com:Math><semantics>R8a<annotation encoding="application / x-tex">R_{8a}< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−OH<annotation encoding="application / x-tex">-OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>−(CH2)1−2O(C1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−C(O)(C1−2)<annotation encoding="application / x-tex">-C(O)(C_{1-2})< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−CH2(C3−6 cycloalkyl)<annotation encoding="application / x-tex">-CH_2(C_{3-6} \text{ cycloalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (methyl phenyl), <com:Math><semantics>−(CH2)1−3<annotation encoding="application / x-tex">-(CH_2)_{1-3}< / annotation>< / semantics>< / com:Math> (pyrrolidinyl), <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (methylpyrazolyl), <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (thiophenyl), <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl, methylpiperidinyl, or pyridinyl; and each R<com:Sub>8b< / com:Sub> is independently F or -CH<com:Sub>3< / com:Sub>. One embodiment provides a compound of Formula (I) or a salt thereof wherein A is -NR<com:Sub>7< / com:Sub>R<com:Sub>8< / com:Sub>; and G, R<com:Sub>1< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>7< / com:Sub>, R<com:Sub>8< / com:Sub>, R<com:Sub>x< / com:Sub>, R<com:Sub>y< / com:Sub>, and n are defined in the first aspect or the second aspect. Included in this embodiment are compounds in which R7 and R8 together with the nitrogen atom to which they are attached form a heterocyclic ring selected azetidinyl, diazabicyclo[2.2.1]heptanyl, diazabicyclo[2.2.2]octanyl, diazabicyclo[3.1.1]heptanyl, diazabicyclo[3.2.1]octanyl, azaspiro[3.3]heptanyl, diazaspiro[2.5]octanyl, diazaspiro[3.3]heptanyl, diazepanonyl, diazepanyl, diazaspiro[3.5]nonanyl, diazaspiro[5.5]undecanyl, imidazolyl, imidazolidinonyl, octahydro-1H-pyrrolo[3,4-b]pyridinyl, oxadiazabicyclo[3.3.1]nonanyl, piperazinyl, piperazinonyl, piperidinyl, pyrrolidinonyl, pyrrolidinyl, and pyrrolyl, wherein said heterocyclic ring is substituted with zero to 1 R<com:Sub>7b< / com:Sub> and zero to 2 R<com:Sub>7c< / com:Sub>; R<com:Sub>7b< / com:Sub> is: (i) –OH, C<com:Sub>1-6< / com:Sub> alkyl, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> aminoalkyl, <com:Math><semantics>−(CH2)2−3C≡CH<annotation encoding="application / x-tex">-(CH_2)_{2-3}C \equiv CH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CRxRx)1−2O(C1−2 alkyl),−(CH2)1−3S(O)2(C1−2 alkyl),−(CH2)0−3NRxRy,<annotation encoding="application / x-tex">-(CR_xR_x)_{1-2}O(C_{1-2} \text{ alkyl}), -(CH_2)_{1-3}S(O)_2(C_{1-2} \text{ alkyl}), -(CH_2)_{0-3}NR_xR_y,< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRyRy<annotation encoding="application / x-tex">-NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(C1−4 hydroxyalkyl)<annotation encoding="application / x-tex">-NR_x(C_{1-4} \text{ hydroxyalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRy(C1−2 cyanoalkyl)<annotation encoding="application / x-tex">-NR_y(C_{1-2} \text{ cyanoalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(C1−2 cyanoalkyl)2<annotation encoding="application / x-tex">-N(C_{1-2} \text{ cyanoalkyl})_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(C1−2 fluoroalkyl)<annotation encoding="application / x-tex">-NR_x(C_{1-2} \text{ fluoroalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(C2−4 hydroxyfluoroalkyl)<annotation encoding="application / x-tex">-NR_x(C_{2-4} \text{ hydroxyfluoroalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CRxRx)1−2C(O)NRxRx<annotation encoding="application / x-tex">-(CR_xR_x)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(CH2)1−2C(O)NRxRx<annotation encoding="application / x-tex">-NR_x(CH_2)_{1-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N((CH2)1−2C(O)NRxRx)2<annotation encoding="application / x-tex">-N((CH_2)_{1-2}C(O)NR_xR_x)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(CH2)1−2S(O)2(C1−2 alkyl),−NRx(CH2)1−3NRxRx,−NRxCH2CH2NRxRx,<annotation encoding="application / x-tex">-NR_x(CH_2)_{1-2}S(O)_2(C_{1-2} \text{ alkyl}), -NR_x(CH_2)_{1-3}NR_xR_x, -NR_xCH_2CH_2NR_xR_x,< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRxC(O)(CH2)1−2NRxRx<annotation encoding="application / x-tex">-NR_xC(O)(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(CH2CH2S(O)2CH3)<annotation encoding="application / x-tex">-NR_x(CH_2CH_2S(O)_2CH_3)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2NRxC(O)(CH2)1−2NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xC(O)(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−O(CH2)1−3NRxRx<annotation encoding="application / x-tex">-O(CH_2)_{1-3}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(CRxRx)1−2NRyRy<annotation encoding="application / x-tex">-C(O)(CR_xR_x)_{1-2}NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(CRxRx)1−2NRy(C1−4 hydroxyalkyl)<annotation encoding="application / x-tex">-C(O)(CR_xR_x)_{1-2}NR_y(C_{1-4} \text{ hydroxyalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(CRxRx)1−2NRx(CH2CH2OCH3),−S(O)2CH2CH2N(CH3)2,−(CH2)1−2R7d,−NRxR7d,<annotation encoding="application / x-tex">-C(O)(CR_xR_x)_{1-2}NR_x(CH_2CH_2OCH_3), -S(O)_2CH_2CH_2N(CH_3)_2, -(CH_2)_{1-2}R_{7d}, -NR_xR_{7d},< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRx(CH2)1−2R7d<annotation encoding="application / x-tex">-NR_x(CH_2)_{1-2}R_{7d}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR7dR7d<annotation encoding="application / x-tex">-NR_{7d}R_{7d}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N((CH2)1−2R7d)2<annotation encoding="application / x-tex">-N((CH_2)_{1-2}R_{7d})_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OR7d<annotation encoding="application / x-tex">-OR_{7d}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)R7d<annotation encoding="application / x-tex">-C(O)R_{7d}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(CRxRx)1−2R7d<annotation encoding="application / x-tex">-C(O)(CR_xR_x)_{1-2}R_{7d}< / annotation>< / semantics>< / com:Math>, or <com:Math><semantics>−C(O)(CRxRx)1−2NRxR7d<annotation encoding="application / x-tex">-C(O)(CR_xR_x)_{1-2}NR_xR_{7d}< / annotation>< / semantics>< / com:Math>; or (ii) azepanyl, azetidinyl, <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl, diazepanyl, dioxotetrahydrothiopyranyl, dioxothiomorpholinyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxetanyl, piperazinonyl, piperazinyl, piperidinyl, pyridinyl, pyrimidinyl, pyrrolidinonyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydroisoquinolinyl, tetrahydropyranyl, or thiadiazolyl, each substituted with zero to 1 R<com:Sub>8a< / com:Sub> and zero to 3 R<com:Sub>8b< / com:Sub>; each R<com:Sub>7c< / com:Sub> is independently F, -CH<com:Sub>3< / com:Sub> or -CH<com:Sub>2< / com:Sub>CN; R<com:Sub>7d< / com:Sub> is azaspiro[3.5]nonanyl, azetidinyl, bicyclo[1.1.1]pentanyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, dioxothiaazaspiro[3.3]heptanyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxaazaspiro[4.4]nonyl, oxetanyl, phenyl, piperidinyl, pyrazolyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydropyranyl, thiadiazolyl, or triazolyl, each substituted with zero to 2 substituents independently selected from F, –OH, C<com:Sub>1-3< / com:Sub> alkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkoxy, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH3<annotation encoding="application / x-tex">-C(O)CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)2CH3<annotation encoding="application / x-tex">-S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, methylpiperidinyl, methylpyrrolidinyl, tetramethylpiperidinyl, -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>(pyrrolidinyl), and -OCH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NHCH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; and zero to 4 substituents selected from -CH<com:Sub>3< / com:Sub>; R<com:Sub>8a< / com:Sub> is -OH, C<com:Sub>1-4< / com:Sub> alkyl, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>−(CH2)1−2O(C1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> alkoxy, <com:Math><semantics>−C(O)(C1−2<annotation encoding="application / x-tex">-C(O)(C_{1-2}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−C(O)O(C1−2 alkyl),−CH2(C3−6 cycloalkyl),−(CH2)1−2 (methyl phenyl),<annotation encoding="application / x-tex">-C(O)O(C_{1-2} \text{ alkyl}), -CH_2(C_{3-6} \text{ cycloalkyl}), -(CH_2)_{1-2} \text{ (methyl phenyl)},< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−(CH2)1−3<annotation encoding="application / x-tex">-(CH_2)_{1-3}< / annotation>< / semantics>< / com:Math> (pyrrolidinyl), <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (methylpyrazolyl), <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (thiophenyl), <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, C<com:Sub>3-6< / com:Sub> cycloalkyl, methylpiperidinyl, or pyridinyl; and each R<com:Sub>8b< / com:Sub> is independently F or <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math>. One embodiment provides a compound of Formula (I) or a salt thereof wherein A is -NR<com:Sub>7< / com:Sub>R<com:Sub>8< / com:Sub>; and G, R<com:Sub>1< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>7< / com:Sub>, R<com:Sub>8< / com:Sub>, and n are defined in the first aspect or the second aspect. Included in this embodiment are compounds in which R7 and R8 together with the nitrogen atom to which they are attached form a heterocyclic ring selected from azetidinyl, diazepanonyl, diazepanyl, diazaspiro[3.5]nonanyl, diazaspiro[5.5]undecanyl, imidazolyl, imidazolidinonyl, octahydro-1H-pyrrolo[3,4-b]pyridinyl, piperazinyl, piperidinyl, pyrrolidinonyl, pyrrolidinyl, and pyrrolyl, wherein said heterocyclic ring is substituted with zero to 1 R<com:Sub>7b< / com:Sub> and zero to 2 R<com:Sub>7c< / com:Sub>; R<com:Sub>7b< / com:Sub> is: (i) C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-3< / com:Sub> hydroxyalkyl, <com:Math><semantics>−(CH2)2−3C=CH1<annotation encoding="application / x-tex">-(CH_2)_{2-3}C = CH_1< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)0−3NRxRx<annotation encoding="application / x-tex">-(CH_2)_{0-3}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRx(CH2)1−3NRxRx<annotation encoding="application / x-tex">-NR_x(CH_2)_{1-3}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH3)CH2CH2NH2<annotation encoding="application / x-tex">-N(CH_3)CH_2CH_2NH_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−O(CH2)1−3NRxRx<annotation encoding="application / x-tex">-O(CH_2)_{1-3}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2R7d<annotation encoding="application / x-tex">-(CH_2)_{1-2}R_{7d}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NHR7d<annotation encoding="application / x-tex">-NHR_{7d}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NH(CH2)1−2R7d<annotation encoding="application / x-tex">-NH(CH_2)_{1-2}R_{7d}< / annotation>< / semantics>< / com:Math>, or <com:Math><semantics>−OR7d<annotation encoding="application / x-tex">-OR_{7d}< / annotation>< / semantics>< / com:Math>; or (ii) azepanyl, diazepanyl, morpholinyl, piperazinyl, piperidinyl, pyridinyl, pyrrolidinonyl, pyrrolidinyl, or tetrahydroisoquinolinyl, each substituted with zero to 1 R<com:Sub>8a< / com:Sub> and zero to 3 R<com:Sub>8b< / com:Sub>; each R<com:Sub>7c< / com:Sub> is independently F, -CH<com:Sub>3< / com:Sub> or -CH<com:Sub>2< / com:Sub>CN; R<com:Sub>8a< / com:Sub> is -OH, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-3< / com:Sub> fluoroalkyl, <com:Math><semantics>−(CH2)1−2O(C1−2 alkyl),−C(O)(C1−2 alkyl),−CH2(C3−6 cycloalkyl),−(CH2)1−2 (methyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-2} \text{ alkyl}), -C(O)(C_{1-2} \text{ alkyl}), -CH_2(C_{3-6} \text{ cycloalkyl}), -(CH_2)_{1-2} \text{ (methyl)}< / annotation>< / semantics>< / com:Math> phenyl), <com:Math><semantics>−(CH2)1−3<annotation encoding="application / x-tex">-(CH_2)_{1-3}< / annotation>< / semantics>< / com:Math> (pyrrolidinyl), <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (methylpyrazolyl), <com:Math><semantics>−(CH2)1−2<annotation encoding="application / x-tex">-(CH_2)_{1-2}< / annotation>< / semantics>< / com:Math> (thiophenyl), -NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, C<com:Sub>3-6< / com:Sub> cycloalkyl, methylpiperidinyl, or pyridinyl; and each R<com:Sub>8b< / com:Sub> is independently F or <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math>. One embodiment provides a compound of Formula (I) or a salt thereof wherein A is <com:Math><semantics>−(CRxRx)1−3R11<annotation encoding="application / x-tex">-(CR_xR_x)_{1-3}R_{11}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CRxRx)1−3NRxC(O)R11<annotation encoding="application / x-tex">-(CR_xR_x)_{1-3}NR_xC(O)R_{11}< / annotation>< / semantics>< / com:Math>, or <com:Math><semantics>−(CRxRx)1−2NRxC(O)(CH2)1−2NRxRx<annotation encoding="application / x-tex">-(CR_xR_x)_{1-2}NR_xC(O)(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>; and G, R<com:Sub>1< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>11< / com:Sub>, R<com:Sub>x< / com:Sub>, and n are defined in the first aspect or the second aspect. Included in this embodiment are compounds in which <com:Math><semantics>R11<annotation encoding="application / x-tex">R_{11}< / annotation>< / semantics>< / com:Math> is azetidinyl, azaspiro[3.5]nonanyl, dioxidothiomorpholinyl, hexahydropyrrolo[3,4-c]pyrrolyl, morpholinyl, piperazinyl, piperidinyl, pyridinyl, or pyrrolidinyl, each substituted with zero to 3 substituents independently selected from F, Cl, -CN, C<com:Sub>1-3< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> aminoalkyl, -CH<com:Sub>2< / com:Sub>(methyloxetanyl), -CH<com:Sub>2< / com:Sub>(triazolyl), -CH<com:Sub>2< / com:Sub>(phenyl), -C(O)CH<com:Sub>2< / com:Sub>NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, <com:Math><semantics>−CH2CRxRxOH<annotation encoding="application / x-tex">-CH_2CR_xR_xOH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)NRxRx<annotation encoding="application / x-tex">-CH_2C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH2S(O)2(C1−3 alkyl)<annotation encoding="application / x-tex">-CH_2CH_2S(O)_2(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH2S(O)(C1−3 alkyl)<annotation encoding="application / x-tex">-CH_2CH_2S(O)(C_{1-3} \text{ alkyl})< / annotation>< / semantics>< / com:Math> alkyl), oxetanyl, tetrahydrofuranyl, and tetrahydropyranyl. Also included in this embodiment are compounds in which R<com:Sub>11< / com:Sub> is azetidinyl, azaspiro[3.5]nonanyl, dioxidothiomorpholinyl, hexahydropyrrolo[3,4-c]pyrrolyl, morpholinyl, piperazinyl, piperidinyl, pyridinyl, or pyrrolidinyl, each substituted with zero to 3 substituents independently selected from F, Cl, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C1−3<annotation encoding="application / x-tex">C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> aminoalkyl, <com:Math><semantics>−CH2<annotation encoding="application / x-tex">-CH_2< / annotation>< / semantics>< / com:Math>(phenyl), <com:Math><semantics>−C(O)CH2NRxRx<annotation encoding="application / x-tex">-C(O)CH_2NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CRxRxOH<annotation encoding="application / x-tex">-CH_2CR_xR_xOH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)NRxRx<annotation encoding="application / x-tex">-CH_2C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH2S(O)2(C1−3alkyl)<annotation encoding="application / x-tex">-CH_2CH_2S(O)_2(C_{1-3} alkyl)< / annotation>< / semantics>< / com:Math>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>S(O)(C<com:Sub>1-3< / com:Sub> alkyl), oxetanyl, tetrahydrofuranyl, and tetrahydropyranyl. One embodiment provides a compound of Formula (I) or a salt thereof wherein A is -CR<com:Sub>x< / com:Sub>R<com:Sub>12< / com:Sub>R<com:Sub>13< / com:Sub>, wherein R<com:Sub>12< / com:Sub> and R<com:Sub>13< / com:Sub> together with the carbon atom to which they are attached form a cyclic group selected from azabicyclo[4.1.1]octanyl, azepanyl, azetidinyl, C<com:Sub>3-7< / com:Sub> cycloalkyl, diazepanyl, azaspiro[3.3]heptanyl, diazaspiro[4.5]decanonyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, piperazinyl, piperidinyl, pyrrolidinyl, and quinuclidinyl, each substituted with zero to 4 R<com:Sub>12a< / com:Sub>; and G, R<com:Sub>1< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>12< / com:Sub>, R<com:Sub>13< / com:Sub>, R<com:Sub>x< / com:Sub>, R<com:Sub>y< / com:Sub>, and n are defined in the first aspect or the second aspect. Included in this embodiment are compounds in which R<com:Sub>12< / com:Sub> and R<com:Sub>13< / com:Sub> together with the carbon atom to which they are attached form a cyclic group selected from azabicyclo[4.1.1]octanyl, azepanyl, azetidinyl, C<com:Sub>3-7< / com:Sub> cycloalkyl, diazepanyl, diazaspiro[4.5]decanonyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, piperazinyl, piperidinyl, pyrrolidinyl, and quinuclidinyl, each substituted with zero to 4 R<com:Sub>12a< / com:Sub>. Also included in this embodiment are compounds in which each R<com:Sub>12a< / com:Sub> is independently -OH, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-3< / com:Sub> fluoroalkyl, C<com:Sub>1-2< / com:Sub> cyanoalkyl, C<com:Sub>1-4< / com:Sub> hydroxyalkyl, <com:Math><semantics>−(CH2)1−2O(C1−2 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)NRxRx<annotation encoding="application / x-tex">-CH_2C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2S(O)2(C1−2 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}S(O)_2(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2NHS(O)2(C1−2 alkyl),−(CH2)1−2NRxRx,C1−2 alkoxy,−NRyRy,−NRx(C1−3)x<annotation encoding="application / x-tex">-(CH_2)_{1-2}NHS(O)_2(C_{1-2} \text{ alkyl}), -(CH_2)_{1-2}NR_xR_x, C_{1-2} \text{ alkoxy}, -NR_yR_y, -NR_x(C_{1-3})_x< / annotation>< / semantics>< / com:Math> [Image disponible dans le document PDF, Image available in the PDF document] diazabicyclo[2.2.1]heptanyl, dioxolanyl, dioxothiaazaspiro[3.3]heptanyl, dioxidotetrahydrothiopyranyl, dioxidothiomorpholinyl, imidazolyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, octahydropyrrolo[3,4-c]pyrrolyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxaazaspiro[4.4]nonanyl, oxetanyl, phenyl, piperazinyl, piperazinonyl, piperidinyl, pyridinyl, pyrrolidinyl, quinuclidinyl, tetrahydrofuranyl, tetrahydropyranyl, or triazolyl, each substituted with zero to 4 substituents independently selected from F, Cl, –OH, C<com:Sub>1-3< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> hydroxyalkyl, C<com:Sub>1-2< / com:Sub> alkoxy, <com:Math><semantics>−(CH2)1−2O(C1−2 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{1-2}O(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NRxRx<annotation encoding="application / x-tex">-C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−CH2S(O)2(C1−2 alkyl)<annotation encoding="application / x-tex">-CH_2S(O)_2(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>. One embodiment provides a compound of Formula (I) or a salt thereof wherein A is an aromatic group selected from [1,2,4]triazolo[1,5-a]pyridinyl, imidazo[1,2-a]pyridinyl, imidazolyl, indazolyl, isoquinolinyl, oxadiazolyl, oxazolyl, phenyl, pyrazinyl, pyrazolo[3,4-b]pyridinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, quinolinonyl, quinolinyl, quinoxalinyl, tetrahydro- [1,2,4]triazolo[1,5-a]pyrazinyl, tetrahydroimidazo[1,2-a]pyrazinyl, tetrahydroisoquinolinyl, tetrahydrothiazolo[5,4-c]pyridinyl, tetrahydrothieno[2,3-c]pyridinyl, thiadiazolyl, thiazolyl, thiooxadiazolyl, and triazolyl, each substituted with zero to 2 R<com:Sub>14a< / com:Sub> and zero to 3 R<com:Sub>14b< / com:Sub>; and G, R<com:Sub>1< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>14a< / com:Sub>, R<com:Sub>14b< / com:Sub>, R<com:Sub>x< / com:Sub>, R<com:Sub>y< / com:Sub>, and n are defined in the first aspect. Included in this embodiment are compounds in which each R<com:Sub>14a< / com:Sub> is independently: (i) H, F, Cl, -OH, C<com:Sub>1-5< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> fluoroalkyl, C<com:Sub>1-2< / com:Sub> hydroxyalkyl, <com:Math><semantics>−(CH2)0−2OCH3<annotation encoding="application / x-tex">-(CH_2)_{0-2}OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CHRxNRx(C1−5 alkyl)<annotation encoding="application / x-tex">-CHR_xNR_x(C_{1-5} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CHRxNRx(C1−2 cyanoalkyl)<annotation encoding="application / x-tex">-CHR_xNR_x(C_{1-2} \text{ cyanoalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CHRxNRx((CH2)1−2OCH3)<annotation encoding="application / x-tex">-CHR_xNR_x((CH_2)_{1-2}OCH_3)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CHRxN((CH2)1−2OCH3)2<annotation encoding="application / x-tex">-CHR_xN((CH_2)_{1-2}OCH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2NRx(CH2C≡CRx)<annotation encoding="application / x-tex">-CH_2NR_x(CH_2C\equiv CR_x)< / annotation>< / semantics>< / com:Math>, [Image disponible dans le document PDF, Image available in the PDF document] azaspiro[3.5]nonanyl, azetidinyl, benzo[c][1,2,5]oxadiazolyl, cyclopentyl, cyclohexyl, diazepanyl, morpholinyl, phenyl, piperazinyl, piperidinyl, pyrazolyl, pyridinyl, pyrrolidinonyl, quinolinyl, quinuclidinyl, tetrahydroisoquinolinyl, tetrahydropyridinyl, or thiazolidinyl, each substituted with zero to 2 substituents independently selected from <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(C1−2)1−2NRxRx<annotation encoding="application / x-tex">-C(O)(C_{1-2})_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−C(O)CH2NRxRx<annotation encoding="application / x-tex">-C(O)CH_2NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)O(C1−3<annotation encoding="application / x-tex">-C(O)O(C_{1-3}< / annotation>< / semantics>< / com:Math> alkyl), <com:Math><semantics>−CH2C(O)NRxRx<annotation encoding="application / x-tex">-CH_2C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl, -CH<com:Sub>2< / com:Sub>(phenyl), -CH<com:Sub>2< / com:Sub>(pyrrolyl), -CH<com:Sub>2< / com:Sub>(morpholinyl), -CH<com:Sub>2< / com:Sub>(methylpiperazinyl), -CH<com:Sub>2< / com:Sub>(thiophenyl), methylpiperidinyl, isobutylpiperidinyl, and pyridinyl; or (iii) -L<com:Sub>3< / com:Sub>-R<com:Sub>14c< / com:Sub>; each R<com:Sub>14b< / com:Sub> is F, -CH<com:Sub>3< / com:Sub>, or -OCH<com:Sub>3< / com:Sub>; and R<com:Sub>14c< / com:Sub> is adamantanyl, azepanyl, azetidinyl, C<com:Sub>3-7< / com:Sub> cycloalkyl, diazepanyl, imidazolyl, indolyl, morpholinyl, octahydropyrrolo[3,4- c|pyrrolyl, phenyl, piperazinonyl, piperazinyl, piperidinyl, pyridinyl, pyrrolidinonyl, pyrrolidinyl, pyrrolyl, triazolyl, or tetrazolyl, each substituted with zero to 1 substituent selected from F, -OH, C<com:Sub>1-4< / com:Sub> alkyl, C<com:Sub>1-3< / com:Sub> hydroxyalkyl, -NR<com:Sub>x< / com:Sub>R<com:Sub>y< / com:Sub>, -NR<com:Sub>x< / com:Sub>C(O)CH<com:Sub>3< / com:Sub>, <com:Math><semantics>−C(O)(C1−2 alkyl),−C(O)NRxRx,−C(O)N(CH2CH3)2,−C(O)(tetrahydrofuranyl),<annotation encoding="application / x-tex">-C(O)(C_{1-2} \text{ alkyl}), -C(O)NR_xR_x, -C(O)N(CH_2CH_3)_2, -C(O)(\text{tetrahydrofuranyl}),< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−C(O)O(C1−2 alkyl),−CH2C(O)NRxRy, morpholinyl, methylpiperidinyl, pyrazinyl,<annotation encoding="application / x-tex">-C(O)O(C_{1-2} \text{ alkyl}), -CH_2C(O)NR_xR_y, \text{ morpholinyl, methylpiperidinyl, pyrazinyl,}< / annotation>< / semantics>< / com:Math> pyridinyl, and pyrrolidinyl. One embodiment provides a compound of Formula (1), N-oxide, or a salt thereof, wherein said compound has the structure: [Image disponible dans le document PDF, Image available in the PDF document] wherein G, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>7b< / com:Sub>, R<com:Sub>7c< / com:Sub>, n, and p are defined in the first aspect or the second [Image disponible dans le document PDF, Image available in the PDF document] aspect. Included in this embodiment are compounds in which G is ; and R<com:Sub>1< / com:Sub> is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>. Also included in this embodiment are compounds in which n is zero. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein said compound has the structure: [Image disponible dans le document PDF, Image available in the PDF document] wherein G, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>7b< / com:Sub>, R<com:Sub>7c< / com:Sub>, n, and p are defined in the first aspect or the second [Image disponible dans le document PDF, Image available in the PDF document] aspect. Included in this embodiment are compounds in which G is is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>. Also included in this embodiment are compounds in which n is zero. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein said compound has the structure: [Image disponible dans le document PDF, Image available in the PDF document] wherein G, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>76< / com:Sub>, R<com:Sub>7c< / com:Sub>, n, and p are defined in the first aspect or the second [Image disponible dans le document PDF, Image available in the PDF document] aspect. Included in this embodiment are compounds in which G is ; and R<com:Sub>1< / com:Sub> is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>. Also included in this embodiment are compounds in which n is zero. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein said compound has the structure: [Image disponible dans le document PDF, Image available in the PDF document] wherein <com:Math><semantics>R7b<annotation encoding="application / x-tex">R_{7b}< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−C(O)(CRxRx)1−2NRyRy<annotation encoding="application / x-tex">-C(O)(CR_xR_x)_{1-2}NR_yR_y< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)(CRxRx)1−2NRy(C1−4<annotation encoding="application / x-tex">-C(O)(CR_xR_x)_{1-2}NR_y(C_{1-4}< / annotation>< / semantics>< / com:Math> hydroxyalkyl), or -C(O)(CR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>)<com:Sub>1-2< / com:Sub>NR<com:Sub>x< / com:Sub>(CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OCH<com:Sub>3< / com:Sub>); and G, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>x< / com:Sub>, R<com:Sub>y< / com:Sub>, n, and p are defined in the first aspect or the second aspect. Included in this embodiment are compounds in [Image disponible dans le document PDF, Image available in the PDF document] which G is ; <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; and n is zero. Also included in this embodiment are compounds in which R<com:Sub>7b< / com:Sub> is -C(O)(CR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>)<com:Sub>1-2< / com:Sub>NR<com:Sub>y< / com:Sub>R<com:Sub>y< / com:Sub>. Additionally, [Image disponible dans le document PDF, Image available in the PDF document] included in this embodiment are compounds in which G is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>; <com:Math><semantics>R7b<annotation encoding="application / x-tex">R_{7b}< / annotation>< / semantics>< / com:Math> is -C(O)CH<com:Sub>2< / com:Sub>N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub> or -C(O)CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub> or and n is zero. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein said compound has the structure: [Image disponible dans le document PDF, Image available in the PDF document] wherein G, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>7b< / com:Sub>, n, and p are defined in the first aspect or the second aspect. [Image disponible dans le document PDF, Image available in the PDF document] Included in this embodiment are compounds in which G is ; and R<com:Sub>1< / com:Sub> is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>. Also included in this embodiment are compounds in which n is zero. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein said compound has the structure: [Image disponible dans le document PDF, Image available in the PDF document] wherein G, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>7b< / com:Sub>, n, and p are defined in the first aspect or the second aspect. [Image disponible dans le document PDF, Image available in the PDF document] Included in this embodiment are compounds in which G is ; and R<com:Sub>1< / com:Sub> is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>. Also included in this embodiment are compounds in which compounds in [Image disponible dans le document PDF, Image available in the PDF document] which G is . Additionally, included in this embodiment are compounds in which n is zero. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein said compound has the structure: [Image disponible dans le document PDF, Image available in the PDF document] wherein G, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>12a< / com:Sub>, n, and p are defined in the first aspect or the second aspect. [Image disponible dans le document PDF, Image available in the PDF document] Included in this embodiment are compounds in which G is ; and R<com:Sub>1< / com:Sub> is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>. Also included in this embodiment are compounds in which n is zero. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein said compound has the structure: [Image disponible dans le document PDF, Image available in the PDF document] wherein G, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>12a< / com:Sub>, n, and p are defined in the first aspect or the second aspect. [Image disponible dans le document PDF, Image available in the PDF document] Included in this embodiment are compounds in which G is ; and R<com:Sub>1< / com:Sub> is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>. Also included in this embodiment are compounds in which n is zero. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein said compound has the structure: [Image disponible dans le document PDF, Image available in the PDF document] wherein G, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>12a< / com:Sub>, n, and p are defined in the first aspect or the second aspect. [Image disponible dans le document PDF, Image available in the PDF document] Included in this embodiment are compounds in which G is ; and R1 is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>. Also included in this embodiment are compounds in which n is zero. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein said compound has the structure: [Image disponible dans le document PDF, Image available in the PDF document] wherein G, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>12a< / com:Sub>, n, and p are defined in the first aspect or the second aspect. [Image disponible dans le document PDF, Image available in the PDF document] Included in this embodiment are compounds in which G is ; and R<com:Sub>1< / com:Sub> is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>. Also included in this embodiment are compounds in which compounds in [Image disponible dans le document PDF, Image available in the PDF document] which G is . Additionally, included in this embodiment are compounds in which n is zero. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein said compound has the structure: [Image disponible dans le document PDF, Image available in the PDF document] wherein G, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>12a< / com:Sub>, n, and p are defined in the first aspect or the second aspect. [Image disponible dans le document PDF, Image available in the PDF document] Included in this embodiment are compounds in which G is ; and <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>. Also included in this embodiment are compounds in which compounds in [Image disponible dans le document PDF, Image available in the PDF document] which G is . Additionally, included in this embodiment are compounds in which n is zero. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein said compound has the structure: [Image disponible dans le document PDF, Image available in the PDF document] wherein <com:Math><semantics>R12a<annotation encoding="application / x-tex">R_{12a}< / annotation>< / semantics>< / com:Math> is -NR<com:Sub>x< / com:Sub>CR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>R<com:Sub>12b< / com:Sub>; <com:Math><semantics>R12b<annotation encoding="application / x-tex">R_{12b}< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl, each substituted with -S(O)<com:Sub>2< / com:Sub>(C<com:Sub>1-2< / com:Sub> alkyl) or -CH<com:Sub>2< / com:Sub>S(O)<com:Sub>2< / com:Sub>(C<com:Sub>1-2< / com:Sub> alkyl); and G, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>x< / com:Sub>, n, and p are defined in the first aspect or the second aspect. Included in this embodiment are compounds in which G is [Image disponible dans le document PDF, Image available in the PDF document] ; and <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>. Also included in this embodiment are compounds [Image disponible dans le document PDF, Image available in the PDF document] in which compounds in which G is ; <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; <com:Math><semantics>R12b<annotation encoding="application / x-tex">R_{12b}< / annotation>< / semantics>< / com:Math> is cyclopropyl substituted with <com:Math><semantics>−S(O)2(C1−2 alkyl)<annotation encoding="application / x-tex">-S(O)_2(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math> or <com:Math><semantics>−CH2S(O)2(C1−2 alkyl)<annotation encoding="application / x-tex">-CH_2S(O)_2(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>; and n is zero. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof, wherein: [Image disponible dans le document PDF, Image available in the PDF document] ٠<com:Br / >پ R<com:Sub>1< / com:Sub> is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>; each R<com:Sub>2< / com:Sub> is independently Cl, -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CN, -OCH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>OCH<com:Sub>3< / com:Sub>, or -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>S(O)<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; and A is -CR<com:Sub>x< / com:Sub>R<com:Sub>12< / com:Sub>R<com:Sub>13< / com:Sub>, wherein R<com:Sub>12< / com:Sub> and R<com:Sub>13< / com:Sub> together with the carbon atom to which they are attached form a cyclic group selected from azaspiro[3.3]heptanyl, C<com:Sub>4-6< / com:Sub> cycloalkyl, [Image disponible dans le document PDF, Image available in the PDF document] with zero to 2 R<com:Sub>12a< / com:Sub>; and R<com:Sub>2a< / com:Sub>, R<com:Sub>2b< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>12a< / com:Sub>, n, and p are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I) or a salt thereof wherein: [Image disponible dans le document PDF, Image available in the PDF document] G is ; <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; each <com:Math><semantics>R2<annotation encoding="application / x-tex">R_2< / annotation>< / semantics>< / com:Math> is independently <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math> or -OCH<com:Sub>3< / com:Sub>; A is -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>R<com:Sub>11< / com:Sub>; and R<com:Sub>11< / com:Sub> is azetidinyl or piperidinyl, each substituted with zero to 2 substituents independently selected from -CH<com:Sub>2< / com:Sub>(methyloxetanyl), [Image disponible dans le document PDF, Image available in the PDF document] -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>S(O)<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, and oxetanyl; and R<com:Sub>5< / com:Sub>, n, and p are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I) or a salt thereof wherein: [Image disponible dans le document PDF, Image available in the PDF document] Gis ; A is <com:Math><semantics>−C(O)NR9R10<annotation encoding="application / x-tex">-C(O)NR_9R_{10}< / annotation>< / semantics>< / com:Math>; <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; each <com:Math><semantics>R2<annotation encoding="application / x-tex">R_2< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−OCH3<annotation encoding="application / x-tex">-OCH_3< / annotation>< / semantics>< / com:Math>; <com:Math><semantics>R9<annotation encoding="application / x-tex">R_9< / annotation>< / semantics>< / com:Math> is -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CF<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, or -(CH<com:Sub>2< / com:Sub>)<com:Sub>0-3< / com:Sub>R<com:Sub>9a< / com:Sub>; R<com:Sub>9a< / com:Sub> is piperidinyl substituted with -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>; R<com:Sub>10< / com:Sub> is H, -CH<com:Sub>3< / com:Sub>, or -CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>; or R<com:Sub>9< / com:Sub> and R<com:Sub>10< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic ring selected from piperazinyl substituted with <com:Math><semantics>−C(O)CH3<annotation encoding="application / x-tex">-C(O)CH_3< / annotation>< / semantics>< / com:Math>; and <com:Math><semantics>R5<annotation encoding="application / x-tex">R_5< / annotation>< / semantics>< / com:Math>, n, and p are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I) or a salt thereof wherein: [Image disponible dans le document PDF, Image available in the PDF document] Gis each R<com:Sub>2< / com:Sub> is independently -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, or -OCH<com:Sub>3< / com:Sub>; R<com:Sub>7< / com:Sub> and R<com:Sub>8< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic ring selected from azetidinyl, diazabicyclo[2.2.1]heptanyl, diazabicyclo[2.2.2]octanyl, diazabicyclo[3.1.1]heptanyl, diazabicyclo[3.2.1]octanyl, azaspiro[3.3]heptanyl, diazaspiro[2.5]octanyl, diazaspiro[3.3]heptanyl, diazepanyl, diazaspiro[3.5]nonanyl, oxadiazabicyclo[3.3.1]nonanyl, piperazinyl, piperazinonyl, piperidinyl, and pyrrolidinyl, wherein said heterocyclic ring is substituted with zero to 1 R76 and zero to 2 R76; R76 is: (i) -OH, C<com:Sub>1-6< / com:Sub> alkyl, C<com:Sub>3-4< / com:Sub> fluoroalkyl, C<com:Sub>3-4< / com:Sub> hydroxyalkyl, -CH<com:Sub>2< / com:Sub>CN, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CN, <com:Math><semantics>−(CRxRx)1−2OCH3<annotation encoding="application / x-tex">-(CR_xR_x)_{1-2}OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)2−3S(O)2CH3<annotation encoding="application / x-tex">-(CH_2)_{2-3}S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)2−3NHS(O)2CH3<annotation encoding="application / x-tex">-(CH_2)_{2-3}NHS(O)_2CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−2NRxRx<annotation encoding="application / x-tex">-(CH_2)_{1-2}NR_xR_x< / annotation>< / semantics>< / com:Math>, [Image disponible dans le document PDF, Image available in the PDF document] <com:Math><semantics>−N((CH2)1−2R7d)2<annotation encoding="application / x-tex">-N((CH_2)_{1-2}R_{7d})_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)R7d<annotation encoding="application / x-tex">-C(O)R_{7d}< / annotation>< / semantics>< / com:Math>, or <com:Math><semantics>−C(O)(CRxRx)1−2R7d<annotation encoding="application / x-tex">-C(O)(CR_xR_x)_{1-2}R_{7d}< / annotation>< / semantics>< / com:Math>; or (ii) azetidinyl, cyclobutyl, cyclohexyl, dioxotetrahydrothiopyranyl, dioxothiomorpholinyl, morpholinyl, oxaazaspiro[4.3]octanyl, oxetanyl, piperazinyl, piperidinyl, pyrimidinyl, tetrahydrofuranyl, tetrahydropyranyl, or thiadiazolyl, each substituted with zero to 1 R<com:Sub>8a< / com:Sub> and zero to 3 R<com:Sub>8b< / com:Sub>; each R<com:Sub>7c< / com:Sub> is independently -CH<com:Sub>3< / com:Sub> or -CH<com:Sub>2< / com:Sub>CN; each R<com:Sub>7d< / com:Sub> is independently azetidinyl, C<com:Sub>3-6< / com:Sub> cycloalkyl, dioxothiaazaspiro[3.3]heptanyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxaazaspiro[4.3]octanyl, oxaazaspiro[4.4]nonyl, oxetanyl, piperidinyl, pyrimidinyl, pyrazolyl, pyrrolidinyl, tetrahydropyranyl, thiadiazolyl, or triazolyl, each substituted with zero to 2 substituents selected from F, -OH, C<com:Sub>1-3< / com:Sub> alkyl, <com:Math><semantics>−CH2OH<annotation encoding="application / x-tex">-CH_2OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OCH3<annotation encoding="application / x-tex">-OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRxRx<annotation encoding="application / x-tex">-NR_xR_x< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−S(O)2CH3<annotation encoding="application / x-tex">-S(O)_2CH_3< / annotation>< / semantics>< / com:Math>; <com:Math><semantics>R8a<annotation encoding="application / x-tex">R_{8a}< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−OH<annotation encoding="application / x-tex">-OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OCH3<annotation encoding="application / x-tex">-OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)CH3<annotation encoding="application / x-tex">-C(O)CH_3< / annotation>< / semantics>< / com:Math>, or -C(O)OCH<com:Sub>3< / com:Sub>; each R<com:Sub>8b< / com:Sub> is -CH<com:Sub>3< / com:Sub>; and R<com:Sub>2< / com:Sub>, R<com:Sub>x< / com:Sub>, R<com:Sub>y< / com:Sub>, R<com:Sub>5< / com:Sub>, n, and p are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I) or a salt thereof wherein: [Image disponible dans le document PDF, Image available in the PDF document] Gis ; A is <com:Math><semantics>−O−L1−R6<annotation encoding="application / x-tex">-O-L_1-R_6< / annotation>< / semantics>< / com:Math>; L<com:Sub>1< / com:Sub> is bond or <com:Math><semantics>−CH2−<annotation encoding="application / x-tex">-CH_2-< / annotation>< / semantics>< / com:Math>; R<com:Sub>1< / com:Sub> is <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; each R<com:Sub>2< / com:Sub> is independently -CH<com:Sub>3< / com:Sub> or -OCH<com:Sub>3< / com:Sub>; R<com:Sub>6< / com:Sub> is: (i) -CH<com:Sub>3< / com:Sub>,; or (ii) azetidinyl, cyclohexyl, or piperidinyl, each substituted with zero to 2 R<com:Sub>6a< / com:Sub>; each R<com:Sub>6a< / com:Sub> is independently -CH<com:Sub>3< / com:Sub>, <com:Math><semantics>−CH2CH2CH3<annotation encoding="application / x-tex">-CH_2CH_2CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(CH3)2<annotation encoding="application / x-tex">-C(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(CH3)2OH<annotation encoding="application / x-tex">-CH_2C(CH_3)_2OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH3)2<annotation encoding="application / x-tex">-N(CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(CH2CH2CH3)2<annotation encoding="application / x-tex">-N(CH_2CH_2CH_3)_2< / annotation>< / semantics>< / com:Math>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>S(O)<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>C(O)N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, or tetrahydropyranyl; and R<com:Sub>5< / com:Sub>, n, and p are defined in the first aspect or the second aspect. One embodiment provides a compound of Formula (I) or a salt thereof wherein: [Image disponible dans le document PDF, Image available in the PDF document] Gis ; R<com:Sub>1< / com:Sub> is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>; A is -CHR<com:Sub>12< / com:Sub>R<com:Sub>13< / com:Sub>, wherein R<com:Sub>12< / com:Sub> and R<com:Sub>13< / com:Sub> together with the carbon atom to which they are attached form a cyclohexyl group; R<com:Sub>1< / com:Sub> is <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; and n is zero. One embodiment provides a compound of Formula (I) or a salt thereof wherein: [Image disponible dans le document PDF, Image available in the PDF document] Gis ; <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; each <com:Math><semantics>R2<annotation encoding="application / x-tex">R_2< / annotation>< / semantics>< / com:Math> is independently <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math> or <com:Math><semantics>−OCH3<annotation encoding="application / x-tex">-OCH_3< / annotation>< / semantics>< / com:Math>; A is -CHR<com:Sub>12< / com:Sub>R<com:Sub>13< / com:Sub>, wherein R<com:Sub>12< / com:Sub> and R<com:Sub>13< / com:Sub> together with the carbon atom to which they are attached form a C<com:Sub>4-6< / com:Sub> cyclohexyl group substituted with R<com:Sub>12a< / com:Sub>; [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] <com:Math><semantics>R12ais:∘∼N→∘∼N→∘<annotation encoding="application / x-tex">R_{12a is:} \circ \sim N \rightarrow \circ \sim N \rightarrow \circ< / annotation>< / semantics>< / com:Math> [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] p is 1 or 2; and n is zero or 1. Included in this embodiment are compounds in which R<com:Sub>12< / com:Sub> and R<com:Sub>13< / com:Sub> together with the carbon atom to which they are attached form a cyclohexyl group substituted with R<com:Sub>12a< / com:Sub>. One embodiment provides a compound of Formula (I) or a salt thereof wherein A [Image disponible dans le document PDF, Image available in the PDF document] is: and G, R<com:Sub>1< / com:Sub>, R<com:Sub>2< / com:Sub>, R<com:Sub>5< / com:Sub>, R<com:Sub>12a< / com:Sub>, n, and p are defined in the first aspect. [Image disponible dans le document PDF, Image available in the PDF document] Included in this embodiment are compounds in which G is -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>; and n is zero. Also included in this embodiment are compounds in which G [Image disponible dans le document PDF, Image available in the PDF document] ; <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; <com:Math><semantics>R12a<annotation encoding="application / x-tex">R_{12a}< / annotation>< / semantics>< / com:Math> is: [Image disponible dans le document PDF, Image available in the PDF document] is <com:Math><semantics>Ω−<annotation encoding="application / x-tex">\Omega_{-}< / annotation>< / semantics>< / com:Math> [Image disponible dans le document PDF, Image available in the PDF document] and n is zero. One embodiment provides a compound of Formula (I) or a salt thereof wherein compound is: [Image disponible dans le document PDF, Image available in the PDF document] 5 1 [Image disponible dans le document PDF, Image available in the PDF document] or • One embodiment provides a compound of Formula (I) or a salt thereof wherein compound is: [Image disponible dans le document PDF, Image available in the PDF document] _ 5 One embodiment provides a compound of Formula (I) or a salt thereof wherein said compound is: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] OI One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof wherein said compound is selected from Examples 1 to 1078. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof wherein said compound is selected from Examples 1 to 736. One embodiment provides a compound of Formula (I), N-oxide, or a salt thereof wherein said compound is selected from Examples 737 to 1078. The present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The invention encompasses all combinations of the aspects and / or embodiments of the invention noted herein. It is understood that any and all embodiments of the present invention may be taken in conjunction with any other embodiment or embodiments to describe additional embodiments. It is also to be understood that each individual element of the embodiments is meant to be combined with any and all other elements from any embodiment to describe an additional embodiment. DEFINITIONS The features and advantages of the invention may be more readily understood by those of ordinary skill in the art upon reading the following detailed description. It is to be appreciated that certain features of the invention that are, for clarity reasons, described above and below in the context of separate embodiments, may also be combined to form a single embodiment. Conversely, various features of the invention that are, for brevity reasons, described in the context of a single embodiment, may also be combined so as to form sub-combinations thereof. Embodiments identified herein as exemplary or preferred are intended to be illustrative and not limiting. Unless specifically stated otherwise herein, references made in the singular may also include the plural. For example, "a" and "an" may refer to either one, or one or more. As used herein, the phrase "compounds" refers to at least one compound. For example, a compound of Formula (I) includes a compound of Formula (I) and two or more compounds of Formula (I). Unless otherwise indicated, any heteroatom with unsatisfied valences is assumed to have hydrogen atoms sufficient to satisfy the valences. Listed below are definitions of various terms used to describe the present invention. These definitions apply to the terms as they are used throughout the specification (unless they are otherwise limited in specific instances) either individually or as part of a larger group. Throughout the specification, groups and substituents thereof may be chosen by one skilled in the field to provide stable moieties and compounds. In accordance with a convention used in the art, [Image disponible dans le document PDF, Image available in the PDF document] is used in structural formulas herein to depict the bond that is the point of attachment of the moiety or substituent to the core or backbone structure. The terms "halo" and "halogen," as used herein, refer to F, Cl, Br, and I. The term "cyano" refers to the group –CN. The term "amino" refers to the group <com:Math><semantics>−NH2<annotation encoding="application / x-tex">-NH_2< / annotation>< / semantics>< / com:Math>. The term "oxo" refers to the group =O. The term "alkyl" as used herein, refers to both branched and straight-chain saturated aliphatic hydrocarbon groups containing, for example, from 1 to 12 carbon atoms, from 1 to 6 carbon atoms, and from 1 to 4 carbon atoms. Examples of alkyl groups include, but are not limited to, methyl (Me), ethyl (Et), propyl (e.g., n-propyl and i-propyl), butyl (e.g., n-butyl, i-butyl, sec-butyl, and t-butyl), and pentyl (e.g., n-pentyl, isopentyl, neopentyl), n-hexyl, 2-methylpentyl, 2-ethylbutyl, 3-methylpentyl, and 4- methylpentyl. When numbers appear in a subscript after the symbol "C", the subscript defines with more specificity the number of carbon atoms that a particular group may contain. For example, "C<com:Sub>1-6< / com:Sub> alkyl" denotes straight and branched chain alkyl groups with one to six carbon atoms. The term "fluoroalkyl" as used herein is intended to include both branched and straight-chain saturated aliphatic hydrocarbon groups substituted with one or more fluorine atoms. For example, "C<com:Sub>1-4< / com:Sub> fluoroalkyl" is intended to include C<com:Sub>1< / com:Sub>, C<com:Sub>2< / com:Sub>, C<com:Sub>3< / com:Sub>, and C<com:Sub>4< / com:Sub> alkyl groups substituted with one or more fluorine atoms. Representative examples of fluoroalkyl groups include, but are not limited to, -CF<com:Sub>3< / com:Sub> and -CH<com:Sub>2< / com:Sub>CF<com:Sub>3< / com:Sub>. The term "cyanoalkyl" includes both branched and straight-chain saturated alkyl groups substituted with one or more cyano groups. For example, "cyanoalkyl" includes <com:Math><semantics>−CH2CN<annotation encoding="application / x-tex">-CH_2CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH2CN<annotation encoding="application / x-tex">-CH_2CH_2CN< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> cyanoalkyl. The term "aminoalkyl" includes both branched and straight-chain saturated alkyl groups substituted with one or more amine groups. For example, "aminoalkyl" includes -CH<com:Sub>2< / com:Sub>NH<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>NH<com:Sub>2< / com:Sub>, and C<com:Sub>1-4< / com:Sub> aminoalkyl. The term "hydroxyalkyl" includes both branched and straight-chain saturated alkyl groups substituted with one or more hydroxyl groups. For example, "hydroxyalkyl" includes –CH<com:Sub>2< / com:Sub>OH, –CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, and C<com:Sub>1-4< / com:Sub> hydroxyalkyl. The term "hydroxy-fluoroalkyl" includes both branched and straight-chain saturated alkyl groups substituted with one or more hydroxyl groups and one or more fluorine atoms. For example, "hydroxy-fluoroalkyl" includes -CHFCH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CHFC(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>OH, and C<com:Sub>1-4< / com:Sub> hydroxy-fluoroalkyl. The term "cycloalkyl," as used herein, refers to a group derived from a non- aromatic monocyclic or polycyclic hydrocarbon molecule by removal of one hydrogen atom from a saturated ring carbon atom. Representative examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclopentyl, and cyclohexyl. When numbers appear in a subscript after the symbol "C", the subscript defines with more specificity the number of carbon atoms that a particular cycloalkyl group may contain. For example, "C<com:Sub>3< / com:Sub>-C<com:Sub>6< / com:Sub> cycloalkyl" denotes cycloalkyl groups with three to six carbon atoms. The term "alkoxy," as used herein, refers to an alkyl group attached to the parent molecular moiety through an oxygen atom, for example, methoxy group (-OCH<com:Sub>3< / com:Sub>). For example, "C<com:Sub>1-3< / com:Sub> alkoxy" denotes alkoxy groups with one to three carbon atoms. The term "alkoxyalkyl," as used herein, refers to an alkoxy group attached through its oxygen atom to an alkyl group, which is attached to the parent molecular moiety, for example, methoxymethyl group (-CH<com:Sub>2< / com:Sub>OCH<com:Sub>3< / com:Sub>). For example, "C<com:Sub>2-4< / com:Sub>" alkoxyalkyl" denotes alkoxyalkyl groups with two to four carbon atoms, such as -CH<com:Sub>2< / com:Sub>OCH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OCH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>OCH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, and -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OCH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>. The phrase "pharmaceutically acceptable" is employed herein to refer to those compounds, materials, compositions, and / or dosage forms which are, within the scope of sound medical judgment, suitable for use in contact with the tissues of human beings and animals without excessive toxicity, irritation, allergic response, or other problem or complication, commensurate with a reasonable benefit / risk ratio. The compounds of Formula (I) can be provided as amorphous solids or crystalline solids. Lyophilization can be employed to provide the compounds of Formula (I) as amorphous solids. It should further be understood that solvates (e.g., hydrates) of the compounds of Formula (I) are also within the scope of the present invention. The term "solvate" means a physical association of a compound of Formula (I) with one or more solvent molecules, whether organic or inorganic. This physical association includes hydrogen bonding. In certain instances the solvate will be capable of isolation, for example when one or more solvent molecules are incorporated in the crystal lattice of the crystalline solid. "Solvate" encompasses both solution-phase and isolable solvates. Exemplary solvates include hydrates, ethanolates, methanolates, isopropanolates, acetonitrile solvates, and ethyl acetate solvates. Methods of solvation are known in the art. Various forms of prodrugs are well known in the art and are described in: a) The Practice of Medicinal Chemistry, Camille G. Wermuth et al., Ch 31, (Academic Press, 1996); b) Design of Prodrugs, edited by H. Bundgaard, (Elsevier, 1985); c) A Textbook of Drug Design and Development, P. Krogsgaard–Larson and H. Bundgaard, eds. Ch 5, pgs 113 – 191 (Harwood Academic Publishers, 1991); and d) Hydrolysis in Drug and Prodrug Metabolism, Bernard Testa and Joachim M. Mayer, (Wiley-VCH, 2003). In addition, compounds of Formula (I), subsequent to their preparation, can be isolated and purified to obtain a composition containing an amount by weight equal to or greater than 99% of a compound of Formula (I) ("substantially pure"), which is then used or formulated as described herein. Such "substantially pure" compounds of Formula (I) are also contemplated herein as part of the present invention. "Stable compound" and "stable structure" are meant to indicate a compound that is sufficiently robust to survive isolation to a useful degree of purity from a reaction mixture, and formulation into an efficacious therapeutic agent. The present invention is intended to embody stable compounds. "Therapeutically effective amount" is intended to include an amount of a compound of the present invention alone or an amount of the combination of compounds claimed or an amount of a compound of the present invention in combination with other active ingredients effective to act as an inhibitor to TLR7 / 8 / 9, or effective to treat or prevent autoimmune and / or inflammatory disease states, such as SLE, IBD, multiple sclerosis (MS), and Sjögren's syndrome, and rheumatoid arthritis. As used herein, "treating" or "treatment" cover the treatment of a disease-state in a mammal, particularly in a human, and include: (a) preventing the disease-state from occurring in a mammal, in particular, when such mammal is predisposed to the disease- state but has not yet been diagnosed as having it; (b) inhibiting the disease-state, i.e., arresting its development; and / or (c) relieving the disease-state, i.e., causing regression of the disease state. The compounds of the present invention are intended to include all isotopes of atoms occurring in the present compounds. Isotopes include those atoms having the same atomic number but different mass numbers. By way of general example and without limitation, isotopes of hydrogen include deuterium (D) and tritium (T). Isotopes of carbon include <com:Sup>13< / com:Sup>C and <com:Sup>14< / com:Sup>C. Isotopically-labeled compounds of the invention can generally be prepared by conventional techniques known to those skilled in the art or by processes analogous to those described herein, using an appropriate isotopically-labeled reagent in place of the non-labeled reagent otherwise employed. For example, methyl (- CH<com:Sub>3< / com:Sub>) also includes deuterated methyl groups such as -CD<com:Sub>3< / com:Sub>. UTILITY The human immune system has evolved to defend the body from micro- organisms, viruses, and parasites that can cause infection, disease or death. Complex regulatory mechanisms ensure that the various cellular components of the immune system target the foreign substances or organisms, while not causing permanent or significant damage to the individual. While the initiating events are not well understood at this time, in autoimmune disease states the immune system directs its inflammatory response to target organs in the afflicted individual. Different autoimmune diseases are typically characterized by the predominate or initial target organ or tissues affected; such as the joint in the case of rheumatoid arthritis, the thyroid gland in the case of Hashimoto's thyroiditis, the central nervous system in the case of multiple sclerosis, the pancreas in the case of type I diabetes, and the bowel in the case of inflammatory bowel disease. The compounds of the invention inhibit signaling through Toll-like receptor 7, or 8, or 9 (TLR7, TLR8, TLR9) or combinations thereof. Accordingly, compounds of Formula (I) have utility in treating conditions associated with the inhibition of signaling through one or more of TLR7, TLR8, or TLR9. Such conditions include TLR7, TLR8, or TLR9 receptor associated diseases in which cytokine levels are modulated as a consequence of intracellular signaling. As used herein, the terms "treating" or "treatment" encompass the treatment of a disease state in a mammal, particularly in a human, and include: (a) preventing or delaying the occurrence of the disease state in a mammal, in particular, when such mammal is predisposed to the disease state but has not yet been diagnosed as having it; (b) inhibiting the disease state, i.e., arresting its development; and / or (c) achieving a full or partial reduction of the symptoms or disease state, and / or alleviating, ameliorating, lessening, or curing the disease or disorder and / or its symptoms. In view of their activity as selective inhibitors of TLR7, TLR8, or TLR9, compounds of Formula (I) are useful in treating TLR7, TLR8, or TLR9 family receptor associated diseases, but not limited to, inflammatory diseases such as Crohn's disease, ulcerative colitis, asthma, graft versus host disease, allograft rejection, chronic obstructive pulmonary disease; autoimmune diseases such as Graves' disease, rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, cutaneous lupus, psoriasis; auto- inflammatory diseases including Cryopyrin-Associated Periodic Syndromes (CAPS), TNF Receptor Associated Periodic Syndrome (TRAPS), Familial Mediterranean Fever (FMF), adult onset stills, systemic onset juvenile idiopathic arthritis, gout, gouty arthritis; metabolic diseases including type 2 diabetes, atherosclerosis, myocardial infarction; destructive bone disorders such as bone resorption disease, osteoarthritis, osteoporosis, multiple myeloma-related bone disorder; proliferative disorders such as acute myelogenous leukemia, chronic myelogenous leukemia; angiogenic disorders such as angiogenic disorders including solid tumors, ocular neovascularization, and infantile haemangiomas; infectious diseases such as sepsis, septic shock, and Shigellosis; neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, cerebral ischemias or neurodegenerative disease caused by traumatic injury, oncologic and viral diseases such as metastatic melanoma, Kaposi's sarcoma, multiple myeloma, and HIV infection and CMV retinitis, AIDS, respectively. More particularly, the specific conditions or diseases that may be treated with the inventive compounds include, without limitation, pancreatitis (acute or chronic), asthma, allergies, adult respiratory distress syndrome, chronic obstructive pulmonary disease, glomerulonephritis, rheumatoid arthritis, systemic lupus erythematosus, scleroderma, chronic thyroiditis, Graves' disease, autoimmune gastritis, diabetes, autoimmune hemolytic anemia, autoimmune neutropenia, thrombocytopenia, atopic dermatitis, chronic active hepatitis, myasthenia gravis, multiple sclerosis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, psoriasis, graft vs. host disease, inflammatory reaction induced by endotoxin, tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, Reiter's syndrome, gout, traumatic arthritis, rubella arthritis, acute synovitis, pancreatic β-cell disease; diseases characterized by massive neutrophil infiltration; rheumatoid spondylitis, gouty arthritis and other arthritic conditions, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcoidosis, bone resorption disease, allograft rejections, fever and myalgias due to infection, cachexia secondary to infection, keloid formation, scar tissue formation, ulcerative colitis, pyresis, influenza, osteoporosis, osteoarthritis, acute myelogenous leukemia, chronic myelogenous leukemia, metastatic melanoma, Kaposi's sarcoma, multiple myeloma, sepsis, septic shock, and Shigellosis; Alzheimer's disease, Parkinson's disease, cerebral ischemias or neurodegenerative disease caused by traumatic injury; angiogenic disorders including solid tumors, ocular neovascularization, and infantile haemangiomas; viral diseases including acute hepatitis infection (including hepatitis A, hepatitis B and hepatitis C), HIV infection and CMV retinitis, AIDS, ARC or malignancy, and herpes; stroke, myocardial ischemia, ischemia in stroke heart attacks, organ hypoxia, vascular hyperplasia, cardiac and renal reperfusion injury, thrombosis, cardiac hypertrophy, thrombin-induced platelet aggregation, endotoxemia and / or toxic shock syndrome, conditions associated with prostaglandin endoperoxidase syndase-2, and pemphigus vulgaris. Included in this embodiment are methods of treatment in which the condition is selected from lupus including lupus nephritis and systemic lupus erythematosus (SLE), Crohn's disease, ulcerative colitis, allograft rejection, rheumatoid arthritis, psoriasis, ankylosing spondylitis, psoriatic arthritis, and pemphigus vulgaris. Also included are methods of treatment in which the condition is selected from ischemia reperfusion injury, including cerebral ischemia reperfusions injury arising from stroke and cardiac ischemia reperfusion injury arising from myocardial infarction. Another method of treatment is one in which the condition is multiple myeloma. In one embodiment, the compounds of Formula (I) are useful in treating cancer, including Waldenstrom's Macroglobulinemia (WM), diffuse large B cell lymphoma (DLBCL), chronic lymphocytic leukemia (CLL), cutaneous diffuse large B cell lymphoma, and primary CNS lymphoma. In addition, the TLR7, TLR8, or TLR9 inhibitors of the present invention inhibit the expression of inducible pro-inflammatory proteins such as prostaglandin endoperoxide synthase-2 (PGHS-2), also referred to as cyclooxygenase-2 (COX-2), IL-1, IL-6, IL-18, chemokines. Accordingly, additional TLR7 / 8 / 9 associated conditions include edema, analgesia, fever and pain, such as neuromuscular pain, headache, pain caused by cancer, dental pain and arthritis pain. The inventive compounds also may be used to treat veterinary viral infections, such as lentivirus infections, including, but not limited to equine infectious anemia virus; or retrovirus infections, including feline immunodeficiency virus, bovine immunodeficiency virus, and canine immunodeficiency virus. The present invention thus provides methods for treating such conditions, comprising administering to a subject in need thereof a therapeutically-effective amount of at least one compound of Formula (I) or a salt thereof. "Therapeutically effective amount" is intended to include an amount of a compound of the present invention that is effective when administered alone or in combination to inhibit autoimmune disease or chronic inflammatory disease. The methods of treating TLR7, TLR8, or TLR9 associated conditions may comprise administering compounds of Formula (I) alone or in combination with each other and / or other suitable therapeutic agents useful in treating such conditions. Accordingly, "therapeutically effective amount" is also intended to include an amount of the combination of compounds claimed that is effective to inhibit TLR7, TLR8, or TLR9 and / or treat diseases associated with TLR7, TLR8, or TLR9. Exemplary of such other therapeutic agents include corticosteroids, rolipram, calphostin, cytokine-suppressive anti-inflammatory drugs (CSAIDs), Interleukin-10, glucocorticoids, salicylates, nitric oxide, and other immunosuppressants; nuclear translocation inhibitors, such as deoxyspergualin (DSG); non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, celecoxib and rofecoxib; steroids such as prednisone or dexamethasone; antiviral agents such as abacavir; antiproliferative agents such as methotrexate, leflunomide, FK506 (tacrolimus, PROGRAF®); anti-malarials such as hydroxychloroquine; cytotoxic drugs such as azathiprine and cyclophosphamide; TNF-α inhibitors such as tenidap, anti-TNF antibodies or soluble TNF receptor, and rapamycin (sirolimus or RAPAMUNE®) or derivatives thereof. The above other therapeutic agents, when employed in combination with the compounds of the present invention, may be used, for example, in those amounts indicated in the Physicians' Desk Reference (PDR) or as otherwise determined by one of ordinary skill in the art. In the methods of the present invention, such other therapeutic agent(s) may be administered prior to, simultaneously with, or following the administration of the inventive compounds. The present invention also provides pharmaceutical compositions capable of treating TLR7 / 8 / 9 receptor-associated conditions, including IL-1 family receptor-mediated diseases as described above. The inventive compositions may contain other therapeutic agents as described above and may be formulated, for example, by employing conventional solid or liquid vehicles or diluents, as well as pharmaceutical additives of a type appropriate to the mode of desired administration (e.g., excipients, binders, preservatives, stabilizers, flavors, etc.) according to techniques such as those well known in the art of pharmaceutical formulation. Accordingly, the present invention further includes compositions comprising one or more compounds of Formula (I) and a pharmaceutically acceptable carrier. A "pharmaceutically acceptable carrier" refers to media generally accepted in the art for the delivery of biologically active agents to animals, in particular, mammals. Pharmaceutically acceptable carriers are formulated according to a number of factors well within the purview of those of ordinary skill in the art. These include without limitation the type and nature of the active agent being formulated; the subject to which the agent- containing composition is to be administered; the intended route of administration of the composition; and, the therapeutic indication being targeted. Pharmaceutically acceptable carriers include both aqueous and non-aqueous liquid media, as well as a variety of solid and semi-solid dosage forms. Such carriers can include a number of different ingredients and additives in addition to the active agent, such additional ingredients being included in the formulation for a variety of reasons, e.g., stabilization of the active agent, binders, etc., well known to those of ordinary skill in the art. Descriptions of suitable pharmaceutically acceptable carriers, and factors involved in their selection, are found in a variety of readily available sources such as, for example, Remington's Pharmaceutical Sciences, 17th Edition (1985). Compounds in accordance with Formula (I) can be administered by any means suitable for the condition to be treated, which can depend on the need for site-specific treatment or quantity of Formula (I) compound to be delivered. Also embraced within this invention is a class of pharmaceutical compositions comprising a compound of Formula (I) and one or more non-toxic, pharmaceutically- acceptable carriers and / or diluents and / or adjuvants (collectively referred to herein as "carrier" materials) and, if desired, other active ingredients. The compounds of Formula (I) may be administered by any suitable route, preferably in the form of a pharmaceutical composition adapted to such a route, and in a dose effective for the treatment intended. The compounds and compositions of the present invention may, for example, be administered orally, mucosally, or parenterally including intravascularly, intravenously, intraperitoneally, subcutaneously, intramuscularly, and intrasternally in dosage unit formulations containing conventional pharmaceutically acceptable carriers, adjuvants, and vehicles. For example, the pharmaceutical carrier may contain a mixture of mannitol or lactose and microcrystalline cellulose. The mixture may contain additional components such as a lubricating agent, e.g. magnesium stearate and a disintegrating agent such as crospovidone. The carrier mixture may be filled into a gelatin capsule or compressed as a tablet. The pharmaceutical composition may be administered as an oral dosage form or an infusion, for example. For oral administration, the pharmaceutical composition may be in the form of, for example, a tablet, capsule, liquid capsule, suspension, or liquid. The pharmaceutical composition is preferably made in the form of a dosage unit containing a particular amount of the active ingredient. For example, the pharmaceutical composition may be provided as a tablet or capsule comprising an amount of active ingredient in the range of from about 0.1 to 1000 mg, preferably from about 0.25 to 250 mg, and more preferably from about 0.5 to 100 mg. A suitable daily dose for a human or other mammal may vary widely depending on the condition of the patient and other factors, but, can be determined using routine methods. Any pharmaceutical composition contemplated herein can, for example, be delivered orally via any acceptable and suitable oral preparations. Exemplary oral preparations, include, but are not limited to, for example, tablets, troches, lozenges, aqueous and oily suspensions, dispersible powders or granules, emulsions, hard and soft capsules, liquid capsules, syrups, and elixirs. Pharmaceutical compositions intended for oral administration can be prepared according to any methods known in the art for manufacturing pharmaceutical compositions intended for oral administration. In order to provide pharmaceutically palatable preparations, a pharmaceutical composition in accordance with the invention can contain at least one agent selected from sweetening agents, flavoring agents, coloring agents, demulcents, antioxidants, and preserving agents. A tablet can, for example, be prepared by admixing at least one compound of Formula (I) with at least one non-toxic pharmaceutically acceptable excipient suitable for the manufacture of tablets. Exemplary excipients include, but are not limited to, for example, inert diluents, such as, for example, calcium carbonate, sodium carbonate, lactose, calcium phosphate, and sodium phosphate; granulating and disintegrating agents, such as, for example, microcrystalline cellulose, sodium crosscarmellose, com starch, and alginic acid; binding agents, such as, for example, starch, gelatin, polyvinyl-pyrrolidone, and acacia; and lubricating agents, such as, for example, magnesium stearate, stearic acid, and talc. Additionally, a tablet can either be uncoated, or coated by known techniques to either mask the bad taste of an unpleasant tasting drug, or delay disintegration and absorption of the active ingredient in the gastrointestinal tract thereby sustaining the effects of the active ingredient for a longer period. Exemplary water soluble taste masking materials, include, but are not limited to, hydroxypropyl-methylcellulose and hydroxypropyl-cellulose. Exemplary time delay materials, include, but are not limited to, ethyl cellulose and cellulose acetate butyrate. Hard gelatin capsules can, for example, be prepared by mixing at least one compound of Formula (I) with at least one inert solid diluent, such as, for example, calcium carbonate; calcium phosphate; and kaolin. Soft gelatin capsules can, for example, be prepared by mixing at least one compound of Formula (I) with at least one water soluble carrier, such as, for example, polyethylene glycol; and at least one oil medium, such as, for example, peanut oil, liquid paraffin, and olive oil. An aqueous suspension can be prepared, for example, by admixing at least one compound of Formula (I) with at least one excipient suitable for the manufacture of an aqueous suspension. Exemplary excipients suitable for the manufacture of an aqueous suspension, include, but are not limited to, for example, suspending agents, such as, for example, sodium carboxymethylcellulose, methylcellulose, hydroxypropylmethyl- cellulose, sodium alginate, alginic acid, polyvinyl-pyrrolidone, gum tragacanth, and gum acacia; dispersing or wetting agents, such as, for example, a naturally-occurring phosphatide, e.g., lecithin; condensation products of alkylene oxide with fatty acids, such as, for example, polyoxyethylene stearate; condensation products of ethylene oxide with long chain aliphatic alcohols, such as, for example heptadecaethylene-oxycetanol; condensation products of ethylene oxide with partial esters derived from fatty acids and hexitol, such as, for example, polyoxyethylene sorbitol monooleate; and condensation products of ethylene oxide with partial esters derived from fatty acids and hexitol anhydrides, such as, for example, polyethylene sorbitan monooleate. An aqueous suspension can also contain at least one preservative, such as, for example, ethyl and n- propyl p-hydroxybenzoate; at least one coloring agent; at least one flavoring agent; and / or at least one sweetening agent, including but not limited to, for example, sucrose, saccharin, and aspartame. Oily suspensions can, for example, be prepared by suspending at least one compound of Formula (I) in either a vegetable oil, such as, for example, arachis oil; olive oil; sesame oil; and coconut oil; or in mineral oil, such as, for example, liquid paraffin. An oily suspension can also contain at least one thickening agent, such as, for example, beeswax; hard paraffin; and cetyl alcohol. In order to provide a palatable oily suspension, at least one of the sweetening agents already described hereinabove, and / or at least one flavoring agent can be added to the oily suspension. An oily suspension can further contain at least one preservative, including, but not limited to, for example, an anti- oxidant, such as, for example, butylated hydroxyanisol, and alpha-tocopherol. Dispersible powders and granules can, for example, be prepared by admixing at least one compound of Formula (I) with at least one dispersing and / or wetting agent; at least one suspending agent; and / or at least one preservative. Suitable dispersing agents, wetting agents, and suspending agents are as already described above. Exemplary preservatives include, but are not limited to, for example, anti-oxidants, e.g., ascorbic acid. In addition, dispersible powders and granules can also contain at least one excipient, including, but not limited to, for example, sweetening agents; flavoring agents; and coloring agents. An emulsion of at least one compound of Formula (I) thereof can, for example, be prepared as an oil-in-water emulsion. The oily phase of the emulsions comprising compounds of Formula (I) may be constituted from known ingredients in a known manner. The oil phase can be provided by, but is not limited to, for example, a vegetable oil, such as, for example, olive oil and arachis oil; a mineral oil, such as, for example, liquid paraffin; and mixtures thereof. While the phase may comprise merely an emulsifier, it may comprise a mixture of at least one emulsifier with a fat or an oil or with both a fat and an oil. Suitable emulsifying agents include, but are not limited to, for example, naturally-occurring phosphatides, e.g., soy bean lecithin; esters or partial esters derived from fatty acids and hexitol anhydrides, such as, for example, sorbitan monooleate; and condensation products of partial esters with ethylene oxide, such as, for example, polyoxyethylene sorbitan monooleate. Preferably, a hydrophilic emulsifier is included together with a lipophilic emulsifier which acts as a stabilizer. It is also preferred to include both an oil and a fat. Together, the emulsifier(s) with or without stabilizer(s) make-up the so-called emulsifying wax, and the wax together with the oil and fat make up the so-called emulsifying ointment base which forms the oily dispersed phase of the cream formulations. An emulsion can also contain a sweetening agent, a flavoring agent, a preservative, and / or an antioxidant. Emulsifiers and emulsion stabilizers suitable for use in the formulation of the present invention include Tween 60, Span 80, cetostearyl alcohol, myristyl alcohol, glyceryl monostearate, sodium lauryl sulfate, glyceryl distearate alone or with a wax, or other materials well known in the art. The compounds of Formula (I) can, for example, also be delivered intravenously, subcutaneously, and / or intramuscularly via any pharmaceutically acceptable and suitable injectable form. Exemplary injectable forms include, but are not limited to, for example, sterile aqueous solutions comprising acceptable vehicles and solvents, such as, for example, water, Ringer's solution, and isotonic sodium chloride solution; sterile oil-in- water microemulsions; and aqueous or oleaginous suspensions. Formulations for parenteral administration may be in the form of aqueous or non- aqueous isotonic sterile injection solutions or suspensions. These solutions and suspensions may be prepared from sterile powders or granules using one or more of the carriers or diluents mentioned for use in the formulations for oral administration or by using other suitable dispersing or wetting agents and suspending agents. The compounds may be dissolved in water, polyethylene glycol, propylene glycol, ethanol, corn oil, cottonseed oil, peanut oil, sesame oil, benzyl alcohol, sodium chloride solution, tragacanth gum, and / or various buffers. Other adjuvants and modes of administration are well and widely known in the pharmaceutical art. The active ingredient may also be administered by injection as a composition with suitable carriers including saline, dextrose, or water, or with cyclodextrin (i.e. Captisol), cosolvent solubilization (i.e. propylene glycol) or micellar solubilization (i.e. Tween 80). The sterile injectable preparation may also be a sterile injectable solution or suspension in a non-toxic parenterally acceptable diluent or solvent, for example as a solution in 1,3-butanediol. Among the acceptable vehicles and solvents that may be employed are water, Ringer's solution, and isotonic sodium chloride solution. In addition, sterile, fixed oils are conventionally employed as a solvent or suspending medium. For this purpose any bland fixed oil may be employed, including synthetic mono- or diglycerides. In addition, fatty acids such as oleic acid find use in the preparation of injectables. ...
Claims
CLAIMS What is claimed is:
1. A compound of Formula (I) [Image disponible dans le document PDF, Image available in the PDF document] (I) N-oxide, or a salt thereof, wherein: G is: [Image disponible dans le document PDF, Image available in the PDF document] A is: (i) <com:Math><semantics>−OR6<annotation encoding="application / x-tex">-OR_6< / annotation>< / semantics>< / com:Math> or <com:Math><semantics>−O(CRxRx)1−2−R6<annotation encoding="application / x-tex">-O(CR_xR_x)_{1-2}-R_6< / annotation>< / semantics>< / com:Math>; <com:Math><semantics>(ii)−NR7R8;<annotation encoding="application / x-tex">(ii) -NR_7R_8;< / annotation>< / semantics>< / com:Math> (iii) -C(O)NR<com:Sub>9< / com:Sub>R<com:Sub>10< / com:Sub>; <com:Math><semantics>(iv)<annotation encoding="application / x-tex">(iv)< / annotation>< / semantics>< / com:Math> –CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>R<com:Sub>11< / com:Sub>; (v) <com:Math><semantics>−CRxR12R13<annotation encoding="application / x-tex">-CR_xR_{12}R_{13}< / annotation>< / semantics>< / com:Math>, wherein <com:Math><semantics>R12<annotation encoding="application / x-tex">R_{12}< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>R13<annotation encoding="application / x-tex">R_{13}< / annotation>< / semantics>< / com:Math> together with the carbon atom to which they are attached form a cyclic group azetidinyl, <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl, morpholinyl, or piperidinyl, each substituted with zero to 4 R<com:Sub>12a< / com:Sub>; or (vi) an aromatic group pyrazolyl substituted with zero to <com:Math><semantics>1R14a<annotation encoding="application / x-tex">1 R_{14a}< / annotation>< / semantics>< / com:Math>; <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math> or <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; each R<com:Sub>2< / com:Sub> is independently Cl, -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CN, -OCH<com:Sub>3< / com:Sub>, <com:Math><semantics>−CH2OCH3<annotation encoding="application / x-tex">-CH2OCH3< / annotation>< / semantics>< / com:Math>, or <com:Math><semantics>−CH2CH2S(O)2CH3<annotation encoding="application / x-tex">-CH2CH2S(O)2CH3< / annotation>< / semantics>< / com:Math>; <com:Math><semantics>R2a<annotation encoding="application / x-tex">R_{2a}< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>C1−2<annotation encoding="application / x-tex">C_{1-2}< / annotation>< / semantics>< / com:Math> fluoroalkyl, <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> hydroxyalkyl, <com:Math><semantics>−(CH2)1−3OCH3<annotation encoding="application / x-tex">-(CH_2)_{1-3}OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>C3−6<annotation encoding="application / x-tex">C_{3-6}< / annotation>< / semantics>< / com:Math> cycloalkyl, <com:Math><semantics>−CH2C(O)NRxRx<annotation encoding="application / x-tex">-CH_2C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2(C3−6 cycloalkyl)<annotation encoding="application / x-tex">-CH_2(C_{3-6} \text{ cycloalkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2(phenyl)<annotation encoding="application / x-tex">-CH_2(\text{phenyl})< / annotation>< / semantics>< / com:Math>, tetrahydrofuranyl, or phenyl; each R<com:Sub>2b< / com:Sub> is independently H, F, Cl, -CN, -NR<com:Sub>x< / com:Sub>R<com:Sub>x< / com:Sub>, C<com:Sub>1-6< / com:Sub> alkyl, C<com:Sub>1-2< / com:Sub> fluoroalkyl, C<com:Sub>1-3< / com:Sub> hydroxyalkyl, <com:Math><semantics>−(CH2)0−2O(C1−2 alkyl)<annotation encoding="application / x-tex">-(CH_2)_{0-2}O(C_{1-2} \text{ alkyl})< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)0−2C(O)NRxRx<annotation encoding="application / x-tex">-(CH_2)_{0-2}C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)1−3(cyclopropyl)<annotation encoding="application / x-tex">-(CH_2)_{1-3}(cyclopropyl)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)O(C1−2 alkyl),−C(O)NRx(C1−3 alkyl),−CRx=CH2, or −CH=CH(C3−6 cycloalkyl);<annotation encoding="application / x-tex">-C(O)O(C_{1-2} \text{ alkyl}), -C(O)NR_x(C_{1-3} \text{ alkyl}), -CR_x=CH_2, \text{ or } -CH=CH(C_{3-6} \text{ cycloalkyl});< / annotation>< / semantics>< / com:Math> R<com:Sub>6< / com:Sub> is: (a) <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math>; or (b) azetidinyl, cyclohexyl, or piperidinyl, each substituted with zero to 2 R<com:Sub>6a< / com:Sub>; each R<com:Sub>6a< / com:Sub> is independently -CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>CH<com:Sub>3< / com:Sub>, -C(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>C(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>OH, -N(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, <com:Math><semantics>−N(CH2CH2CH3)2<annotation encoding="application / x-tex">-N(CH_2CH_2CH_3)_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2CH2S(O)2CH3<annotation encoding="application / x-tex">-CH_2CH_2S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)N(CH3)2<annotation encoding="application / x-tex">-CH_2C(O)N(CH_3)_2< / annotation>< / semantics>< / com:Math>, or tetrahydropyranyl; R<com:Sub>7< / com:Sub> and R<com:Sub>8< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic ring azetidinyl, diazepanyl, diazaspiro[3.5]nonanyl, piperazinonyl, piperazinyl, piperidinyl, or pyrrolidinyl, wherein said heterocyclic ring is substituted with zero to 1 R<com:Sub>7b< / com:Sub> and zero to 2 R<com:Sub>7c< / com:Sub>; R<com:Sub>7b< / com:Sub> is: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] _ [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] _ [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] or R<com:Sub>9< / com:Sub> and R<com:Sub>10< / com:Sub> together with the nitrogen atom to which they are attached form a heterocyclic [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] <com:Math><semantics>−CH2CH2S(O)2CH3<annotation encoding="application / x-tex">-CH_2CH_2S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, or oxetanyl; -( [Image disponible dans le document PDF, Image available in the PDF document] R<com:Sub>12b< / com:Sub> is azaspiro[3.5]nonanyl, azetidinyl, cyclopropyl, cyclopentyl, dioxotetrahydrothiofuranyl, dioxidotetrahydrothiopyranyl, dioxothiaazaspiro[3.3]heptanyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxazolyl, oxetanyl, phenyl, piperazinonyl, piperidinyl, pyrazinyl, pyridinyl, pyrimidinyl, pyrrolidinyl, pyrrolidinonyl, tetrahydrofuranyl, tetrahydropyranyl, or triazolyl, each substituted with zero to 4 substituents independently F, -CN, -CH<com:Sub>3< / com:Sub>, -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, C<com:Sub>1-2< / com:Sub> cyanoalkyl, <com:Math><semantics>−OCH3<annotation encoding="application / x-tex">-OCH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(O)NH(CH3)<annotation encoding="application / x-tex">-CH_2C(O)NH(CH_3)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NRxRx<annotation encoding="application / x-tex">-C(O)NR_xR_x< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)2CH3<annotation encoding="application / x-tex">-S(O)_2CH_3< / annotation>< / semantics>< / com:Math>, or <com:Math><semantics>−CH2S(O)2CH3<annotation encoding="application / x-tex">-CH_2S(O)_2CH_3< / annotation>< / semantics>< / com:Math>; <com:Math><semantics>R14a<annotation encoding="application / x-tex">R_{14a}< / annotation>< / semantics>< / com:Math> is piperidinyl or <com:Math><semantics>−CH2CH2<annotation encoding="application / x-tex">-CH_2CH_2< / annotation>< / semantics>< / com:Math> (morpholinyl); each <com:Math><semantics>Rx<annotation encoding="application / x-tex">R_x< / annotation>< / semantics>< / com:Math> is independently H or <com:Math><semantics>−CH3<annotation encoding="application / x-tex">-CH_3< / annotation>< / semantics>< / com:Math>; each <com:Math><semantics>Ry<annotation encoding="application / x-tex">R_y< / annotation>< / semantics>< / com:Math> is independently H or <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl; n is zero, 1, or 2; and p is zero, 1, 2, 3, or 4.
2. The compound according to claim 1 or a salt thereof, wherein: [Image disponible dans le document PDF, Image available in the PDF document] G is A is <com:Math><semantics>−CRxR12R13<annotation encoding="application / x-tex">-CR_xR_{12}R_{13}< / annotation>< / semantics>< / com:Math>, wherein <com:Math><semantics>R12<annotation encoding="application / x-tex">R_{12}< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>R13<annotation encoding="application / x-tex">R_{13}< / annotation>< / semantics>< / com:Math> together with the carbon atom to which they are attached form a cyclic group azetidinyl, <com:Math><semantics>C4−6<annotation encoding="application / x-tex">C_{4-6}< / annotation>< / semantics>< / com:Math> cycloalkyl, or piperidinyl, each substituted with zero to 4 <com:Math><semantics>R12a<annotation encoding="application / x-tex">R_{12a}< / annotation>< / semantics>< / com:Math>.
3. The compound according to claim 1 or a salt thereof, wherein: [Image disponible dans le document PDF, Image available in the PDF document] G is A is <com:Math><semantics>−CRxR12R13<annotation encoding="application / x-tex">-CR_xR_{12}R_{13}< / annotation>< / semantics>< / com:Math>, wherein <com:Math><semantics>R12<annotation encoding="application / x-tex">R_{12}< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>R13<annotation encoding="application / x-tex">R_{13}< / annotation>< / semantics>< / com:Math> together with the carbon atom to which they are attached form a cyclic group cyclopentyl or cyclohexyl, each substituted with zero to 1 <com:Math><semantics>R12a<annotation encoding="application / x-tex">R_{12a}< / annotation>< / semantics>< / com:Math>; [Image disponible dans le document PDF, Image available in the PDF document] R<com:Sub>12b< / com:Sub> is cyclopropyl, cyclopentyl, dioxotetrahydrothiofuranyl, dioxidotetrahydrothiopyranyl, morpholinyl, oxaazaspiro[3.3]heptanyl, oxazolyl, oxetanyl, phenyl, piperidinyl, pyrazinyl, pyridinyl, pyrimidinyl, pyrrolidinyl, pyrrolidinonyl, tetrahydrofuranyl, tetrahydropyranyl, or triazolyl, each substituted with zero to 4 substituents independently F, -CN, -CH<com:Sub>3< / com:Sub>, -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, C<com:Sub>1-2< / com:Sub> cyanoalkyl, 409 [Image disponible dans le document PDF, Image available in the PDF document] 4. The compound according to claim 1 or a salt thereof, wherein: [Image disponible dans le document PDF, Image available in the PDF document] A is <com:Math><semantics>−NR7R8<annotation encoding="application / x-tex">-NR_7R_8< / annotation>< / semantics>< / com:Math>.
5. The compound according to claim 1 or a salt thereof, wherein: [Image disponible dans le document PDF, Image available in the PDF document] G is <com:Math><semantics>R1<annotation encoding="application / x-tex">R_1< / annotation>< / semantics>< / com:Math> is <com:Math><semantics>−CH(CH3)2<annotation encoding="application / x-tex">-CH(CH_3)_2< / annotation>< / semantics>< / com:Math>; and A is piperazinyl.
6. The compound according to claim 1 or a salt thereof, wherein said compound is: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] 7. The compound according to claim 1 or a salt thereof, wherein said compound is: [Image disponible dans le document PDF, Image available in the PDF document] 8. The compound according to claim 1 or a salt thereof, wherein said compound is: 411 [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] 9. The compound according to claim 1, N-oxide, or a salt thereof, wherein said compound is: 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b] pyridin- 5-yl)-N-(tetrahydro-2H-pyran-4-yl)azetidin-3-amine (1); 6-(3-isopropyl-5-(piperazin-1-yl)- 1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (2); 1-(4-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl)-2-(dimethylamino)ethan-1-one (3); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-((1- (methylsulfonyl)cyclopropyl)methyl)cyclohexan-1-amine (4); 2-(3,4-dimethoxyphenyl)-5-(1'- isobutyl-[1,4'-bipiperidin]-4-yl)-3-methyl-1H-pyrrolo[3,2-b]pyridine (5); N-(2- (dimethylamino)ethyl)-N-ethyl-3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)- 6-methyl-1H-pyrrolo[3,2-b]pyridine-5-carboxamide (6); 3-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclopentan-1-one (7-9); 2- <com:Math><semantics>((3−(3−isopropyl−2−(8−methoxy−[1,2,4]triazolo[1,5−a]pyridin−6−yl)−1H−pyrrolo[3,2−b]pyridin−6−yl)<annotation encoding="application / x-tex">((3-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-6-yl)< / annotation>< / semantics>< / com:Math> 5-yl)cyclopentyl)amino)-N-methylacetamide (10); 6-(6-fluoro-3-isopropyl-5-(piperidin-4-yl)- 1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methyl-[1,2,4]triazolo[1,5-a]pyridine (11); 1-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N,N- dimethylazetidin-3-amine (12); 1-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N,N-dimethylazetidin-3-amine (13); 1-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)azetidin-3- amine (14); N-(1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-5-yl)azetidin-3-yl)-2-(dimethylamino)acetamide (15); 1-(3-isopropyl-2- (8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)azetidin-3- amine (16); 2-(dimethylamino)-N-(1-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin- 6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)azetidin-3-yl)acetamide (17); 2-((1-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)azetidin-3- yl)amino)-N,N-dimethylacetamide (18, 27); N-(1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)azetidin-3-yl)-2-(dimethylamino)- N-methylacetamide (19, 25); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methylazetidin-3-amine (20, 23);2-((1-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)azetidin-3-yl)(methyl)amino)-N,N-dimethylacetamide (21); 2-((1-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)azetidin-3- yl)amino)-N,N-dimethylacetamide (22, 26); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin- 6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methyl-N-(tetrahydro-2H-pyran-4- yl)azetidin-3-amine (24); 2-(dimethylamino)-N-(1-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)azetidin-3-yl)-N- methylacetamide (28); 1-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-N-(tetrahydro-2H-pyran-4-yl)azetidin-3-amine (29); 1-(3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N- ((3-methyloxetan-3-yl)methyl)azetidin-3-amine (30); 1-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methylazetidin-3-amine (31); 1-(3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)azetidin-3-amine (32, 35); 1-(3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-N-(tetrahydro-2H-pyran-4-yl)azetidin-3-amine (33, 36); 2-((1-(3- isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)azetidin-3-yl)amino)-N,N-dimethylacetamide (34, 37); 1-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)azetidin-3-ol (38); 4-(1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)azetidin-3-yl)morpholine (39); 1-(1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)azetidin-3-yl)piperidin-4-ol (40); 4-(1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)azetidin-3-yl)thiomorpholine 1,1-dioxide (41); methyl 4-(1-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)azetidin-3- yl)piperazine-1-carboxylate (42); 6-(3-isopropyl-5-(2,7-diazaspiro[3.5]nonan-2-yl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (43); 2-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,7- diazaspiro[3.5]nonan-7-yl)-N,N-dimethylacetamide (44); 6-(3-isopropyl-5-(7-(2- (methylsulfonyl)ethyl)-2,7-diazaspiro[3.5]nonan-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridine (45); 6-(3-isopropyl-5-(7-isopropyl-2,7- diazaspiro[3.5]nonan-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridine (46); 6-(3-isopropyl-5-(7-(oxetan-3-yl)-2,7-diazaspiro[3.5]nonan-2-yl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (47); N,N-bis((1H- 1,2,3-triazol-4-yl)methyl)-1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl- 1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-4-amine (48); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(tetrahydro-2H-pyran-4- yl)piperidin-4-amine (49); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl- 1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-4-amine (50); 2,2'-((1-(3-isopropyl-2-(1-methyl-1H- pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-4- yl)azanediyl)diacetonitrile (51); 2,2'-((1-(3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin- 3-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-4-yl)azanediyl)diacetonitrile (52-53); 2,2'-((1- (3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperidin-4-yl)azanediyl)bis(N,N-dimethylacetamide) (54); 1-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methyl-N- (tetrahydro-2H-pyran-4-yl)piperidin-4-amine (55); N-((1,2,3-thiadiazol-4-yl)methyl)-1-(2- (7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)piperidin-4-amine (56); N-cyclobutyl-1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-4-amine (57); N- (cyclopropylmethyl)-1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-5-yl)-N-methylpiperidin-4-amine (58); N-cyclobutyl-1-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N- methylpiperidin-4-amine (59); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methyl-N-(pyrimidin-2-ylmethyl)piperidin-4- amine (60); N-((4,6-dimethoxypyrimidin-5-yl)methyl)-1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methylpiperidin-4-amine (61); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin- 5-yl)-N-methyl-N-((1-methyl-1H-pyrazol-5-yl)methyl)piperidin-4-amine (62); 1-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N- methyl-N-((1-methyl-1H-1,2,4-triazol-5-yl)methyl)piperidin-4-amine (63, 68); 1-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N- methyl-N-((2-methylpyrimidin-5-yl)methyl)piperidin-4-amine (64); 1-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methyl-N- (oxetan-3-yl)piperidin-4-amine (65); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-ethyl-N-methylpiperidin-4-amine (66); 1-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N- ((2-methoxypyrimidin-5-yl)methyl)-N-methylpiperidin-4-amine (67); N-((4,6- dimethoxypyrimidin-5-yl)methyl)-1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-4-amine (69); 1-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N,N- diethylpiperidin-4-amine (70); N,N-bis((4,6-dimethoxypyrimidin-5-yl)methyl)-1-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)piperidin-4-amine (71); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl- 1H-pyrrolo[3,2-b]pyridin-5-yl)-N-((2-methoxypyrimidin-5-yl)methyl)piperidin-4-amine (72); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin- 5-yl)-N,N-bis((1-methyl-1H-1,2,3-triazol-4-yl)methyl)piperidin-4-amine (73, 76); 1-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N,N- bis((2-methylpyrimidin-4-yl)methyl)piperidin-4-amine (74); 1-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N,N-bis((2- methoxypyrimidin-5-yl)methyl)piperidin-4-amine (75); N-((1,2,3-thiadiazol-4-yl)methyl)-1- (2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)-N-methylpiperidin-4-amine (77); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methyl-N-(pyrimidin-2-ylmethyl)piperidin-4- amine (78); (6-(5-(4-aminopiperidin-1-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)- [1,2,4]triazolo[1,5-a]pyridin-8-yl)methanol (79); (6-(3-isopropyl-5-(4-((tetrahydro-2H-pyran- 4-yl)amino)piperidin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-8- yl)methanol (80); (6-(3-isopropyl-5-(4-(oxetan-3-ylamino)piperidin-1-yl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-8-yl)methanol (81); (6-(3-isopropyl-5-(4-(((3-isopropyl-5-(4-(((3-isopropyl-5-(4-(((3-isopropyl-5-(4-(((3-isopropyl-5-(4-(((3-isopropyl-5-(4-(((3-isopropyl-5-(4-(((3-isopropyl- methyloxetan-3-yl)methyl)amino)piperidin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)- [1,2,4]triazolo[1,5-a]pyridin-8-yl)methanol (82); 2-((1-(2-(8-(hydroxymethyl)- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-4- yl)amino)acetonitrile (83); 2-((1-(2-(8-(hydroxymethyl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-4-yl)amino)-N,N-dimethylacetamide (84- 85); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)-N-(oxetan-3-yl)piperidin-3-amine (86); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-((1- (methylsulfonyl)cyclopropyl)methyl)piperidin-3-amine (87); 6-(3-isopropyl-5-(piperazin-1- yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methyl-[1,2,4]triazolo[1,5-a]pyridine (88); 6-(3- isopropyl-5-(piperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5- a]pyridine (89); 2-(dimethylamino)-1-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)ethan-1-one (90); 6-(3- isopropyl-5-(4-methylpiperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (91); 6-(3-isopropyl-5-(4-isopropylpiperazin-1-yl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (92); 6-(3-isopropyl-5- (4-(oxetan-3-yl)piperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (93); 2-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)acetonitrile (94); 6-(3-isopropyl- 5-(4-(2-(methylsulfonyl)ethyl)piperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (95); 6-(3-isopropyl-5-(4-methylpiperazin-1-yl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (96); 6-(3-isopropyl-5- (4-((3-methyloxetan-3-yl)methyl)piperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridine (97); 1-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)-3- (dimethylamino)propan-1-one (98); 3-(dimethylamino)-1-(4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)propan-1-one (99); 6-(3-isopropyl-5-(4-isopropylpiperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridine (100); 6-(3-isopropyl-5-(4-(tetrahydro-2H-pyran-4- yl)piperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (101); 6-(3-isopropyl-5-(4-((3-methyloxetan-3-yl)methyl)piperazin-1-yl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (102); 6-(3-isopropyl-5-(4- (tetrahydrofuran-3-yl)piperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (103); 6-(3-isopropyl-5-(4-(tetrahydro-2H-pyran-4-yl)piperazin- 1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (104); 1-(4-(2- (7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl)-2-methylpropan-2-ol (105); 1-(4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)-2- methylpropan-2-ol (106); 6-(3-isopropyl-5-(4-((tetrahydrofuran-3-yl)methyl)piperazin-1-yl)- 1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (107); 6-(5-(4- cyclobutylpiperazin-1-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (108); 6-(5-(4-isobutylpiperazin-1-yl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (109); 6-(5-(4- isopentylpiperazin-1-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (110); 6-(3-isopropyl-5-(4-neopentylpiperazin-1-yl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (111); 6-(3-isopropyl-5- (4-(1-methoxypropan-2-yl)piperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (112); 4-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)cyclohexan-1-ol (113); 6-(5-(4- (3,3-dimethylbutyl)piperazin-1-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (114); 6-(5-(4-butylpiperazin-1-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (115); 6-(3-isopropyl-5-(4-(3,3,3- trifluoropropyl)piperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5- a]pyridine (116); 2-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)propan-1-ol (117); 3-(4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)butan-1-ol (118); 6-(5-(4-ethylpiperazin-1-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (119); 6-(5-(4-(cyclopropylmethyl)piperazin-1-yl)-3-isopropyl- 1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (120); 1-(4-(4-(3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl)piperidin-1-yl)ethan-1-one (121); 5-(3-isopropyl-5-(piperazin-1-yl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidine (122); 2-(dimethylamino)- 1-(4-(3-isopropyl-2-(7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl)ethan-1-one (123); 3-(dimethylamino)-1-(4-(3-isopropyl-2-(7-methyl-7H- pyrrolo[2,3-d]pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)propan-1-one (124); 5-(3-isopropyl-5-(4-methylpiperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7-methyl- 7H-pyrrolo[2,3-d]pyrimidine (125); 5-(3-isopropyl-5-(4-isopropylpiperazin-1-yl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidine (125); 5-(3-isopropyl-5- (4-(tetrahydro-2H-pyran-4-yl)piperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7-methyl-7H- pyrrolo[2,3-d]pyrimidine (127); 2-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin- 6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)-N,N-dimethylacetamide (128); 6-(3- isopropyl-5-(4-((1-methyl-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (129); 2-(4-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1- yl)acetamide (130); 6-(3-isopropyl-5-(4-(2-methoxyethyl)piperazin-1-yl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (131); 6-(3-isopropyl-5-(4-(3- (methylsulfonyl)propyl)piperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (132); 4-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)tetrahydro-2H-thiopyran 1,1- dioxide (133); N-(2-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)ethyl)methanesulfonamide (134); 6-(3-isopropyl-5- (4-(4,4,4-trifluorobutyl)piperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (135); 3-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)-N,N-dimethylpropanamide (136); 3-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)piperazin-1-yl)propanamide (137); 2-(4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)-N- methylacetamide (138); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl- 1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-2-one (139); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-(oxetan-3-yl)piperazin-2-one (140); 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)-3-oxopiperazin-1-yl)-N,N-dimethylacetamide (141); 1-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-4- methylpiperazin-2-one (142); 1-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)-2-morpholinoethan-1-one (143); 2- (4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin- 5-yl)piperazin-1-yl)-N,N-dimethylacetamide (144); 1-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)-2-(pyrrolidin-1- yl)ethan-1-one (145); 2-(azetidin-1-yl)-1-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)ethan-1-one (146); 6-(3- isopropyl-5-(4-(3-(methylsulfonyl)propyl)piperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridine (147); 3-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)propanenitrile (148); 3-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)piperazin-1-yl)propanamide (149); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-2-one (150); 2-((4-(2- (7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl)sulfonyl)-N,N-dimethylethan-1-amine (151); (S)-6-(3-isopropyl-5-(2- methylpiperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridine (152); (R)-6-(3-isopropyl-5-(2-methylpiperazin-1-yl)-1H-pyrrolo[3,2-b]pyridin-2- yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (153); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-1-(2-morpholinoethyl)piperazin- 2-one (154-155); 2-(cyclobutylamino)-1-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)ethan-1-one (156); 1-(4-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl)-2-(isopropylamino)ethan-1-one (157); 1-(4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)- 2-((2-hydroxyethyl)amino)ethan-1-one (158); 1-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)-2-((2- methoxyethyl)amino)ethan-1-one (159); 1-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin- 6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl)-2-(4-hydroxypiperidin-1- yl)ethan-1-one (160); 2-((cyclopropylmethyl)amino)-1-(4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1- yl)ethan-1-one (161); 6-(5-(1,4-diazepan-1-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)- 7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (162); 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-1,4-diazepan-1-yl)-N,N- dimethylacetamide (163); 1-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl- 1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(oxetan-3-yl)pyrrolidin-3-amine (164); 1-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-((1- (methylsulfonyl)cyclopropyl)methyl)pyrrolidin-3-amine (165); 3-((4-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)propanenitrile (166, 175); N-isopropyl-4-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexan-1- amine (167, 193); N-isopropyl-4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methylcyclohexan-1-amine (168, 170); 2-((4-(3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)ethan-1-ol (169, 191); N-cyclopropyl-4-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N- methylcyclohexan-1-amine (171-172);(S)-(1-(4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)pyrrolidin-2- yl)methanol (173, 197); 6-(3-isopropyl-5-(4-(pyrrolidin-1-yl)cyclohexyl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (174, 192, 195, 199); 4-(3-isopropyl- 2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexan- 1-one (176); 4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-N,N-dimethylcyclohexan-1-amine (177, 179, 187); N-(4-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)oxetan-3-amine (178, 180, 186); 2-((4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)-N,N- dimethylacetamide (181, 231-232); 2-((4-(3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin- 3-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)-N,N-dimethylacetamide (182-183); N-(4-(3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)oxetan-3-amine (184-185); 4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methylcyclohexan-1-amine (188-189); 4-(3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N- ((5-methylpyrazin-2-yl)methyl)cyclohexan-1-amine (190, 196); 4-(4-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)morpholine (194); 4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(2-methoxyethyl)-N-methylcyclohexan-1-amine (198); 2-((4-(3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)-N,N-dimethylacetamide (200-201); 4-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methyl-N-((5- methylpyrazin-2-yl)methyl)cyclohexan-1-amine (202-203); 4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(oxazol-5- ylmethyl)cyclohexan-1-amine (204, 206); 4-(3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3- b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-((5-methylpyrazin-2-yl)methyl)cyclohexan- 1-amine (205, 207); 4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-N-methyl-N-(pyrimidin-2-ylmethyl)cyclohexan-1-amine (208- 209); 2-((4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl)(methyl)amino)-N-methylacetamide (210, 227-228); 2-((4-(3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)-N,N-dimethylacetamide (211, 226); 2-((4-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)acetamide (212, 225); 2-((4-(3-isopropyl-2-(8- (methoxymethyl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)amino)-N,N-dimethylacetamide (213, 230); N-(4-(3-isopropyl-2-(8- (methoxymethyl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)oxetan-3-amine (214, 229); (6-(3-isopropyl-5-(4-(oxetan-3- ylamino)cyclohexyl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-8- yl)methanol (215, 220); 2-((4-(2-(8-(hydroxymethyl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)-N,N-dimethylacetamide (216, 222); (6-(3-isopropyl-5-(4-(((5-methylpyrazin-2-yl)methyl)amino)cyclohexyl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-8-yl)methanol (217); (6-(5-(4-(((1H- 1,2,3-triazol-4-yl)methyl)amino)cyclohexyl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)- [1,2,4]triazolo[1,5-a]pyridin-8-yl)methanol (218, 221); 4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-((1- (methylsulfonyl)cyclopropyl)methyl)cyclohexan-1-amine (219); 4-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-((1- (methylsulfonyl)cyclopropyl)methyl)cyclohexan-1-amine (223); N-(4-(2-(7,8-dimethyl- [1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)oxetan-3-amine (233-234); (6-(3-isopropyl-5-(4-(oxetan-3- ylamino)cyclohexyl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-8- yl)methanol (235); 4-(3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-N-((1-(methylsulfonyl)cyclopropyl)methyl)cyclohexan-1-amine (236, 238); N-cyclopropyl-N-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)oxetan-3-amine (237, 239); N-(4-(3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)-N-methyloxetan-3-amine (240); 4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methyl-N-(2- (methylsulfonyl)ethyl)cyclohexan-1-amine (241-242); N-cyclopropyl-4-(3-isopropyl-2-(1- methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexan-1-amine (243); 6-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl)-2-oxa-6-azaspiro[3.3]heptane (244); 6-(4-(3-isopropyl-2-(1- methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)-2-oxa-6- azaspiro[3.3]heptane (245); (6-(3-isopropyl-5-(4-(methyl(oxetan-3-yl)amino)cyclohexyl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-8-yl)methanol (246, 252); 4-(3- isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(2- (methylsulfonyl)ethyl)cyclohexan-1-amine (247, 251); 6-(4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)-2-thia-6- azaspiro[3.3]heptane 2,2-dioxide (248); 5-(3-isopropyl-5-(4-(methyl(oxetan-3- yl)amino)cyclohexyl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,3,4-trimethylpyridin-2(1H)-one (249, 254); 5-(3-isopropyl-5-(4-(methyl(oxetan-3-yl)amino)cyclohexyl)-1H-pyrrolo[3,2-b]pyridin- 2-yl)-1,3-dimethylpyridin-2(1H)-one (250); 6-(4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)-2-thia-6- azaspiro[3.3]heptane 2,2-dioxide (253); 6-(4-(3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3- b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)-2-thia-6-azaspiro[3.3]heptane 2,2- dioxide (255-256); 2-((4-(3-isopropyl-2-(1-(2-(methylsulfonyl)ethyl)-1H-pyrrolo[2,3- b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)-N,N-dimethylacetamide (257, 261); 6-(4-(3-isopropyl-2-(1-(2-(methylsulfonyl)ethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)- 1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)-2-oxa-6-azaspiro[3.3]heptane (258); 4-(3- isopropyl-2-(1-(2-(methylsulfonyl)ethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-N-((1-(methylsulfonyl)cyclopropyl)methyl)cyclohexan-1-amine (259, 262); 4- (3-isopropyl-2-(1-(2-(methylsulfonyl)ethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexan-1-ol (260); 2-(3-(3-isopropyl-5-(4-(methylamino)cyclohexyl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetonitrile (263, 270); 4-(3- isopropyl-2-(1-(2-(methylsulfonyl)ethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-N-methylcyclohexan-1-amine (264, 269); N-(4-(3-isopropyl-2-(1-methyl-1H- pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)tetrahydro-2H-pyran-4- amine (265, 267); N-(4-(3-isopropyl-2-(1-(2-(methylsulfonyl)ethyl)-1H-pyrrolo[2,3- b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)tetrahydro-2H-pyran-4-amine (266, 271); 2-(3-(3-isopropyl-5-(4-((tetrahydro-2H-pyran-4-yl)amino)cyclohexyl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetonitrile (268, 274); 2-((4-(2-(1- (cyanomethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)amino)-N,N-dimethylacetamide (272, 276); 2-(3-(3-isopropyl-5-(4-((2- (methylsulfonyl)ethyl)amino)cyclohexyl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1H-pyrrolo[2,3- b]pyridin-1-yl)acetonitrile (273, 275); 2-((4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)(oxetan-3-yl)amino)acetonitrile (277); 4-(3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-N-(2-methyl-2-(methylsulfonyl)propyl)cyclohexan-1-amine (278, 285); N-(4-(3- isopropyl-2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)oxetan-3-amine (279, 284); 2-((4-(3-isopropyl-2-(8-methyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)-N,N-dimethylacetamide (280); 6-(4-(3-isopropyl-2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl)-2-oxa-6-azaspiro[3.3]heptane (281, 288); N-(4-(2-(2,6- dimethylpyridin-4-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)oxetan-3-amine (282, 287); 6-(4-(2-(2,6-dimethylpyridin-4-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)-2-oxa-6-azaspiro[3.3]heptane (283, 286); N-(4-(2-(1-ethyl-1H-pyrrolo[2,3- b]pyridin-3-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)tetrahydro-2H-pyran- 4-amine (289); 6-(4-(2-(1-ethyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl)-2-oxa-6-azaspiro[3.3]heptane (290, 294); 2-((4-(2-(1-ethyl-1H- pyrrolo[2,3-b]pyridin-3-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)- N,N-dimethylacetamide (291); N-(4-(2-(1-ethyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-3-isopropyl- 1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)tetrahydro-2H-pyran-4-amine (292); 4-(2-(1-ethyl- 1H-pyrrolo[2,3-b]pyridin-3-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexan-1-ol (293); 2-(3-(3-isopropyl-5-(4-(methylamino)cyclohexyl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1H- pyrrolo[2,3-b]pyridin-1-yl)ethan-1-ol (295, 299); 4-(3-isopropyl-2-(7-methyl-7H-pyrrolo[2,3- d]pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methylcyclohexan-1-amine (296, 301); 4-(3-isopropyl-2-(5-methyl-5H-pyrrolo[2,3-b]pyrazin-7-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- N-methylcyclohexan-1-amine (297, 300); 4-(3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3- b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methylcyclohexan-1-amine (302); 2-((4-(3- isopropyl-2-(7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)amino)-N,N-dimethylacetamide (303); 4-(3-isopropyl-2-(7-methyl-7H- pyrrolo[2,3-d]pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(2- (methylsulfonyl)ethyl)cyclohexan-1-amine (304); N-(4-(3-isopropyl-2-(7-methyl-7H- pyrrolo[2,3-d]pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)tetrahydro-2H- pyran-4-amine (305); (6-(5-(4-((4-fluorobenzyl)(methyl)amino)cyclohexyl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-8-yl)methanol (306); (6-(3- isopropyl-5-(4-((3,3,3-trifluoropropyl)amino)cyclohexyl)-1H-pyrrolo[3,2-b]pyridin-2-yl)- [1,2,4]triazolo[1,5-a]pyridin-8-yl)methanol (307-308); N-(4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-methyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)oxetan-3-amine (309, 316); N-(4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-methyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)-3- methyloxetan-3-amine (310-311); 4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin- 6-yl)-6-methyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-((3-methyloxetan-3-yl)methyl)cyclohexan- 1-amine (312, 315); N-ethyl-4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)- 6-methyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methylcyclohexan-1-amine (313); 1-((4-(3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-methyl-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl)amino)-2-methylpropan-2-ol (314, 321); 6-(4-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-methyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)-2-oxa-6-azaspiro[3.3]heptane (317, 319); 4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-methyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexan-1- amine (318, 323); N-ethyl-4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6- methyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methylcyclohexan-1-amine (320); N-(2,2- difluoroethyl)-4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-methyl-1H- pyrrolo[3,2-b]pyridin-5-yl)cyclohexan-1-amine (322, 324); 6-(5-(4-(azetidin-1- yl)cyclohexyl)-3-isopropyl-6-methyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (325-326); 4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-6-methyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(2-methoxyethyl)cyclohexan-1- amine (327, 335); N-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6- methyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)tetrahydrofuran-3-amine (328-329); N-(4- (3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-methyl-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl)-N-methyloxetan-3-amine (330-331); 4-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-methyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N- methyl-N-((1-methyl-1H-1,2,4-triazol-3-yl)methyl)cyclohexan-1-amine (332-333); 4-(3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-methyl-1H-pyrrolo[3,2- b]pyridin-5-yl)-N-methyl-N-neopentylcyclohexan-1-amine (334, 336); 6-(5-(4-(3,3- difluoroazetidin-1-yl)cyclohexyl)-3-isopropyl-6-methyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-8- methoxy-[1,2,4]triazolo[1,5-a]pyridine (337-338); 3-((4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-methyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)propanenitrile (339-340); 4-(6-fluoro-3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-((3- methyloxetan-3-yl)methyl)cyclohexan-1-amine (341-342); 6-(4-(6-fluoro-3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)-2- oxa-6-azaspiro[3.3]heptane (343-344); N-(4-(6-fluoro-3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)oxetan-3-amine (345-346); 4-(6-fluoro-3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-N-methylcyclohexan-1-amine (347-348); 4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexan-1- one (349); N-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)oxetan-3-amine (350-351); 2-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)amino)-N,N-dimethylacetamide (352, 354); 4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N,N- dimethylcyclohexan-1-amine (353, 355-356); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-((5-methylpyrazin-2- yl)methyl)cyclohexan-1-amine (357, 359); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-isopropylcyclohexan-1-amine (358, 363); 6-(3-isopropyl-5-(4-(pyrrolidin-1-yl)cyclohexyl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridine (360, 407); 3-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)propanenitrile (361); 4-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)morpholine (362); 4- (2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)-N-isopropyl-N-methylcyclohexan-1-amine (364); 2-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)ethan-1-ol (365); 3-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)propanenitrile (366); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methylcyclohexan-1-amine (367, 369); 2-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)(methyl)amino)-N,N-dimethylacetamide (368); 6-(5- (4-(3,3-difluoroazetidin-1-yl)cyclohexyl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridine (370, 374); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(prop-2-yn-1-yl)cyclohexan-1- amine (371, 375); (R)-(1-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl- 1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)pyrrolidin-2-yl)methanol (372, 377); 4-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N- (3,3,3-trifluoropropyl)cyclohexan-1-amine (373, 376); (R)-(1-(4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)pyrrolidin-2-yl)methanol (377); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N,N-diethylcyclohexan-1-amine (378-411); 2-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)ethan-1-ol (379, 409); N-cyclopropyl-4-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N- methylcyclohexan-1-amine (380, 387); 6-(5-(4-(4,4-difluoropiperidin-1-yl)cyclohexyl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (381, 385); 4-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl)thiomorpholine 1,1-dioxide (382-383); 3-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)amino)propanenitrile (384, 432); 6-(5-(4-(azetidin-1-yl)cyclohexyl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (386); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin- 5-yl)-N-ethyl-N-methylcyclohexan-1-amine (388, 390); 4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(2- methoxyethyl)-N-methylcyclohexan-1-amine (389); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(2-methoxyethyl)-N- methylcyclohexan-1-amine (391); (S)-(1-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)pyrrolidin-2-yl)methanol (392- 393); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)-N-methyl-N-((2-methylpyrimidin-5-yl)methyl)cyclohexan-1-amine (394, 402); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)-N-((2-methoxypyrimidin-5-yl)methyl)-N-methylcyclohexan-1-amine (395, 405); N-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl)-2-(dimethylamino)-N-methylacetamide (396, 404); N-((1H-1,2,3- triazol-4-yl)methyl)-4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-5-yl)-N-methylcyclohexan-1-amine (397, 399); 2-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)acetamide (398, 406); 2-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)-N-methylacetamide (400, 403, 420, 422); N-(4-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)-N-methyloxetan-3-amine (401, 424, 430); 2-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)-N,N-dimethylacetamide (408, 410); N-((1H-1,2,3-triazol-4- yl)methyl)-4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexan-1-amine (412); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(oxazol-5-ylmethyl)cyclohexan-1-amine (413, 416); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)-N-methyl-N-((5-methylpyrazin-2-yl)methyl)cyclohexan-1-amine (414-415); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin- 5-yl)-N-methyl-N-(pyrimidin-2-ylmethyl)cyclohexan-1-amine (417-418); 4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-((1- (methylsulfonyl)cyclopropyl)methyl)cyclohexan-1-amine (419); 2-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)-N-methylacetamide (420); N-cyclopropyl-4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexan-1- amine (421, 426); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-5-yl)-N-(2-((trifluoromethyl)sulfonyl)ethyl)cyclohexan-1-amine (423); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin- 5-yl)-N-methyl-N-(2-(methylsulfonyl)ethyl)cyclohexan-1-amine (425, 427); 3- (cyclopropyl(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)propanenitrile (428, 433); 4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(2- methoxyethyl)cyclohexan-1-amine (429, 431); 3-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)propanenitrile (433); 1-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl)azetidine-3-carbonitrile (434, 436); 6-(4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)-2- oxa-6-azaspiro[3.3]heptane (435, 437); 6-((1r,4r)-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)-2-thia-6- azaspiro[3.3]heptane 2,2-dioxide (438); N-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)-N-methylacetamide (439-440); 2- ((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin- 5-yl)cyclohexyl)(oxetan-3-yl)amino)acetonitrile (441); 4-(4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)-1- methylpiperazin-2-one (442, 443); 2-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)- 3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)(oxetan-3-yl)amino)ethan-1-ol (444); 6-(3-isopropyl-5-(4-(3-(methylsulfonyl)azetidin-1-yl)cyclohexyl)-1H-pyrrolo[3,2-b]pyridin-2- yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (445, 448); 2-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)amino)ethane-1-sulfonamide (446-447); 2-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(oxetan-3-yl)amino)-N-methylacetamide (449); 4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(2- (methylsulfonyl)ethyl)cyclohexan-1-amine (450, 452); N-(4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)tetrahydro-2H-pyran-4-amine (451, 453); 4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(2-methyl-2- (methylsulfonyl)propyl)cyclohexan-1-amine (454-455); 2-((cyanomethyl)(4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)amino)-N,N-dimethylacetamide (456, 459); 2-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)(2- (methylsulfonyl)ethyl)amino)acetonitrile (457-458); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-ethyl-N-(2- (methylsulfonyl)ethyl)cyclohexan-1-amine (460); 2-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)(2- (methylsulfonyl)ethyl)amino)ethan-1-ol (461); 2-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)(ethyl)amino)-N,N- dimethylacetamide (462, 467); 2-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)(2-hydroxyethyl)amino)-N,N- dimethylacetamide (463, 468); 2-(((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)methyl)tetrahydro-2H-thiopyran 1,1-dioxide (464); 3-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)tetrahydrothiophene 1,1-dioxide (465); 4-(2- (7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexan-1-amine (466-469); 3-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)- 3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)tetrahydrothiophene 1,1-dioxide (470); 2-(((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl)amino)methyl)tetrahydro-2H-thiopyran 1,1-dioxide (471); N-(4-(2- (7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)-3-methyloxetan-3-amine (472-473); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-((3-methyloxetan-3- yl)methyl)cyclohexan-1-amine (474, 477); 2-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)((1- (methylsulfonyl)cyclopropyl)methyl)amino)acetonitrile (475, 478); 4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methyl-N- ((1-(methylsulfonyl)cyclopropyl)methyl)cyclohexan-1-amine (476, 479); 4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-ethyl-N-((1- (methylsulfonyl)cyclopropyl)methyl)cyclohexan-1-amine (480); 2-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)((1- (methylsulfonyl)cyclopropyl)methyl)amino)ethan-1-ol (481-482); (3-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)amino)oxetan-3-yl)methanol (483-484); N-(tert-butyl)-2-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)amino)acetamide (485); 2-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)-N-(2-methoxyethyl)-N- methylacetamide (486, 488); 2-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)-N,2-dimethylpropanamide (487); N-(tert-butyl)-2-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)amino)acetamide (489); 2-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)amino)-1-morpholinoethan-1-one (490); 6-(3-isopropyl-5-(2- azaspiro[3.5]nonan-7-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridine (491); 6-(3-isopropyl-5-(2-isopropyl-2-azaspiro[3.5]nonan-7-yl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (492-493); 1-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)amino)-N,N-dimethylcyclopentane-1-carboxamide (494, 497); 2-((4-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)amino)-N,N,2-trimethylpropanamide (495); 2-((4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)amino)-2-methyl-1-morpholinopropan-1-one (496, 498); (3-((4-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(2-methoxyethyl)amino)oxetan-3-yl)methanol (499-500); 2-((4-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl)(methyl)amino)acetamide (501); N-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-6-methyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)oxetan-3- amine (502-503); N-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-fluoro-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)tetrahydro-2H-pyran-4-amine (504-505); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-fluoro-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexan-1-amine (506-507); 2-((4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-6-fluoro-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)(ethyl)amino)- N,N-dimethylacetamide (508-509); 4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6- fluoro-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-ethyl-N-(2- (methylsulfonyl)ethyl)cyclohexan-1-amine (510-511); 2-(2,6-dimethylpyridin-4-yl)-3- isopropyl-5-(piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridine (512); 5-(3-isopropyl-5-(piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridine (512); 5-(3-isopropyl-5-(piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridine (512); 5-(3-isopropyl-5-(piperidi yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1-methylpyridin-2(1H)-one (513); 6-(3-isopropyl-5- (piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-2,4-dimethylpyridazin-3(2H)-one (514); 5-(3- isopropyl-5-(piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,3-dimethylpyridin-2(1H)-one (515); 6-(3-isopropyl-5-(piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methyl- [1,2,4]triazolo[1,5-a]pyridine (516, 518); 6-(3-isopropyl-5-(piperidin-4-yl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-8-methyltetrazolo[1,5-a]pyridine (517); 5-(3-isopropyl-5-(piperidin-4-yl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-1,3,4-trimethylpyridin-2(1H)-one (519); 6-(3-isopropyl-5- (piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (520); 6-(3-isopropyl-5-(piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridine (521); 2-(2,6-dimethylpyridin-4-yl)-3-isopropyl-6-methyl-5- (piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridine (522); 6-(3-isopropyl-6-methyl-5-(piperidin-4-yl)- 1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (523); 6-(6-fluoro-3- isopropyl-5-(piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5- a]pyridine (524); 6-(3-isopropyl-6-methyl-5-(piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)- 8-methyl-[1,2,4]triazolo[1,5-a]pyridine (525); 2-(3,4-dimethoxyphenyl)-3-isopropyl-5- (piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridine (526); 5-(3-isopropyl-5-(1-(tetrahydro-2H-pyran- 4-yl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,3-dimethylpyridin-2(1H)-one (527); 5- (3-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,3- dimethylpyridin-2(1H)-one (528); 2-(4-(2-(1,5-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)-N,N-dimethylacetamide (529); 2-(4- (2-(1,5-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)piperidin-1-yl)-N-methylacetamide (530); 5-(5-(1-(dimethylglycyl)piperidin-4-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,3-dimethylpyridin-2(1H)-one (531); 2-(4-(3- isopropyl-2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperidin-1-yl)-N-methylacetamide (532); 2-(4-(3-isopropyl-2-(8-methyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)-N,N- dimethylacetamide (533); 6-(3-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-8-methyl-[1,2,4]triazolo[1,5-a]pyridine (534); 6-(3-isopropyl-5-(1-(oxetan-3- yl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (535); 2-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)piperidin-1-yl)-N-methylacetamide (536); 2-(4-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)-N,N- dimethylacetamide (537); 6-(3-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (538); 2-(4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)- N-methylacetamide (539); 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)-N,N-dimethylacetamide (540); 1-(4- (2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)piperidin-1-yl)-2-methylpropan-2-ol (541); 5-(3-isopropyl-5-(1-(oxetan-3-yl)piperidin-4- yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,3,4-trimethylpyridin-2(1H)-one (542); 5-(3-isopropyl-5- (1-(tetrahydro-2H-pyran-4-yl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,3,4- trimethylpyridin-2(1H)-one (543); 2-(4-(3-isopropyl-2-(1,4,5-trimethyl-6-oxo-1,6- dihydropyridin-3-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)-N-methylacetamide (544); 2-(4-(3-isopropyl-2-(1,4,5-trimethyl-6-oxo-1,6-dihydropyridin-3-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)piperidin-1-yl)-N,N-dimethylacetamide (545); 5-(5-(1-(2-hydroxy-2- methylpropyl)piperidin-4-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,3,4- trimethylpyridin-2(1H)-one (546); 1-(4-(3-isopropyl-2-(8-methyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)-2-methylpropan-2-ol (547); 1- (4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperidin-1-yl)-2-methylpropan-2-ol (548); 2-(dimethylamino)-1-(4-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1- yl)ethan-1-one (549-550); 1-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)-2-(dimethylamino)ethan-1-one (551); 6-(3-isopropyl-5-(1-(2-(methylsulfonyl)ethyl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)- 8-methyl-[1,2,4]triazolo[1,5-a]pyridine (552); 2-(4-(3-isopropyl-2-(8-methyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)acetonitrile (553); 6-(3-isopropyl-5-(1-(2-(methylsulfonyl)ethyl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin- 2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (554); 6-(3-isopropyl-5-(1-(2- (methylsulfonyl)ethyl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridine (556); 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)- 3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)acetonitrile (557); 2-(4-(3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperidin-1-yl)acetamide (558); 2-(4-(3-isopropyl-2-(8-methyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)acetamide (559); 2-(4-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)piperidin-1-yl)acetamide (560); 3-(4-(3-isopropyl-2-(8-methyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)-1-methylpyrrolidin-2-one (561); 3-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)piperidin-1-yl)-1-methylpyrrolidin-2-one (562); 3-(4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)- 1-methylpyrrolidin-2-one (563); 3-chloro-5-(3-isopropyl-5-(1-(tetrahydro-2H-pyran-4- yl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,4-dimethylpyridin-2(1H)-one (564); 2-(4- (2-(5-chloro-1,4-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)piperidin-1-yl)-N-methylacetamide (565); 3-chloro-5-(3-isopropyl-5-(1- (oxetan-3-yl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,4-dimethylpyridin-2(1H)-one (566); 2-(4-(2-(5-chloro-1,4-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)-N,N-dimethylacetamide (567); 3-chloro-5-(3- isopropyl-5-(1-propylpiperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,4-dimethylpyridin- 2(1H)-one (568); 3-chloro-5-(5-(1-isobutylpiperidin-4-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-2-yl)-1,4-dimethylpyridin-2(1H)-one (569); 3-chloro-5-(5-(1- (dimethylglycyl)piperidin-4-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,4- dimethylpyridin-2(1H)-one (570); 3-chloro-5-(5-(1-(2-hydroxy-2-methylpropyl)piperidin-4- yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,4-dimethylpyridin-2(1H)-one (571); 1-(4-(3- isopropyl-6-methyl-2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)piperidin-1-yl)-2-methylpropan-2-ol (572); 6-(6-fluoro-3-isopropyl-5-(1-(2- (methylsulfonyl)ethyl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (573); 6-(6-fluoro-3-isopropyl-5-(1-(oxetan-3-yl)piperidin-4- yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (574); 6-(3- isopropyl-6-methyl-5-(1-(tetrahydro-2H-pyran-4-yl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin- 2-yl)-8-methyl-[1,2,4]triazolo[1,5-a]pyridine (575); 2-(dimethylamino)-1-(4-(3-isopropyl-2- (8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-methyl-1H-pyrrolo[3,2-b]pyridin-5- yl)piperidin-1-yl)ethan-1-one (576); 2-(dimethylamino)-1-(4-(6-fluoro-3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1- yl)ethan-1-one (577); 6-(3-isopropyl-6-methyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-8-methyl-[1,2,4]triazolo[1,5-a]pyridine (578); 6-(3-isopropyl-6- methyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (579); 2-(4-(6-fluoro-3-isopropyl-2-(8-methyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)-N,N- dimethylacetamide (580); 2-(4-(3-isopropyl-6-methyl-2-(8-methyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)-N,N-dimethylacetamide (581); 6-(6-fluoro-3-isopropyl-5-(1-(2-(methylsulfonyl)ethyl)piperidin-4-yl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-8-methyl-[1,2,4]triazolo[1,5-a]pyridine (582); 2-(4-(6-fluoro-3-isopropyl-2- (8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)- N,N-dimethylacetamide (583); 2-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin- 6-yl)-6-methyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)-N,N-dimethylacetamide (584); 2-(dimethylamino)-1-(4-(6-fluoro-3-isopropyl-2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)- 1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)ethan-1-one (585); 2-(dimethylamino)-1-(4-(3- isopropyl-6-methyl-2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)piperidin-1-yl)ethan-1-one (586); 1-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-6-methyl-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin-1-yl)-2-methylpropan-2-ol (587); 6-(6-fluoro-3-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2- yl)-8-methyl-[1,2,4]triazolo[1,5-a]pyridine (588); 6-(3-isopropyl-6-methyl-5-(1-(tetrahydro- 2H-pyran-4-yl)piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5- a]pyridine (589); 6-(3-isopropyl-5-((1-methylpiperidin-4-yl)methoxy)-1H-pyrrolo[3,2- b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (590); 6-(3-isopropyl-5-((1- (tetrahydro-2H-pyran-4-yl)piperidin-4-yl)methoxy)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8- methoxy-[1,2,4]triazolo[1,5-a]pyridine (591); 6-(3-isopropyl-5-((1-isopropylazetidin-3- yl)methoxy)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (592); 6-(3-isopropyl-5-((1-propylpiperidin-4-yl)oxy)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (593); 6-(3-isopropyl-5-((1-methylpiperidin-4-yl)oxy)-1H- pyrrolo[3,2-b]pyridin-2-yl)-8-methyl-[1,2,4]triazolo[1,5-a]pyridine (594); 6-(3-isopropyl-5- ((1-(tetrahydro-2H-pyran-4-yl)azetidin-3-yl)oxy)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (595); 6-(3-isopropyl-5-((1-methylazetidin-3-yl)oxy)-1H- pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (596); 1-(4-(((3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)oxy)methyl)piperidin-1-yl)-2-methylpropan-2-ol (597); 6-(3-isopropyl-5-((1- isopropylpiperidin-4-yl)methoxy)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (598); 1-(3-(((3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)oxy)methyl)azetidin-1-yl)-2-methylpropan-2-ol (599); 6-(3-isopropyl-5-((1-methylpiperidin-4-yl)oxy)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8- methoxy-[1,2,4]triazolo[1,5-a]pyridine (600); 6-(3-isopropyl-5-methoxy-1H-pyrrolo[3,2- b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (601); 2-(4-(((3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)oxy)methyl)piperidin-1-yl)-N,N-dimethylacetamide (602); 6-(3-isopropyl-5-((1- isopropylpiperidin-4-yl)oxy)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5- a]pyridine (603); 6-(3-isopropyl-5-((1-(2-(methylsulfonyl)ethyl)piperidin-4-yl)methoxy)-1H- pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (604); 4-((3-isopropyl- 2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)oxy)-N,N- dipropylcyclohexan-1-amine (605, 611); 6-(3-isopropyl-5-((1-propylpiperidin-4-yl)methoxy)- 1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (606); 6-(3- isopropyl-5-((1-(tetrahydro-2H-pyran-4-yl)piperidin-4-yl)oxy)-1H-pyrrolo[3,2-b]pyridin-2- yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (607); 6-(3-isopropyl-5-((1-methylazetidin-3- yl)methoxy)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (608); 2-(4-((3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)oxy)piperidin-1-yl)-N,N-dimethylacetamide (609); 4-((3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)oxy)-N,N- dimethylcyclohexan-1-amine (610); 6-(3-isopropyl-5-((1-isopropylazetidin-3-yl)oxy)-1H- pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (612); 1-(4-((3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)oxy)piperidin-1-yl)-2-methylpropan-2-ol (613); 4-((3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)oxy)-N,N- dimethylcyclohexan-1-amine (614); N-(3-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)- 3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclobutyl)-2-(dimethylamino)-N- methylacetamide (615); 3-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-N-((3-methyloxetan-3-yl)methyl)cyclobutan-1-amine (616); 3-(2- (7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclobutan-1-amine (617); 3-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N,N-dimethylcyclobutan-1-amine (618-623); 2- (dimethylamino)-N-(3-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)cyclobutyl)acetamide (619, 638); 3-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclobutan-1-amine (620); 3-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin- 5-yl)-N-methyl-N-(2-(methylsulfonyl)ethyl)cyclobutan-1-amine (621, 636); 2-((3-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclobutyl)(methyl)amino)-N,N-dimethylacetamide (622); 3-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(2- (methylsulfonyl)ethyl)cyclobutan-1-amine (624); 2-(dimethylamino)-N-(3-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclobutyl)-N- methylacetamide (625, 630); 3-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methyl-N-((3-methyloxetan-3- yl)methyl)cyclobutan-1-amine (626); 2-((3-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclobutyl)(methyl)amino)-N,N- dimethylacetamide (627); 2-((3-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclobutyl)amino)-N-methylacetamide (628); 3-(3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- N,N-dimethylcyclobutan-1-amine (629, 639); 2-((3-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclobutyl)amino)-N- methylacetamide (631); N-(3-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)- 1H-pyrrolo[3,2-b]pyridin-5-yl)cyclobutyl)tetrahydro-2H-pyran-4-amine (632); 3-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-N,N- bis((3-methyloxetan-3-yl)methyl)cyclobutan-1-amine (633); 3-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(2- (methylsulfonyl)ethyl)cyclobutan-1-amine (634); N-(3-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclobutyl)tetrahydro-2H-pyran-4- amine (635); 3-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H- pyrrolo[3,2-b]pyridin-5-yl)-N-((3-methyloxetan-3-yl)methyl)cyclobutan-1-amine (637); 3-(3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N- methyl-N-(2-(methylsulfonyl)ethyl)cyclobutan-1-amine (640, 642); 1-((3-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclobutyl)(methyl)amino)-2-methylpropan-2-ol (641); 3-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methyl-N-((3- methyloxetan-3-yl)methyl)cyclobutan-1-amine (643); N-(3-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclobutyl)-2- (dimethylamino)acetamide (644); 2-(3-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)azetidin-1-yl)acetamide (645); 2-(3-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)azetidin-1-yl)acetamide (646); 6-(3-isopropyl-5-(1-(2-(methylsulfonyl)ethyl)azetidin-3-yl)- 1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (647, 653); 6-(5- (azetidin-3-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5- a]pyridine (648); 6-(5-(azetidin-3-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridine (649); 1-(3-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)azetidin-1-yl)-2- (dimethylamino)ethan-1-one (650); 6-(5-(1-((1H-1,2,3-triazol-4-yl)methyl)azetidin-3-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (651); 2- (dimethylamino)-1-(3-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)azetidin-1-yl)ethan-1-one (652); 1-(3-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)azetidin-1-yl)- 2-methylpropan-2-ol (654); 6-(3-isopropyl-5-(1-isopropylazetidin-3-yl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (655); 6-(3-isopropyl-5-(1- isopropylazetidin-3-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridine (656); 1-(3-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)azetidin-1-yl)-2-methylpropan-2-ol (657); 2-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-4- isopropylmorpholine (658); 2-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)- 1H-pyrrolo[3,2-b]pyridin-5-yl)-4-(tetrahydro-2H-pyran-4-yl)morpholine (659); 4-isopropyl-2- (3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)morpholine (660); 2-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-4-methylmorpholine (661); 2-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)morpholine (662); 1-(2-(7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5- yl)morpholino)-2-(dimethylamino)ethan-1-one (663); 2-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-(tetrahydro-2H-pyran-4- yl)morpholine (664); 5-(3-isopropyl-5-(4-methylmorpholin-2-yl)-1H-pyrrolo[3,2-b]pyridin-2- yl)-1,3-dimethylpyridin-2(1H)-one (665); 2-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)morpholine (666, 671, 676); 5-(3-isopropyl-5- (4-(oxetan-3-yl)morpholin-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,3-dimethylpyridin-2(1H)- one (667); 2-(dimethylamino)-1-(2-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin- 6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)morpholino)ethan-1-one (668); 5-(3-isopropyl-5- (morpholin-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,3-dimethylpyridin-2(1H)-one (669, 675, 679); 2-(2-(2-(1,5-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-5-yl)morpholino)acetonitrile (670); 3-(dimethylamino)-1-(2-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)morpholino)propan-1-one (672); 2-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-methylmorpholine (673); 2-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-(2- (methylsulfonyl)ethyl)morpholine (674); 5-(5-(4-(dimethylglycyl)morpholin-2-yl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,3-dimethylpyridin-2(1H)-one (677); 5-(3- isopropyl-5-(4-isopropylmorpholin-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-1,3-dimethylpyridin- 2(1H)-one (678); 6-(3-isopropyl-5-(piperazin-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridine (680); 6-(3-isopropyl-5-(2-(piperidin-1-yl)ethyl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-8-methyl-[1,2,4]triazolo[1,5-a]pyridine (681); 6-(3-isopropyl-5- (2-(piperidin-1-yl)ethyl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5- a]pyridine (682); 2-(3-(2-(3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)ethyl)azetidin-1-yl)-N,N-dimethylacetamide (683); 3-isopropyl-2- (1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-(2-(1-(2-(methylsulfonyl)ethyl)azetidin-3- yl)ethyl)-1H-pyrrolo[3,2-b]pyridine (684); 1-(3-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)ethyl)azetidin-1-yl)-2- (dimethylamino)ethan-1-one (685); 6-(3-isopropyl-5-(2-(1-(oxetan-3-yl)azetidin-3-yl)ethyl)- 1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (686-687); 6-(5- (2-(1-((1H-1,2,3-triazol-4-yl)methyl)azetidin-3-yl)ethyl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (688); 2-(3-(2-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)ethyl)azetidin-1- yl)-N,N-dimethylacetamide (689); 5-(2-(azetidin-3-yl)ethyl)-3-isopropyl-2-(1-methyl-1H- pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrolo[3,2-b]pyridine (690); 3-isopropyl-2-(1-methyl-1H- pyrrolo[2,3-b]pyridin-3-yl)-5-(2-(1-((3-methyloxetan-3-yl)methyl)azetidin-3-yl)ethyl)-1H- pyrrolo[3,2-b]pyridine (691); 6-(5-(2-(azetidin-3-yl)ethyl)-3-isopropyl-1H-pyrrolo[3,2- b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (692); 1-(3-(2-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)ethyl)azetidin-1- yl)-2-methylpropan-2-ol (693); 3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-(2- (1-(oxetan-3-yl)azetidin-3-yl)ethyl)-1H-pyrrolo[3,2-b]pyridine (694); 6-(3-isopropyl-5-(2-(1- (2-(methylsulfonyl)ethyl)azetidin-3-yl)ethyl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridine (695); 2-(3-(2-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)ethyl)azetidin-1-yl)-N,N-dimethylacetamide (696); 6-(5-(2-(azetidin-3-yl)ethyl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (697); 6-(3-isopropyl-5-(2-(1-(2-(methylsulfonyl)ethyl)azetidin- 3-yl)ethyl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (698); 2- (dimethylamino)-1-(3-(2-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)ethyl)azetidin-1-yl)ethan-1-one (699); 6-(3-isopropyl-5-(2-(1- (oxetan-3-yl)azetidin-3-yl)ethyl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methoxy- [1,2,4]triazolo[1,5-a]pyridine (700); 1-(3-(2-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)ethyl)azetidin-1-yl)-2-methylpropan-2-ol (701); 6-(3-isopropyl-5-(2-(1-((3-methyloxetan-3-yl)methyl)azetidin-3-yl)ethyl)-1H- pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (702); 2- (dimethylamino)-1-(3-(2-(3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)ethyl)azetidin-1-yl)ethan-1-one (703); 5-(2-(1-((1H-1,2,3-triazol-4- yl)methyl)azetidin-3-yl)ethyl)-3-isopropyl-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1H- pyrrolo[3,2-b]pyridine (704); 6-(5-(2-(1-((1H-1,2,3-triazol-4-yl)methyl)azetidin-3-yl)ethyl)-3- isopropyl-1H-pyrrolo[3,2-b]pyridin-2-yl)-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine (705); 6-(3-isopropyl-5-(2-(1-((3-methyloxetan-3-yl)methyl)azetidin-3-yl)ethyl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine (706); N-(3-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclopentyl)tetrahydro-2H-pyran-4-amine (707, 710, 721, 727); 2,2'-((3-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclopentyl)azanediyl)diacetamide (708, 720); 3-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(2- (methylsulfonyl)ethyl)cyclopentan-1-amine (709); 3-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-((3-methyloxetan-3- yl)methyl)cyclopentan-1-amine (711, 718, 728); 2-(dimethylamino)-N-(3-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclopentyl)acetamide (712); 2,2'-((3-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclopentyl)azanediyl)diacetonitrile (713, 730); N-(3-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclopentyl)-1-methylpiperidine-4-carboxamide (714); N-(3-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclopentyl)oxetan-3-amine (715); 2-((3-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclopentyl)amino)acetonitrile (716); 3-(3- isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- N,N-bis(2-(methylsulfonyl)ethyl)cyclopentan-1-amine (717, 726); 2-((3-(3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclopentyl)amino)-N-methylacetamide (719, 725); 2,2'-((3-(3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclopentyl)azanediyl)bis(N,N-dimethylacetamide) (722); N-isopropyl-3-(3-isopropyl-2- (8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclopentan-1- amine (723); N-(1-cyclopropylethyl)-3-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclopentan-1-amine (724); N-(3-(3-isopropyl- 2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclopentyl)- 2,2-dimethyltetrahydro-2H-pyran-4-amine (729); 3-isopropyl-N-(1-isopropylpiperidin-4-yl)- 2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-methyl-1H-pyrrolo[3,2-b]pyridine-5- carboxamide (731); N-(2-(dimethylamino)ethyl)-3-isopropyl-2-(8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-N,6-dimethyl-1H-pyrrolo[3,2-b]pyridine-5-carboxamide (732); 1-(4-(3-isopropyl-2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-methyl-1H- pyrrolo[3,2-b]pyridine-5-carbonyl)piperazin-1-yl)ethan-1-one (733); 3-isopropyl-2-(8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-N,6-dimethyl-N-(3,3,3-trifluoropropyl)-1H- pyrrolo[3,2-b]pyridine-5-carboxamide (734); 6-(3-isopropyl-5-(1-(piperidin-4-yl)-1H- pyrazol-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)-8-methyl-[1,2,4]triazolo[1,5-a]pyridine (735); 4-(2-(4-(3-isopropyl-2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-1H-pyrazol-1-yl)ethyl)morpholine (736); (2S,5R)-1-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- dimethylpiperazine (737); 1-[(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}- 3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]-2-(pyrrolidin-1- yl)ethan-1-one (738); 1-[(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]-3-(pyrrolidin-1- yl)propan-1-one (739); 2-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2- yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6-diazaspiro[3.3]heptane (740); 2-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-6-methyl- 2,6-diazaspiro[3.3]heptane (741); 2-[6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6-diazaspiro[3.3]heptan-2-yl]-N,N- dimethylacetamide (742); 1-[6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6-diazaspiro[3.3]heptan-2-yl]-2- (dimethylamino)ethan-1-one (743); 2-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-6-ethyl-2,6-diazaspiro[3.3]heptane (744); 6-(2- <Formule mathématique disponible dans le document PDF, Math available in the PDF document display="block">\label{eq:continuous} \ensuremath{\text{[1,2,4]triazolo[1,5-a]pyridin-6-yl]}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-6-yl} 5-yl)-2-azaspiro[3.3]heptane (745); 1-[6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}- 3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-azaspiro[3.3]heptan-2-yl]-3- (dimethylamino)propan-1-one (746); 1-[(1R,5S)-8-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,8-diazabicyclo[3.2.1]octan- 3-yl]-2-(dimethylamino)ethan-1-one (747); (1R,5S)-8-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-(2-methanesulfonylethyl)- 3,8-diazabicyclo[3.2.1]octane (748); 3-[(1R,5S)-8-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,8-diazabicyclo[3.2.1]octan- 3-yl]propanamide (749); 1-[(1R,5S)-3-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,9-diazabicyclo[3.3.1]nonan-9-yl]-2- (dimethylamino)ethan-1-one (750); (1R,5S)-3-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin- 6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-9-(2-methanesulfonylethyl)-3,9- diazabicyclo[3.3.1]nonane (751); 1-[(3S,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin- 6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,5-dimethylpiperazin-1-yl]-2- (dimethylamino)ethan-1-one (752); 3-[(3S,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,5-dimethylpiperazin-1- yl]propanamide (753); 1-[(1R,5S)-3-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,6-diazabicyclo[3.1.1]heptan-6-yl]-2- (dimethylamino)ethan-1-one (754); (1R,5S)-3-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin- 6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-6-(propan-2-yl)-3,6- diazabicyclo[3.1.1]heptane (755); 3-[(1R,5S)-3-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,6- diazabicyclo[3.1.1]heptan-6-yl]propanamide (756); (3S,5S)-1-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,5- dimethylpiperazine (757); 3-[(2S,6S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}- 3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6-dimethylpiperazin-1-yl]propanamide (758); 2-[(2S,6S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2,6-dimethylpiperazin-1-yl]acetamide (759); 1-[(2S,6S)-4-(2- <com:Math><semantics>{7,8−dimethyl−[1,2,4]triazolo[1,5−a]pyridin−6−yl}−3−(propan−2−yl)−1H−pyrrolo[3,2−b]pyridin−6−yl}<annotation encoding="application / x-tex">\{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl\}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-6-yl\}< / annotation>< / semantics>< / com:Math> 5-yl)-2,6-dimethylpiperazin-1-yl]-2-(dimethylamino)ethan-1-one (760); 1-[(2S,6S)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,6-dimethylpiperazin-1-yl]-3-(dimethylamino)propan-1-one (761); 2-[(1R,4R)-5-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,5-diazabicyclo[2.2.1]heptan-2-yl]acetamide (762); 3-[(1R,4R)-5-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- diazabicyclo[2.2.1]heptan-2-yl]propanamide (763); (1R,4R)-2-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-5-(2- methanesulfonylethyl)-2,5-diazabicyclo[2.2.1]heptane (764); (1R,4R)-2-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-5-(3- methanesulfonylpropyl)-2,5-diazabicyclo[2.2.1]heptane (765); 2-[(1R,4R)-5-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,5-diazabicyclo[2.2.1]heptan-2-yl]acetonitrile (766); 3-[(1R,4R)-5-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- diazabicyclo[2.2.1]heptan-2-yl]-N,N-dimethylpropanamide (767); (1R,4R)-2-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 5-(oxetan-3-yl)-2,5-diazabicyclo[2.2.1]heptane (768); (1R,4R)-2-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-5-(oxan-4- yl)-2,5-diazabicyclo[2.2.1]heptane (769); 4-[(1R,4R)-5-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- diazabicyclo[2.2.1]heptan-2-yl]-<com:Math><semantics>1λ6<annotation encoding="application / x-tex">1\lambda^6< / annotation>< / semantics>< / com:Math>-thiane-1,1-dione (770); (1R,4R)-2-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-5-(oxolan- 3-yl)-2,5-diazabicyclo[2.2.1]heptane (771); 1-[(1R,4R)-5-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- diazabicyclo[2.2.1]heptan-2-yl]-2-(dimethylamino)ethan-1-one (772); 1-[(1R,4R)-5-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,5-diazabicyclo[2.2.1]heptan-2-yl]-3-(dimethylamino)propan-1-one (773); 2-[(1S,4S)-5-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]acetamide (774); 3-[(1S,4S)-5-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- diazabicyclo[2.2.1]heptan-2-yl]propanamide (775); 3-[(1S,4S)-5-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- diazabicyclo[2.2.1]heptan-2-yl]-N,N-dimethylpropanamide (776); (1S,4S)-2-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 5-(2-methanesulfonylethyl)-2,5-diazabicyclo[2.2.1]heptane (777); (1S,4S)-2-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 5-(3-methanesulfonylpropyl)-2,5-diazabicyclo[2.2.1]heptane (778); (1S,4S)-2-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 5-(oxetan-3-yl)-2,5-diazabicyclo[2.2.1]heptane (779); (1S,4S)-2-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-5-(oxan-4- yl)-2,5-diazabicyclo[2.2.1]heptane (780); 4-[(1S,4S)-5-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- diazabicyclo[2.2.1]heptan-2-yl]-<com:Math><semantics>1λ6<annotation encoding="application / x-tex">1\lambda^6< / annotation>< / semantics>< / com:Math>-thiane-1,1-dione (781); (1S,4S)-2-(2-{7,8-dimethyl- <com:Math><semantics>[1,2,4]<annotation encoding="application / x-tex">[1,2,4]< / annotation>< / semantics>< / com:Math>triazolo<com:Math><semantics>[1,5−a]<annotation encoding="application / x-tex">[1,5-a]< / annotation>< / semantics>< / com:Math>pyridin-6-yl<com:Math><semantics>}<annotation encoding="application / x-tex">\}< / annotation>< / semantics>< / com:Math>-3-(propan-2-yl)-1H-pyrrolo<com:Math><semantics>[3,2−b]<annotation encoding="application / x-tex">[3,2-b]< / annotation>< / semantics>< / com:Math>pyridin-5-yl)-5-(oxolan- 3-yl)-2,5-diazabicyclo[2.2.1]heptane (782); (1S,4S)-2-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-5-(propan-2-yl)-2,5- diazabicyclo[2.2.1]heptane (783); 1-[(1S,4S)-5-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- diazabicyclo[2.2.1]heptan-2-yl]-2-(dimethylamino)ethan-1-one (784); 1-[(1S,4S)-5-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,5-diazabicyclo[2.2.1]heptan-2-yl]-3-(dimethylamino)propan-1-one (785); (1R,4R)-2-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-5-(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane (786); (1S,4S)-2-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-5-[(1- methyl-1H-1,2,3-triazol-4-yl)methyl]-2,5-diazabicyclo[2.2.1]heptane (787); 1-[(2S,5S)-4-(2- <com:Math><semantics>{7,8−dimethyl−[1,2,4]triazolo[1,5−a]pyridin−6−yl}−3−(propan−2−yl)−1H−pyrrolo[3,2−b]pyridin−6−yl}<annotation encoding="application / x-tex">\{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl\}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-6-yl\}< / annotation>< / semantics>< / com:Math> 5-yl)-2,5-dimethylpiperazin-1-yl]-2-(dimethylamino)ethan-1-one (788); 1-[(2S,5S)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,5-dimethylpiperazin-1-yl]-3-(dimethylamino)propan-1-one (789); 1-[(2S)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2-methylpiperazin-1-yl]-3-(dimethylamino)propan-1-one (790); 3-[(2S)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2- methylpiperazin-1-yl]propanamide (791); (2S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methyl-1-(propan-2- yl)piperazine (792); (2S,5S)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethyl-4-(propan-2-yl)piperazine (793); 3-[(2S,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]propanamide (794); (2S,5S)-1-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-4-(3-methanesulfonylpropyl)-2,5-dimethylpiperazine (795); 1-[(2R,5R)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,5-dimethylpiperazin-1-yl]-2-(dimethylamino)ethan-1-one (796); 1-[(2R,5R)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,5-dimethylpiperazin-1-yl]-3-(dimethylamino)propan-1-one (797); 3-[(2R,5R)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,5-dimethylpiperazin-1-yl]propanamide (798); 2-[(2R,5R)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- dimethylpiperazin-1-yl]acetamide (799); 2-[(2R,5R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1- yl]acetamide (800); 1-[(3S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan- 2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]-2-(dimethylamino)ethan-1-one (801); 1-[(3S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]-2-methylpropan-2-ol (802); 2-[(3S)-4-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-3-methylpiperazin-1-yl]-N,N-dimethylacetamide (803); 3-[(3S)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3- methylpiperazin-1-yl]propanamide (804); (2S)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-(3-methanesulfonylpropyl)- 2-methylpiperazine (805); (2R)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-(3-methanesulfonylpropyl)-2- methylpiperazine (806); 3-[(3R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]propanamide (807); 1- [(3R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-3-methylpiperazin-1-yl]-2-(dimethylamino)ethan-1-one (808); 2-[(3S)-4-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-3-methylpiperazin-1-yl]acetamide (809); 2-[(3S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1- yl]acetonitrile (810); 1-[(3S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]-3- (dimethylamino)propan-1-one (811); 2-[(3S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]-N- methylacetamide (812); (2S)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methyl-4-(oxetan-3-yl)piperazine (813); (2S)- 1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-2-methyl-4-(oxolan-3-yl)piperazine (814); 4-[(3S)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3- methylpiperazin-1-yl]-<com:Math><semantics>1λ6<annotation encoding="application / x-tex">1\lambda^6< / annotation>< / semantics>< / com:Math>-thiane-1,1-dione (815); (2S)-1-(2-<com:Math><semantics>{7,8<annotation encoding="application / x-tex">\{7,8< / annotation>< / semantics>< / com:Math>-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methyl- 4-(propan-2-yl)piperazine (816); (2S)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}- 3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-(2-methanesulfonylethyl)-2- methylpiperazine (817); 3-[(3S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]-N-methylpropanamide (818); 3-[(3S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]-N,N-dimethylpropanamide (819); (2S)-1- (2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-2-methyl-4-(oxan-4-yl)piperazine (820); (2S,6S)-1-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6- dimethylpiperazine (821); (3R)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazine (822); 1-[(3R)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 3-methylpiperazin-1-yl]-3-(dimethylamino)propan-1-one (823); 2-(azetidin-1-yl)-1-[(3S)-4- (2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-3-methylpiperazin-1-yl]ethan-1-one (824); 1-[(3S)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3- methylpiperazin-1-yl]-2-(pyrrolidin-1-yl)ethan-1-one (825); 2-(cyclopropylamino)-1-[(3S)-4- (2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-3-methylpiperazin-1-yl]ethan-1-one (826); 1-[(3S)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3- methylpiperazin-1-yl]-2-[(propan-2-yl)amino]ethan-1-one (827); 1-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-(1- methylazetidine-3-carbonyl)piperazine (828); (2S)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methyl-4-(1- methylazetidine-3-carbonyl)piperazine (829); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]-2- (methylamino)ethan-1-one (830); <Formule mathématique disponible dans le document PDF, Math available in the PDF document>2-[di(^2H_3)methylamino]-1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin- 1-yl]ethan-1-one (831); 2-amino-1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]ethan-1-one (832); (2R)-1-(2- <com:Math><semantics>{7,8−dimethyl−[1,2,4]triazolo[1,5−a]pyridin−6−yl}−3−(propan−2−yl)−1H−pyrrolo[3,2−b]pyridin−6−yl}<annotation encoding="application / x-tex">\{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl\}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-6-yl\}< / annotation>< / semantics>< / com:Math> 5-yl)-2-methyl-4-(propan-2-yl)piperazine (833); 2-(azetidin-1-yl)-1-[(3R)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3- methylpiperazin-1-yl]ethan-1-one (834); 1-[(3R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]-2- (pyrrolidin-1-yl)ethan-1-one (835); 2-(cyclopropylamino)-1-[(3R)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3- methylpiperazin-1-yl]ethan-1-one (836); 1-[(3R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]-2- [(propan-2-yl)amino]ethan-1-one (837); <com:Math><semantics>2−[di(2H3)]<annotation encoding="application / x-tex">2-[di(^{2}H_{3})]< / annotation>< / semantics>< / com:Math>methylamino]-1-[(3R)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3- methylpiperazin-1-yl]ethan-1-one (838); 1-[(2S,5R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]- 2-(dimethylamino)ethan-1-one (839); 1-[(2S,5R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]- 3-(dimethylamino)propan-1-one (840); (2R,5S)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethyl-4-(propan-2- yl)piperazine (841); 1-[(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]-2- (dimethylamino)ethan-1-one (842); 1-[(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]- 3-(dimethylamino)propan-1-one (843); (2S,5R)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethyl-4-(propan-2- yl)piperazine (844); (2R,5S)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-(3-methanesulfonylpropyl)-2,5- dimethylpiperazine (845); (2S,5R)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-(3-methanesulfonylpropyl)-2,5- dimethylpiperazine (846); 3-[(2S,5R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}- 3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]propanamide (847); 3-[(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]propanamide (848); 1-[(2R)-4-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-2-methylpiperazin-1-yl]-2-(dimethylamino)ethan-1-one (849); 1-[(2R)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2-methylpiperazin-1-yl]-3-(dimethylamino)propan-1-one (850); (2R)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methyl- 1-(propan-2-yl)piperazine (851); 3-[(2R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methylpiperazin-1-yl]propanamide (852); (2S)-1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]-2-(dimethylamino)propan-1-one (853); 1-[4-(2- <com:Math><semantics>{7,8−dimethyl−[1,2,4]triazolo[1,5−a]pyridin−6−yl}−3−(propan−2−yl)−1H−pyrrolo[3,2−b]pyridin−6−yl}<annotation encoding="application / x-tex">\{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl\}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-6-yl\}< / annotation>< / semantics>< / com:Math> 5-yl)piperazine-1-carbonyl]-N,N-dimethylcyclopropan-1-amine (854); (2R)-1-[4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl]-2-(dimethylamino)propan-1-one (855); (2R)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-1-(3- methanesulfonylpropyl)-2-methylpiperazine (856); 1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)(2,2,3,3,5,5,6,6-2H<com:Sub>8< / com:Sub>)piperazine (857); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)(2,2,3,3,5,5,6,6-2H<com:Sub>8< / com:Sub>)piperazin-1-yl]-2-(dimethylamino)ethan-1-one <com:Math><semantics>(858)<annotation encoding="application / x-tex">(858)< / annotation>< / semantics>< / com:Math>; 2-[di(<com:Math><semantics>2H3<annotation encoding="application / x-tex">{}^{2}H_{3}< / annotation>< / semantics>< / com:Math>)methylamino]-1-[4-<com:Math><semantics>(2−{7,8−dimethyl−[1,2,4]triazolo[1,5−a]pyridin−6−yl}−3−<annotation encoding="application / x-tex">(2-\{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl\}-3-< / annotation>< / semantics>< / com:Math> (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)(2,2,3,3,5,5,6,6-2H<com:Sub>8< / com:Sub>)piperazin-1-yl]ethan-1-one (859); 1-[(2R,6S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2,6-dimethylpiperazin-1-yl]-3-(dimethylamino)propan-1-one (860); (2R,6R)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2,6-dimethylpiperazine (861); 1-[(2R,6S)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6- dimethylpiperazin-1-yl]-2-(dimethylamino)ethan-1-one (862); 1-[(3R,5R)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 3,5-dimethylpiperazin-1-yl]-2-(dimethylamino)ethan-1-one (863); 1-[(3R,5R)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 3,5-dimethylpiperazin-1-yl]-3-(dimethylamino)propan-1-one (864); (2R,6R)-1-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,6-dimethyl-4-(propan-2-yl)piperazine (865); 2-[(3R,5R)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,5- dimethylpiperazin-1-yl]acetamide (866); 2-[(2R,6S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6-dimethylpiperazin-1- yl]acetamide (867); (2R,6S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-1-(3-methanesulfonylpropyl)-2,6- dimethylpiperazine (868); (2R,6R)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-(3-methanesulfonylpropyl)-2,6- dimethylpiperazine (869); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]-2-[ethyl(methyl)amino]ethan-1- one (870); 2-(diethylamino)-1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]ethan-1-one (871); 1-[4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl]-2-[methyl(propan-2-yl)amino]ethan-1-one (872); 1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin- 1-yl]-2-[methyl(propyl)amino]ethan-1-one (873); 2-[butyl(methyl)amino]-1-[4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl]ethan-1-one (874); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]-2-[methyl(2- methylpropyl)amino]ethan-1-one (875); 2-[butyl(ethyl)amino]-1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin- 1-yl]ethan-1-one (876); 2-(tert-butylamino)-1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]ethan-1-one (877); 2-[tert-butyl(methyl)amino]-1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}- 3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]ethan-1-one (878); 1-[4-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)piperazin-1-yl]-2-[ethyl(propan-2-yl)amino]ethan-1-one (879); 1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin- 1-yl]-2-[(2-methylpropyl)(propan-2-yl)amino]ethan-1-one (880); 2-[bis(2- methylpropyl)amino]-1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2- yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]ethan-1-one (881); 2-[butyl(propan-2- yl)amino]-1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]ethan-1-one (882); 2-[bis(propan-2-yl)amino]-1-[4- (2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)piperazin-1-yl]ethan-1-one (883); (3R,5R)-1-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,5- dimethylpiperazine (884); 1-[(2R,6R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}- 3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6-dimethylpiperazin-1-yl]-2- (dimethylamino)ethan-1-one (885); 1-[(2R,6R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6-dimethylpiperazin-1-yl]- 3-(dimethylamino)propan-1-one (886); 1-[(2S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methylpiperazin-1-yl]-2- (dimethylamino)ethan-1-one (887); <com:Math><semantics>2−[di(2H3)]<annotation encoding="application / x-tex">2-[di(^{2}H_{3})]< / annotation>< / semantics>< / com:Math> methylamino]-1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin- <com:Math><semantics>1−y1](2H2)<annotation encoding="application / x-tex">1-y1](^{2}H_{2})< / annotation>< / semantics>< / com:Math>ethan-1-one (888); <com:Math><semantics>1−[4−(2−{7,8−dimethyl−[1,2,4]triazolo[1,5−a]pyridin−6−yl}−3−<annotation encoding="application / x-tex">1-[4-(2-\{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl\}-3-< / annotation>< / semantics>< / com:Math> (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]-2-(dimethylamino)(<com:Sup>2< / com:Sup>H<com:Sub>2< / com:Sub>)ethan-1- one (889); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)(2,2,3,3,5,5,6,6-2H<com:Sub>8< / com:Sub>)piperazin-1-yl]-2-(dimethylamino)(2H<com:Sub>2< / com:Sub>)ethan- 1-one (890); 2-[di(<com:Sup>2< / com:Sup>H<com:Sub>3< / com:Sub>)methylamino]-1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)(2,2,3,3,5,5,6,6-2H<com:Sub>8< / com:Sub>)piperazin-1- <Formule mathématique disponible dans le document PDF, Math available in the PDF document>yl](^{2}H_{2})ethan-1-one (891); 3-(azetidin-1-yl)-1-[(2R,5S)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- dimethylpiperazin-1-yl]propan-1-one (892); 1-[(2R,5S)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- dimethylpiperazin-1-yl]-2-[ethyl(methyl)amino]ethan-1-one (893); 1-[(2R,5S)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,5-dimethylpiperazin-1-yl]-2-[methyl(propyl)amino]ethan-1-one (894); 2-(diethylamino)-1- [(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]ethan-1-one (895); 1-[(2R,5S)-4-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-2,5-dimethylpiperazin-1-yl]-2-{2-oxa-6-azaspiro[3.3]heptan-6-yl}ethan-1-one (896); 1- [(2S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-2-methylpiperazin-1-yl]-2-[ethyl(methyl)amino]ethan-1-one (897); 2- (diethylamino)-1-[(2S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2- yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methylpiperazin-1-yl]ethan-1-one (898); 1-[(2S)-4-(2- <com:Math><semantics>{7,8−dimethyl−[1,2,4]triazolo[1,5−a]pyridin−6−yl}−3−(propan−2−yl)−1H−pyrrolo[3,2−b]pyridin−6−yl}<annotation encoding="application / x-tex">\{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl\}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-6-yl\}< / annotation>< / semantics>< / com:Math> 5-yl)-2-methylpiperazin-1-yl]-2-(pyrrolidin-1-yl)ethan-1-one (899); 1-[(2S)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2-methylpiperazin-1-yl]-2-{2-oxa-6-azaspiro[3.3]heptan-6-yl}ethan-1-one (900); 1-[(3S)-4- (2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-3-methylpiperazin-1-yl]-2-{2-oxa-6-azaspiro[3.3]heptan-6-yl}ethan-1-one (901); 2-(diethylamino)-1-[(3S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]ethan-1-one (902); 2- [bis(propan-2-yl)amino]-1-[(3S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]ethan-1-one (903); 2- [tert-butyl(methyl)amino]-1-[(2S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methylpiperazin-1-yl]ethan-1-one (904); 2- [tert-butyl(methyl)amino]-1-[(3S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]ethan-1-one (905); 1- [(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]-3-[ethyl(methyl)amino]propan-1-one (906); 1-[(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]-3-(morpholin-4-yl)propan-1-one (907); 1-[(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]-3-{2-oxa-6-azaspiro[3.3]heptan-6- yl}propan-1-one (908); 1-[(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]-3-(3- fluoropyrrolidin-1-yl)propan-1-one (909); 2-[bis(propan-2-yl)amino]-1-[(2R,5S)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,5-dimethylpiperazin-1-yl]ethan-1-one (910); 2-[tert-butyl(methyl)amino]-1-[(2R,5S)-4-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-2,5-dimethylpiperazin-1-yl]ethan-1-one (911); 1-[(2R,5S)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- dimethylpiperazin-1-yl]-2-[ethyl(propan-2-yl)amino]ethan-1-one (912); 1-[(1R,5S)-8-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 3,8-diazabicyclo[3.2.1]octan-3-yl]-3-(dimethylamino)propan-1-one (913); 3-[tert- butyl(methyl)amino]-1-[(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]propan-1-one (914); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)piperazin-1-yl]-2-(3,3-dimethylazetidin-1-yl)ethan-1-one (915); 1-[4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl]-2-(3-methoxyazetidin-1-yl)ethan-1-one (916); 1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin- 1-yl]-2-(3-fluoropyrrolidin-1-yl)ethan-1-one (917); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]-2-{1-oxa-6- azaspiro[3.3]heptan-6-yl}ethan-1-one (918); 2-(3,3-difluoropyrrolidin-1-yl)-1-[4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl]ethan-1-one (919); 1-[(1R,5S)-8-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,8-diazabicyclo[3.2.1]octan- 3-yl]-2-{2-oxa-6-azaspiro[3.3]heptan-6-yl}ethan-1-one (920); 1-[(1R,5S)-8-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,8- diazabicyclo[3.2.1]octan-3-yl]-2-(pyrrolidin-1-yl)ethan-1-one (921); 1-[(1R,5S)-8-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 3,8-diazabicyclo[3.2.1]octan-3-yl]-2-[ethyl(methyl)amino]ethan-1-one (922); 1-[(1R,5S)-8- (2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-3,8-diazabicyclo[3.2.1]octan-3-yl]-2-[methyl(propan-2-yl)amino]ethan-1-one (923); 2-[tert-butyl(methyl)amino]-1-[(1R,5S)-8-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,8-diazabicyclo[3.2.1]octan- 3-yl]ethan-1-one (924); 2-[tert-butyl(2-hydroxyethyl)amino]-1-[(1R,5S)-8-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,8- diazabicyclo[3.2.1]octan-3-yl]ethan-1-one (925); 2-[tert-butyl(methyl)amino]-1-[(2R,6R)-4- (2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-2,6-dimethylpiperazin-1-yl]ethan-1-one (926); 1-[(2R,6R)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,6-dimethylpiperazin-1-yl]-2-[ethyl(methyl)amino]ethan-1-one (927); 1-[(2R,6R)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,6-dimethylpiperazin-1-yl]-2-(pyrrolidin-1-yl)ethan-1-one (928); 1-[(2R,6R)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2,6-dimethylpiperazin-1-yl]-2-{2-oxa-6-azaspiro[3.3]heptan-6-yl}ethan-1-one (929); 2-[tert- butyl(2-hydroxyethyl)amino]-1-[(2R,6R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6-dimethylpiperazin-1-yl]ethan-1-one (930); 1-[(3R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]-2-{2-oxa-6-azaspiro[3.3]heptan-6- yl}ethan-1-one (931); 1-[(3R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]-2- [ethyl(methyl)amino]ethan-1-one (932); 1-[(3R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]-2- [methyl(propan-2-yl)amino]ethan-1-one (933); 2-[tert-butyl(methyl)amino]-1-[(3R)-4-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-3-methylpiperazin-1-yl]ethan-1-one (934); 1-[(2S,5R)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- dimethylpiperazin-1-yl]-2-{2-oxa-6-azaspiro[3.3]heptan-6-yl}ethan-1-one (935); 1-[(2S,5R)- 4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]-2-(pyrrolidin-1-yl)ethan-1-one (936); 1-[(2S,5R)- 4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]-2-[ethyl(methyl)amino]ethan-1-one (937); 1- [(2S,5R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]-2-[methyl(propan-2-yl)amino]ethan- 1-one (938); 2-[tert-butyl(methyl)amino]-1-[(2S,5R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1- yl]ethan-1-one (939); 1-[(2R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methylpiperazin-1-yl]-2-{2-oxa-6- azaspiro[3.3]heptan-6-yl}ethan-1-one (940); 1-[(2R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methylpiperazin-1-yl]-2- (pyrrolidin-1-yl)ethan-1-one (941); 1-[(2R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin- 6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methylpiperazin-1-yl]-2- [ethyl(methyl)amino]ethan-1-one (942); 1-[(2R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methylpiperazin-1-yl]-2- [methyl(propan-2-yl)amino]ethan-1-one (943); 2-[tert-butyl(methyl)amino]-1-[(2R)-4-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-2-methylpiperazin-1-yl]ethan-1-one (944); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]-3-methyl-3- {2-oxa-6-azaspiro[3.3]heptan-6-yl}butan-1-one (945); 1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin- 1-yl]-2-(3-hydroxy-3-methylazetidin-1-yl)ethan-1-one (946); 1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin- 1-yl]-2-{2-oxa-7-azaspiro[4.4]nonan-7-yl}ethan-1-one (947); 1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin- 1-yl]-2-(3-hydroxy-3-methylpyrrolidin-1-yl)ethan-1-one (948); 1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin- 1-yl]-2-[(2-hydroxy-2-methylpropyl)(methyl)amino]ethan-1-one (949); 1-[4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl]-2-(3,3-dimethylmorpholin-4-yl)ethan-1-one (950); 6-{2-[4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl]-2-oxoethyl}-<com:Math><semantics>2λ6<annotation encoding="application / x-tex">2\lambda^{6}< / annotation>< / semantics>< / com:Math>-thia-6-azaspiro[3.3]heptane-2,2-dione (951); 1-[4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)piperazin-1-yl]-2-[(<com:Sup>2< / com:Sup>H<com:Sub>3< / com:Sub>)methylamino]ethan-1-one (952); 2-[tert-butyl(2- hydroxyethyl)amino]-1-[(3R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-methylpiperazin-1-yl]ethan-1-one (953); 2- [tert-butyl(2-hydroxyethyl)amino]-1-[(2S,5R)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1- yl]ethan-1-one (954); 2-[tert-butyl(2-hydroxyethyl)amino]-1-[(2R)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2- methylpiperazin-1-yl]ethan-1-one (955); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin- 6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]-2-{6-oxa-2- azaspiro[3.4]octan-2-yl}ethan-1-one (956); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]-2-{2-oxa-6- azaspiro[3.4]octan-6-yl}ethan-1-one (957); 1-[(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]- 3-{1-oxa-6-azaspiro[3.3]heptan-6-yl}propan-1-one (958); 6-{3-[(2R,5S)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- dimethylpiperazin-1-yl]-3-oxopropyl}-<com:Math><semantics>2λ6<annotation encoding="application / x-tex">2\lambda^6< / annotation>< / semantics>< / com:Math>-thia-6-azaspiro[3.3]heptane-2,2-dione (959); 1- [(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]-3-{6-oxa-2-azaspiro[3.4]octan-2- yl}propan-1-one (960); 1-[(2R,5S)-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]-3-{2-oxa-6- azaspiro[3.4]octan-6-yl}propan-1-one (961); 3-(3,3-difluoropyrrolidin-1-yl)-1-[(2R,5S)-4-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-2,5-dimethylpiperazin-1-yl]propan-1-one (962); 1-[(2R,5S)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- dimethylpiperazin-1-yl]-3-(3,3-dimethylmorpholin-4-yl)propan-1-one (963); 1-[(2R,5S)-4-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-2,5-dimethylpiperazin-1-yl]-3-[(<com:Sup>2< / com:Sup>H<com:Sub>3< / com:Sub>)methylamino]propan-1-one (964); 3- <com:Math><semantics>[di(2H3)]<annotation encoding="application / x-tex">[di(^{2}H_{3})]< / annotation>< / semantics>< / com:Math>methylamino]-1-<com:Math><semantics>[(2R,5S)−4−(2−{7,8−dimethyl−[1,2,4]triazolo[1,5−a]pyridin−6−yl}−3−<annotation encoding="application / x-tex">[(2R,5S)-4-(2-\{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl\}-3-< / annotation>< / semantics>< / com:Math> (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazin-1-yl]propan-1-one (965); 2-[(cyclopropylmethyl)(methyl)amino]-1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]ethan-1-one (966); 1-[4-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)piperazin-1-yl]-2-[methyl(oxetan-3-yl)amino]ethan-1-one (967); 2-(cyclopropylamino)- 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)piperazin-1-yl]ethan-1-one (968); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]-2-[(2- hydroxyethyl)(methyl)amino]ethan-1-one (969); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]-2- (ethylamino)ethan-1-one (970); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]-2-[4-(hydroxymethyl)piperidin- 1-yl]ethan-1-one (971); 9-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2- yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-oxa-7,9-diazabicyclo[3.3.1]nonane (972); 3-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 3,8-diazabicyclo[3.2.1]octane (973); (1R,5S)-3-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,9- diazabicyclo[3.3.1]nonane (974); (3S)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}- 3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-(2-methylpropyl)piperazine (975); (3R,5S)- 1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-3,5-dimethylpiperazine (976); 1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,3-dimethylpiperazine (977); 6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-3,6-diazabicyclo[3.1.1]heptane (978); (1R,5S)-8-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,8- diazabicyclo[3.2.1]octane (979); (1R,4R)-2-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-diazabicyclo[2.2.2]octane (980); (1R,4R)-2-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2,5-diazabicyclo[2.2.1]heptane (981); 4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-4,7- diazaspiro[2.5]octane (982); (3S)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3-(propan-2-yl)piperazine (983); (1S,4S)-2-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-2,5-diazabicyclo[2.2.1]heptane (984); (1R,5S)-3-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-3,6- diazabicyclo[3.1.1]heptane (985); (2S)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-propylpiperazine (986); [(2S)-4-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)piperazin-2-yl]methanol (987); (2S)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-ethylpiperazine (988); (3S)-1-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 3-methylpiperazine (989); (2R,5S)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazine (990); (2S,5S)-1-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-2,5-dimethylpiperazine (991); (2S)-1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-(propan-2-yl)piperazine (992); <com:Math><semantics>(2R,5R)−1−(2−{7,8−dimethyl−[1,2,4]triazolo[1,5−a]pyridin−6−yl}−3−(propan−2−yl)−1H−<annotation encoding="application / x-tex">(2R,5R)-1-(2-\{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl\}-3-(propan-2-yl)-1H-< / annotation>< / semantics>< / com:Math> pyrrolo[3,2-b]pyridin-5-yl)-2,5-dimethylpiperazine (993); [(2S)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin- 2-yl]methanol (994); 1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)- 1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methylpiperidin-4-amine (995); 1-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-methyl- N-[(3-methyloxetan-3-yl)methyl]piperidin-4-amine (996); 2-{[1-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperidin- 4-yl](methyl)amino}-N,N-dimethylacetamide (997); 1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(2-methanesulfonylethyl)- N-methylpiperidin-4-amine (998); 1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-N-(propan-2-yl)azetidin-3-amine (999); 1-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-N-(2-methoxyethyl)azetidin-3-amine (1000); N1-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)ethane-1,2-diamine (1001); N- {2-[(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)amino]ethyl}-2-(dimethylamino)acetamide (1002); 2-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-6-(propan- 2-yl)-2,6-diazaspiro[3.3]heptane (1003); 1-[6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin- 6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6-diazaspiro[3.3]heptan-2-yl]-2- methylpropan-2-ol (1004); 3-[6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6-diazaspiro[3.3]heptan-2-yl]propanamide (1005); 1-[6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2,6-diazaspiro[3.3]heptan-2-yl]-3-(dimethylamino)propan-1-one (1006); 2-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-6-(3-methanesulfonylpropyl)-2,6-diazaspiro[3.3]heptane (1007); 2-[6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-2,6-diazaspiro[3.3]heptan-2-yl]acetonitrile (1008); 2-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-6-(2- methylpropyl)-2,6-diazaspiro[3.3]heptane (1009); 2-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-6-(2,2-dimethylpropyl)-2,6- diazaspiro[3.3]heptane (1010); 2-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-6-(oxetan-3-yl)-2,6-diazaspiro[3.3]heptane (1011); 2-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-6-(oxan-4-yl)-2,6-diazaspiro[3.3]heptane (1012); 2-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 6-(2-methoxyethyl)-2,6-diazaspiro[3.3]heptane (1013); 3-[6-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6- diazaspiro[3.3]heptan-2-yl]propanenitrile (1014); 2-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a|pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b|pyridin-5-yl)-6-propyl-2,6- diazaspiro[3.3]heptane (1015); 2-(2-{8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6-diazaspiro[3.3]heptane (1016); 2-(2-{8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 6-methyl-2,6-diazaspiro[3.3]heptane (1017); 2-ethyl-6-(2-{8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6-diazaspiro[3.3]heptane (1018); 2-(2-{8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)-6-propyl-2,6-diazaspiro[3.3]heptane (1019); 2-(2-{8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-6-(propan- 2-yl)-2,6-diazaspiro[3.3]heptane (1020); 1-[6-(2-{8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6- yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,6-diazaspiro[3.3]heptan-2-yl]-2- methylpropan-2-ol (1021); 6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan- 2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-methyl-2-azaspiro[3.3]heptane (1022); 6-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)- 2-(propan-2-yl)-2-azaspiro[3.3]heptane (1023); 6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-(oxan-4-yl)-2- azaspiro[3.3]heptane (1024); 6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-[(3-methyloxetan-3-yl)methyl]-2- azaspiro[3.3]heptane (1025); 6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-(2-methanesulfonylethyl)-2- azaspiro[3.3]heptane (1026); 1-[6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-azaspiro[3.3]heptan-2-yl]-2- (dimethylamino)ethan-1-one (1027); 1-[6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6- yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-azaspiro[3.3]heptan-2-yl]-2- methylpropan-2-ol (1028); 3-[6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2-azaspiro[3.3]heptan-2-yl]propanamide (1029); 6-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)-2-(3-methanesulfonylpropyl)-2-azaspiro[3.3]heptane (1030); 6-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-2-(2-methoxyethyl)-2-azaspiro[3.3]heptane (1031); 4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-1-[2- (dimethylamino)ethyl]piperazin-2-one (1032); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)piperazin-1-yl]-2-{2-oxa-6- azaspiro[3.3]heptan-6-yl}ethan-1-one (1033); 1-[(2R,5S)-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)-2,5- dimethylpiperazin-1-yl]-3-(methylamino)propan-1-one (1034); 1-(aminomethyl)-4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexan-1-ol (1035); 6-[4-(2-{1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl}-3-(propan-2- yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-2-oxa-6-azaspiro[3.3]heptane (1036); 6-[4-(2- {8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]-2-oxa-6-azaspiro[3.3]heptane (1037); N-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]-N-ethyloxetan-3-amine (1038); N-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-N-ethyloxetan-3- amine (1039); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-3,3-dimethylazetidine (1040); 1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]-3-methylazetidin-3-ol (1041); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-3- methoxyazetidine (1042); 4-{[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]amino}-1λ<com:Sup>6< / com:Sup>-thiane-1,1-dione (1043); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl]-3-methylazetidin-3-ol (1044); 1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]-3-methoxyazetidine (1045); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]azetidin-3-ol (1046); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H- pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-N,N-dimethylazetidine-3-carboxamide (1047); 4-(2- {7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin- 5-yl)-N-methyl-N-(propan-2-yl)cyclohexan-1-amine (1048); 1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]azetidin-3-ol (1049); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}- 3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-N,N-dimethylazetidine-3- carboxamide (1050); 1-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2- yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]azetidine (1051); 1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]-3,3-dimethylazetidine (1052); 6-((1s,4s)-4-(2-(7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl)-2- thia-6-azaspiro[3.3]heptane 2,2-dioxide (1053); N-tert-butyl-4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexan-1-amine (1054); 6-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-1-oxa-6-azaspiro[3.3]heptane (1055); N-tert-butyl-4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)- 1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexan-1-amine (1056); 6-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]-1-oxa-6-azaspiro[3.3]heptane (1057); 1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]-3-fluoropyrrolidine (1058); 7-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-2-oxa-7- azaspiro[4.4]nonane (1059); 6-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-2-oxa-6-azaspiro[3.4]octane (1060); 2-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl]-6-oxa-2-azaspiro[3.4]octane (1061); 1-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]-3-fluoropyrrolidine (1062); 6-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-2-oxa-6- azaspiro[3.4]octane (1063); 4-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]morpholine (1064); 2-[4-(2-{7,8- dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]-6-oxa-2-azaspiro[3.4]octane (1065); 7-[4-(2-{7,8-dimethyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-2-oxa-7- azaspiro[4.4]nonane (1066); 3-fluoro-1-[4-(2-{8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl}- 3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]pyrrolidine (1067); 6-[4-(2-{8- methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]-2-oxa-6-azaspiro[3.4]octane (1068); 2-[4-(2-{8-methoxy-[1,2,4]triazolo[1,5- a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-6-oxa-2- azaspiro[3.4]octane (1069); 2-[4-(2-{8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-6-oxa-2-azaspiro[3.4]octane (1070); 4-[4-(2-{8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl]morpholine (1071); 3-fluoro-1-[4-(2-{8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]pyrrolidine (1072); 6-[4-(2-{8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3- (propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5-yl)cyclohexyl]-2-oxa-6-azaspiro[3.4]octane (1073); 6-[4-(2-{8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2- b]pyridin-5-yl)cyclohexyl]-1-oxa-6-azaspiro[3.3]heptane (1074); 6-[4-(2-{8-methoxy- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]-1-oxa-6-azaspiro[3.3]heptane (1075); 6-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]-<com:Math><semantics>1λ6<annotation encoding="application / x-tex">1\lambda^6< / annotation>< / semantics>< / com:Math>-thia-6-azaspiro[3.3]heptane-1,1-dione (1076); 6-[4-(2-{7,8-dimethyl- [1,2,4]triazolo[1,5-a]pyridin-6-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexyl]-<com:Math><semantics>1λ6<annotation encoding="application / x-tex">1\lambda^6< / annotation>< / semantics>< / com:Math>-thia-6-azaspiro[3.3]heptane-1,1-dione (1077); or N-methyl-4-(2-<com:Math><semantics>{7−1}<annotation encoding="application / x-tex">\{7-1\}< / annotation>< / semantics>< / com:Math> methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl}-3-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridin-5- yl)cyclohexan-1-amine (1078).
10. A compound according to claim 1 or a salt thereof, wherein the compound is: [Image disponible dans le document PDF, Image available in the PDF document] 11. A compound according to claim 1 or a salt thereof, wherein the compound is: [Image disponible dans le document PDF, Image available in the PDF document] 12. A pharmaceutical composition comprising a compound according to any one of claims 1- 11 or a pharmaceutically-acceptable salt thereof; and a pharmaceutically acceptable carrier.
13. A compound according to any one of claims 1-11 or a pharmaceutically-acceptable salt thereof, for treating autoimmune disease or chronic inflammatory disease.
14. A compound according to any one of claims 1-11 or a pharmaceutically-acceptable salt thereof, for use in the manufacture of a medicament for treatment of autoimmune disease or chronic inflammatory disease.
15. The compound according to claim 13 or 14 or a pharmaceutically-acceptable salt thereof, wherein said autoimmune disease or chronic inflammatory disease is systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis (MS), or Sjögren's syndrome.
16. Use of a compound according to any one of claims 1-11 or a pharmaceutically-acceptable salt thereof, for treating autoimmune disease or chronic inflammatory disease.
17. Use of a compound according to any one of claims 1-11 or a pharmaceutically-acceptable salt thereof, in the manufacture of a medicament for treatment of autoimmune disease or chronic inflammatory disease.
18. The use according to claim 16 or 17, wherein said autoimmune disease or chronic inflammatory disease is systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis (MS), or Sjögren's syndrome.
